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ABSTRACT OF DISSERTATION

DETECTION OF ANTIBODIES AGAINST PARASCARIS EQUORUM EXCRETORY-SECRETORY
ANTIGENS
Parascaris equorum is a nematode parasite that infects young horses, sometimes
causing unthriftiness, respiratory signs, or intestinal impaction in severe cases. Infection
can be diagnosed by detection of eggs in feces, but this is only possible after the worms
are fully mature. The goal of this study was to develop an antibody-based test for
prepatent diagnosis of P. equorum infection. To produce western blot (WB) antigen, P.
equorum larvae were cultured for collection of excretory-secretory antigens (ESA). Sera
from 18 pregnant broodmares, their subsequent foals, and a group of 12 older mares
and geldings were analyzed. In order to check for cross-reactivity between P. equorum
and other ascarid species and equine parasites, additional sera were analyzed. Sera
from a horse with monospecific P. equorum infection was compared to horses with
monospecific Strongyloides westeri or cyathostome infections, rabbits inoculated with
Baylisascaris procyonis or Toxocara canis eggs, dogs naturally infected with T. canis, and
rabbits immunized with B. procyonis or P. equorum ESA. Molecular weights of silverstained P. equorum larval ESA ranged between 12 to 94 kDa. In WB analysis, sera from
94% of broodmares contained IgG(T) antibody that recognized multiple P. equorum
larval ESA. Foals showed no IgG(T) antibodies pre-suckle, but antibodies similar to their
dams were observed post-suckle and thereafter. Of the older mares and geldings, 58%
had IgG(T) antibodies recognizing larval ESA. Serum IgG(T) antibodies against P.
equorum larval ESA were also found in parasite-free and monospecific infection equine
sera. Ascarid positive foals did not produce detectable amounts of IgE or IgM antibodies
against larval ESA. When P. equorum, T. canis, and B. procyonis antibody reactivity was
compared, antigens at 19 kDa and 34 kDa had the highest potential for identification of
larval P. equorum infections. When immature adult P. equorum ESA was examined,
IgG(T) antibody recognition was demonstrated in 50% of broodmares and 17% of the
older horses, and appeared several weeks prior to patency in foal serum. Results
indicate that IgG(T) antibodies against P. equorum ESA are common in mature horses,
and are transferred from mare to foal, limiting the diagnostic potential of an antibodybased test.

KEYWORDS: Parascaris equorum, horse, western blot, diagnosis, antibody

Steffanie V. Burk
August 2013

DETECTION OF ANTIBODIES AGAINST PARASCARIS EQUORUM EXCRETORY-SECRETORY
ANTIGENS

By
Steffanie Valentine Burk

Dr. Mary G. Rossano
Co-Director of Dissertation
Dr. Eric Vanzant
Co-Director of Dissertation
Dr. David Harmon
Director of Graduate Studies
August 2013

This dissertation is dedicated to the memory of my grandparents:
Dorothy and Sam Burk
Florence and Paul Dresser

ACKNOWLEDGEMENTS
The completion of this project would not have been possible without the efforts
of many different individuals. I would like to thank all of you for your contributions to
my research.
Firstly, I express my utmost gratitude to Dr. Mary Rossano for her mentoring and
support during my time at the University of Kentucky. I appreciate your optimism and
confidence in me, especially when my larvae were not hatching! I would also like to
thank all of my committee members: Dr. Craig Carter, Dr. Robert Harmon, Dr. Dan
Howe, and Dr. Eric Vanzant, for your wisdom and assistance. I also thank Dr. Martin
Nielsen for serving as my external examiner.
I am grateful to those who were willing to share their technical and scientific
knowledge. I thank Tammy Brewster-Barnes for her laboratory expertise, and for her
humor in the lab. I would like to thank Dr. Sriveny Dangoudoubiyam for her patience
and willingness to help with larval culture procedures. I thank Dr. Eugene Lyons and Dr.
Martin Nielsen for sharing their extensive knowledge of parasitology. I express thanks to
Jess Gould and Lyn Ennis for introducing me to parasitology laboratory techniques. I
would also like to thank Dr. Noel Inocencio, Susan Hayes, Dr. Ulla Vestergaard Andersen,
and Dr. Craig Reinemeyer for their technical expertise.
I am tremendously appreciative of the individuals who assisted with specimen
collection. Dr. Uneeda Bryant did an exceptional job with coordinating specimen
collection at the Veterinary Diagnostic Lab. Stacy White, Dr. Chris Christensen and the
iii

Critter Control staff, Dr. Liz Ubelhor and the Lexington Humane Society staff, and Dr. Bill
Silvia and Hugo Hamilton were integral for collection of roundworms from raccoons or
dogs. I also thank Dr. Martin Nielsen and Dr. Eugene Lyons for their willingness to share
equine roundworm specimens.
This project would not have been possible without the expertise and
cooperation of the Maine Chance Farm staff. Bryan Cassill, Frank Berry, Kristin Fox, and
Laura Strasinger were extremely helpful throughout the year when equine samples
were collected. I appreciate the contributions that the Maine Chance mares and foals
made to this research. I would also like to thank Courtney Gramlich and Dr. Rob Kissick
for providing additional equine samples.
I am grateful to Dr. Kathryn Coyle, Dr. Dan Howe, Dr. Laurie Lawrence, Dr. James
Matthews and Kwangwon Son, Dr. Melissa Newman and Kabby Akers, Dr. Bill Silvia, Dr.
Surendrenath Suman, and Dr. Kristine Urschel for equipment use during this project.
I thank Dr. Robert Harmon of the Department of Animal and Food Science and
Dr. Nancy Cox of the College of Agriculture at the University of Kentucky for their
financial contributions to this project.
Finally, I would like to thank my friends and family for standing by me during this
journey. I appreciate my fellow graduate students, including my roommate, Megan Van
Benschoten, who have provided friendship and moral support. I thank my parents for
their support and encouragement in beginning this endeavor. I also thank Adam Judd
for his patience, support, and his willingness to cook dinner nearly every night.

iv

TABLE OF CONTENTS
DETECTION OF ANTIBODIES AGAINST PARASCARIS EQUORUM EXCRETORY-SECRETORY
ANTIGENS ........................................................................................................................................ iii
ABSTRACT OF DISSERTATION .......................................................................................................... iv
ACKNOWLEDGEMENTS ................................................................................................................... iii
LIST OF TABLES ................................................................................................................................ ix
LIST OF FIGURES ............................................................................................................................... x
ABBREVIATIONS ............................................................................................................................. xii
CHAPTER 1: INTRODUCTION ............................................................................................................ 1
CHAPTER 2: STUDY RATIONALE, HYPOTHESIS, AND OBJECTIVES .................................................... 4
Hypothesis ................................................................................................................................... 5
Goal and Objectives ..................................................................................................................... 5
CHAPTER 3: REVIEW OF THE LITERATURE ....................................................................................... 7
Life cycle....................................................................................................................................... 7
Biology.......................................................................................................................................... 9
Chromosomal Makeup............................................................................................................. 9
Reproduction ......................................................................................................................... 10
Body Structure and Locomotion ............................................................................................ 12
Feeding................................................................................................................................... 13
Excretion/Secretion ............................................................................................................... 14
Behavior ................................................................................................................................. 15
Pathology and Clinical Signs ....................................................................................................... 16
Diagnosis .................................................................................................................................... 20
Epidemiology ............................................................................................................................. 26
Prevention.................................................................................................................................. 31
Treatment .................................................................................................................................. 34
Immunoglobulin Types and Levels in the Young Horse ............................................................. 39
The Immune Response to P. equorum and other Parasites ...................................................... 45
Immunological Diagnostics for Ascarid Infections ..................................................................... 50

v

CHAPTER 4: IN VITRO CULTURE OF PARASCARIS EQUORUM AND PRELIMINARY INVESTIGATION
OF LARVAL EXCRETORY-SECRETORY ANTIGENS ............................................................................ 54
Introduction ............................................................................................................................... 54
Materials and Methods.............................................................................................................. 56
Parasite Egg Collection ........................................................................................................... 57
Larval ESA Collection .............................................................................................................. 58
Immature Adult P. equorum ESA Collection .......................................................................... 60
Sera Collection ....................................................................................................................... 61
Gel Electrophoresis and Silver Staining ................................................................................. 63
Gel Electrophoresis and Western Blotting............................................................................. 63
Statistical Analysis .................................................................................................................. 65
Results ........................................................................................................................................ 66
Specimen Collection............................................................................................................... 66
Larval Culture ......................................................................................................................... 66
SDS-PAGE ............................................................................................................................... 67
Western Blotting .................................................................................................................... 68
Discussion .................................................................................................................................. 69
Larval Culture ......................................................................................................................... 69
SDS-PAGE ............................................................................................................................... 72
Western Blotting .................................................................................................................... 73
Specimen Collection............................................................................................................... 75
Conclusion.................................................................................................................................. 76
CHAPTER 5: ANTIBODY RESPONSE OF HORSES TO PARASCARIS EQUORUM EXCRETORYSECRETORY ANTIGENS ................................................................................................................... 89
Introduction ............................................................................................................................... 89
Materials and Methods.............................................................................................................. 91
Antigen Collection .................................................................................................................. 92
Animals and Housing.............................................................................................................. 92
Sera and Fecal Collection Procedures .................................................................................... 93
Sera and Fecal Collection Schedule ....................................................................................... 94
Western Blotting .................................................................................................................... 96
Results ........................................................................................................................................ 99
vi

IgE, IgM, and IgG(T) Antibodies ............................................................................................. 99
MCF Mare and Foal Fecal Flotation Tests .............................................................................. 99
MCF Mare Sera and Foal Sera over Time ............................................................................. 100
Parasite-Free and Monospecific Infection Sera ................................................................... 101
Discussion ................................................................................................................................ 102
IgE, IgM, and IgG(T) Antibodies ........................................................................................... 102
MCF Mare and Foal Fecal Flotation Tests ............................................................................ 104
MCF Mare Sera and Foal Sera over Time ............................................................................. 106
Parasite-Free and Monospecific Infection Sera ................................................................... 109
Conclusion................................................................................................................................ 110
CHAPTER 6: SERUM IgG(T) RESPONSES TO L2/L3 AND L5 PARASCARIS EQUORUM ANTIGENS BY
HORSES IN LOW AND HIGH RISK ENVIRONMENTS ...................................................................... 125
Introduction ............................................................................................................................. 125
Materials and Methods............................................................................................................ 127
Antigen Collection ................................................................................................................ 127
Animals and Housing............................................................................................................ 127
Sera and Fecal Collection ..................................................................................................... 129
Western Blot Analyses ......................................................................................................... 130
Statistical Analyses ............................................................................................................... 130
Results ...................................................................................................................................... 131
Copromicroscopic Results .................................................................................................... 131
Older Horse IgG(T) Recognition of L2/L3 ESA ...................................................................... 131
Foal, Broodmare, and Older Horse Recognition of L5 ESA .................................................. 132
Discussion ................................................................................................................................ 133
Older Horse IgG(T) Recognition of L2/L3 ESA ...................................................................... 133
Foal, Broodmare, and Older Horse Recognition of L5 ESA .................................................. 134
Conclusion................................................................................................................................ 136
CHAPTER 7: CONCLUSIONS AND IMPLICATIONS ......................................................................... 142
APPENDIX A:................................................................................................................................. 146
APPENDIX B: LABORATORY PROTOCOLS ..................................................................................... 147
Ascarid Dissection Protocol ..................................................................................................... 147
Ascarid Hatching Protocol........................................................................................................ 150
vii

Excretory-Secretory Protein Collection Protocol ..................................................................... 156
Protein Concentration Estimation ........................................................................................... 159
Fecal Flotation Protocol ........................................................................................................... 162
Modified Stoll Fecal Egg Count Protocol.................................................................................. 164
Polyacrylamide Gel Casting Protocol ....................................................................................... 165
Polyacrylamide Gradient Gel Casting Protocol ........................................................................ 170
Running an SDS-PAGE Gel Protocol ......................................................................................... 174
Western Blotting Protocol ....................................................................................................... 178
Literature Cited ............................................................................................................................ 188
VITA .............................................................................................................................................. 208

viii

LIST OF TABLES
Table 4.1. Mean and standard deviation of P. equorum larval mortality percentage by
type of protease inhibitor cocktail.....………………………………………………………….……………….77
Table 4.2. Mean and standard deviation of lengths and widths of P. equorum and B.
procyonis larvae (µm)……………………………………………………………………………………………….….78
Table 4.3. Number of animals exhibiting antibodies to P. equorum ESA……………………….79
Table 5.1. Percentage of foals and percentage of fecal flotation tests positive for
different parasite types over the course of the study…………………………………………………111
Table 5.2. Percentage of mares and foals with IgG(T) antibodies recognizing
immunodominant P. equorum larval antigens………………………………………………..………….112
Table 6.1. Older horse data………………………………………………………………………………………..137

ix

LIST OF FIGURES
Figure 3.1. Life cycle of P. equorum………………………………………………………………………………52
Figure 4.1. Eggs of B. procyonis, T. canis, and P. equorum………………………………………….…80
Figure 4.2. Cuticle shedding of P. equorum larvae, day 21 in culture………………………….…81
Figure 4.3. Cuticle shedding of B. procyonis larva, day 14 in culture…………………………....82
Figure 4.4. Silver-stained P. equorum and B. procyonis ESA on a 4-20% gradient gel.…..83
Figure 4.5. Western blot of larval P. equorum ESA recognized by P. equorum naturally
infected equine IgG(T) and P. equorum ESA immunized rabbit IgG ………………………………84
Figure 4.6. Western blot of larval P. equorum ESA recognized by P. equorum naturally
infected equine IgG(T), B. procyonis or T. canis inoculated rabbit IgG, and T. canis
naturally infected canine IgG………………………………………………………………...................……..85
Figure 4.7. Western blot of larval B. procyonis ESA recognized by P. equorum naturally
infected equine IgG(T) and P. equorum or B. procyonis immunized rabbit IgG. ……………86
Figure 4.8. Western blot of larval B. procyonis ESA recognized by naturally infected
equine IgG(T), inoculated rabbit IgG, and naturally infected canine IgG……………….………87
Figure 5.1. Western blot of VSF2, Mare4, and earliest Foal4 samples with IgM
recognition of larval P. equorum ESA………………………………………………………………………….113
Figure 5.2. Number of MCF foals that have begun shedding P. equorum eggs by age in
weeks………………………………………………………………………………………………………………………...114
Figure 5.3. The number of MCF foals remaining on the trial by age…………………………...115
Figure 5.4. Western blot of earliest Foal3 samples with IgG(T) recognition of larval P.
equorum ESA………………………………………………………………………………………………………………116
Figure 5.5. Western blot of earliest Foal4 samples with IgG(T) recognition of larval P.
equorum ESA………………………………………………………………………………………………………………117
Figure 5.6. Western blot of latest Foal3 and Foal4 samples with IgG(T) recognition of
larval P. equorum ESA…………………………………………………………………………………………………118

x

Figure 5.7. Western blot of earliest Foal13 samples with IgG(T) recognition of larval P.
equorum ESA……………………………………………………………………………………………………………..119
Figure 5.8. Western blot of last Foal13 samples with IgG(T) recognition of larval P.
equorum ESA………………………………………………………………………………………………………………120
Figure 5.9. Western blot of earliest Foal1 samples with IgG(T) recognition of larval P.
equorum ESA………………………………………………………………………………………………………………121
Figure 5.10. Western blot of last Foal1 samples with IgG(T) recognition of larval P.
equorum ESA………………………………………………………………………………………………………………122
Figure 5.11. Western blot of monospecific or parasite-free control IgG(T) antibody
recognition of larval P. equorum ESA………………………………………………………………………….123
Figure 6.1. Western blot of older horse IgG(T) antibody recognition of P. equorum larval
ESA………………………………………………………………………………………………………………………..…..138
Figure 6.2. Western blot of IgG(T) antibody recognition of P. equorum immature adult
ESA by foals with patent infections…………………………………………………………………………….139
Figure 6.3. Western blot of Foal4 IgG(T) antibody recognition of P. equorum immature
adult ESA over time…………………………………………………………………………………………………….140

xi

ABBREVIATIONS
EPG- Eggs per gram
ESA- Excretory-secretory antigens
ELISA- Enzyme-linked immunosorbent assay
FEC- Fecal egg count
FECRT- Fecal egg count reduction test
(H+L)- Heavy and light immunoglobulin chains
HRP- Horseradish peroxidase
IgE- Immunoglobulin E
IgG- Immunoglobulin G
IgG(T)- Combination of equine IgG isotypes IgG3 and IgG5
IgM- Immunoglobulin M
L1- First stage, larva
L2- Second stage, larva
L3- Third stage, larva
L4- Fourth stage, larva
L5- Fifth stage, immature adult
xii

MCF- Maine Chance Farm
MW- Molecular weight
MWCO- Molecular weight cut off
PIC- Protease inhibitor cocktail
PVDF- Polyvinylidene difluoride
SD- Standard deviation
TBST- Tris buffered saline with Tween 20
VSF- Veterinary Science farm
WB- Western blot

Parasite Scientific Names
Ascaris lumbricoides- Human ascarid
Ascaris suum- Swine ascarid
Baylisascaris procyonis- Raccoon ascarid
Parascaris equorum- Equine ascarid
Strongyloides westeri- Equine threadworm
Toxocara canis- Dog ascarid
xiii

Toxocara cati- Cat ascarid
Toxascaris leonina- Ascarid found in cats, dogs, and foxes
Toxocara vitulorum- Cattle and buffalo ascarid

xiv

CHAPTER 1: INTRODUCTION
Parascaris equorum is a parasitic roundworm commonly found in young horses.
This parasite was formerly known as Ascaris megalocephala, and was studied as early as
1883, when Edouard Van Beneden used eggs of the species to first describe the heredity
of chromosomes through meiosis [1]. Parascaris equorum is a member of the phylum
Nematoda, a diverse group of terrestrial and marine roundworms. One review
estimated the number of nematode species to range between 100,000 to 100 million
[2]. Along with P. equorum, many other parasites in the order Ascaridida are hostspecific, especially those that parasitize mammals.
Parascaris equorum has a wide geographical range, and has been found in North
America [3, 4], South America [5], Europe [6, 7], Africa [8], Asia [9, 10], and Australia
[11]. In addition to horses, P. equorum infects other equids, including zebras [12],
Przewalski’s horses [12], donkeys [8, 10], and mules [10]. The parasite typically infects
younger equids, with foals and yearlings more likely to have patent infections than
animals two years of age or older [7, 11]. Mature horses appear to develop immunity to
P. equorum, and efforts to induce patent egg shedding in adult horses have been
unsuccessful [13, 14].
The life cycle of P. equorum begins when an infected equid sheds eggs in the
feces. A single foal can contaminate the environment with a large number of eggs. One
foal with an artificial infection was found to shed up to 50 million eggs per day [15].
After an equid ingests infective eggs, larvae hatch and migrate from the small intestine
1

to the liver, then to the lungs, and finally back to the small intestine via the tracheoeosophageal route [15]. The worms mature and reproduce in the small intestine, thus
beginning the life cycle again. Pathogenicity may occur at several points during the life
cycle. Larval migration can cause lesions in the liver, lungs, and bronchial and hepatic
lymph nodes [16]. During larval migration, equids may display clinical signs such as
coughing and nasal discharge [17]. As infection progresses, other clinical signs include
depression, anorexia, weight loss [17]. Large ascarid burdens in the small intestine can
lead to intestinal impaction and colic, or even intestinal rupture [18-20]. Because of the
damage caused by heavy ascarid infections, prevention and control are of paramount
importance, particularly in young horses that have not yet developed an adequate
immune response.
The eggs of P. equorum are very durable, and can remain viable for years [21,
22]. The eggs have a proteinaceous outer coating [23], allowing them to affix to objects
and spread passively. However, there are several methods to control the eggs
environmentally. Eggs can become unviable at very high temperatures [24, 25], as is
found when composting manure [26]. Removal of manure from stalls and pasture also
helps to decrease prevalence of ascarid eggs [7]. More often, owners focus on the use of
anthelmintics to treat ascarid infections [7].
There are several anthelmintics currently on the market that are used to treat P.
equorum infections. With the rise of cyathostome resistance to several anthelmintic
classes, parasite resistance is becoming a major concern. Benzimidazole compounds,
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including fenbendazole and oxibendazole, are effective in treating ascarid infections at a
dosage of 10 mg/kg body weight [27]. One case study reported possible resistance to
fenbendazole in a miniature horse [28], and veterinarians have suggested that
resistance may exist in Kentucky [29], but there have been no published reports of
resistance to this class of drug. Tetrahydropyrimidines, including pyrantel tartrate and
pyrantel pamoate, are also used to treat P. equorum infections. There are multiple
reports of P. equorum resistance to tetrahydrophyrimidines in North America [30-32].
Resistance of P. equorum to the macrocyclic lactones (ivermectin and moxidectin) is well
documented in North America and Europe [30, 32-36]. Concern over drug-resistant
ascarid populations increases the importance of prevention and timely diagnosis.
Methods for P. equorum diagnosis include microscopic examination for helminth
eggs in feces (copromicroscopic techniques) and necropsy. Occasionally infection can be
diagnosed by the presence of an adult worm in the feces, typically after treatment with
anthelmintics, or as the horse develops immunity. For horse owners, copromicroscopic
examination is currently best method for diagnosis. There are several methods that can
be used to check for infection, including the fecal egg count (FEC) or the qualitative fecal
flotation. The FEC provides a quantitative measure of infection by calculation of the eggs
per gram (EPG) in feces, and performs well at identifying positive horses [37]. However,
there are several issues with copromicroscopic methods that could be mitigated by the
development of new diagnostic tools.
Copyright © Steffanie Valentine Burk 2013
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CHAPTER 2: STUDY RATIONALE, HYPOTHESIS, AND OBJECTIVES
The development of additional diagnostic tools could allow for detection of
parasites earlier in the infection process. Infection cannot be diagnosed using
copromicroscopic methods until the life cycle of the ascarid is completed and female
worms begin reproducing. As clinical respiratory signs typically occur during the
migratory stage, diagnosis occurs after clinical symptoms are observed. Additionally,
copromicroscopic methods rely on the presence of reproductively active adult female
worms, and do not detect the presence of migratory larvae, immature adults, or mature
adult male parasites. The EPG is not correlated with actual worm burden in the small
intestine [37]. Although the FEC has high specificity and positive predictive value, a
negative result on the test does not conclusively indicate that the horse is uninfected
[37]. The development of new diagnostic tools could target diagnosis at earlier stages of
ascarid infection, and attempt to increase sensitivity and negative predictive value. This
could be useful for research and clinical purposes.
Furthermore, the immune response of equines to ascarids has not been studied
in great detail. The timing of the appearance of P. equorum antibodies that recognize P.
equorum larval ESA is currently unknown. This project will study the value of a
serological test for P. equorum, test adult horses for the presence of antibody, and
identify when antibodies to P. equorum larval ESA first appear in foal sera.

4

Hypothesis
Ha: Excretory-secretory proteins produced by P. equorum contain at least one antigen
that can be used for serological diagnosis of infection in horses.
Goal and Objectives
Goal: Develop a western blot test specific for P. equorum larval ES antigens.
Chapter 4 Objectives
1. Hatch and maintain P. equorum and Baylisascaris procyonis in culture for
collection of ESA.
2. Compare ESA produced by B. procyonis and P. equorum using SDS-PAGE and
silver stain.
3. Identify IgG or IgG(T) recognition of P. equorum ESA through western blot
analyses using sera from animals with P. equorum, B. procyonis, or Toxocara
canis inoculations, immunizations, or natural infections.

5

Chapter 5 Objectives
1. Compare IgG(T), IgE, and IgM antibody recognition of larval P. equorum
ESA using sera from infected horses.
2. Test the sera from a cohort of broodmares and their foals from birth
until a period of no egg shedding.
3. Examine equine controls with monospecific parasite infections to identify
possible cross-reactivity.
Chapter 6 Objectives
1. Compare IgG(T) recognition of larval P. equorum ESA by a group of lowexposure horses with previous results from a group of high P. equorum
exposure horses.
2. Compare IgG(T) recognition of adult P. equorum ESA by sera from
broodmares, older horses, and foals shedding ascarid eggs.

Copyright © Steffanie Valentine Burk 2013
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CHAPTER 3: REVIEW OF THE LITERATURE
Life cycle
Infection with P. equorum begins when a foal ingests larvated eggs from the
environment [38]. Infection with some ascarid species, such as Toxocara canis (the
canine ascarid) and Toxocara cati (the feline ascarid), begins when larvae are
transmitted to the offspring through the mother’s milk [39, 40]. Toxocara canis can also
be transmitted through the placenta [41]. Additionally Strongyloides westeri, the equine
threadworm, arrests in the mare’s tissue and then passes to the foal through the milk
[42]. However, it does not appear that P. equorum is transmitted from mare to foal
through the milk, as attempts to recover larvae from colostrum or milk have been
unsuccessful [38].
The life cycle of P. equorum begins when fertilized eggs are released by adult
female worms in the horse’s small intestine (Figure 3.1). The eggs then pass through the
rest of the gastrointestinal tract and are released to the environment in the horse’s
feces. Within the egg, embryos become vermiform and molt once, going from a first
stage larva (L1) to a second stage larva (L2) [23]. At optimum temperatures of 25-37 ˚C,
eggs passed in feces require 10 days to become infective L2 [23, 38]. At 15 ˚C,
embryonation occurs more slowly, and at 0 ˚C, eggs will not embryonate but will remain
viable indefinitely [23]. Eggs have been shown to embryonate in 10-19 days in
laboratory conditions when obtained directly from female worms [17, 25]. The period
during which eggs are in the environment is the only free-living phase of the life cycle.
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Once eggs are ingested by an appropriate host, the parasitic phase of the life
cycle begins. Although P. equorum larvae have been shown to hatch and migrate
through the liver and lungs in guinea pigs and mice, the larvae are not able to return to
the small intestine and reach maturity [43]. Thus, it appears that the complete P.
equorum life cycle is only possible in the equine.
In the horse, larvated eggs appear to hatch in the stomach or small intestine and
penetrate the wall of the jejunum, as larvae have been found in the villi of the jejunum
24 hours post-infection [16]. The larvae then migrate to the liver through the lymph and
blood vessels [16]. Larvae have been found in the mesenteric lymph nodes 24 hours
post-infection [16]. After 7 days post-infection, the majority of larvae can be found in
the liver [15]. In P. equorum, it appears that the molt from L2 to third stage larvae (L3)
may occur before larvae reach the liver, although this has not been confirmed with
multiple larvae [15]. Research with Ascaris suum (swine ascarid) indicates that the
second molt is initiated within the egg, prior to hatching [44, 45]. The time of
completion of the second molt varied from within the egg to the time at which larvae
reached the liver [45]. By day 14, most P. equorum larvae have migrated to the
pulmonary parenchyma and airways of the lungs [15, 46]. On day 16, some larvae have
traveled to the lymph follicles of the lungs [16]. Between 17 and 23 days after infection,
some larvae remain in the pulmonary parenchyma of the lungs, but the majority of
larvae had migrated up the trachea, where they have been coughed up, swallowed, and
migrate back to the small intestine [15, 16, 46]. Shortly after returning to the small
intestine, larvae undergo another molt, from L3 to fourth stage (L4) larvae. [15]. The
8

final molt from L4 to immature adult (L5) must then occur in the small intestine. The
worms mature in the duodenum and proximal jejunum, and complete the life cycle by
reproducing 10-15 weeks post-infection [15, 17, 46, 47]. Earlier appearance of eggs in
foal feces may be due to coprophagy [48].
Infected animals can shed large quantities of eggs that could infect future
generations of foals. An individual female Ascaris lumbricoides (the human ascarid) can
shed up to 200,000 eggs per day [49]. Egg-shedding estimates for one foal with an
artificial P. equorum infection reached a maximum of 50 million eggs per day [15]. Once
the eggs become infective and are ingested by another animal, the life cycle begins
again.
Biology
Chromosomal Makeup
Genetic research has led to some debate over the number of ascarid species
infecting equines. Chromosomal investigations suggest that there are two distinct
species: P. equorum and Parascaris univalens. The diploid genome of P. equorum has 4
chromosomes, while P. univalens has 2 chromosomes (and therefore only one pair of
chromosomes) [50]. It has been proposed that P.equorum and P. univalens can
interbreed, with sterility in the resulting offspring [50]. Evidence of hybridization has
been noted in other parasite species, including A. suum and A. lumbricoides [51], leading
to some debate over whether they are even two separate species [52].
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Additional study is needed to determine the geographic range and prevalence of
P. univalens. One group of researchers using DNA fingerprinting found low genetic
diversity among ascarids in equids from the US (Kentucky), Sweden, Norway, Iceland,
Germany, and Brazil; although genetic differences in one Norwegian sample were
explained by the possibility of P. univalens infection [53]. The prevalence of P. univalens
has not been well characterized and the majority of published research refers to P.
equorum without regard to chromosomal examination. Thus, the nomenclature P.
equorum will be used here to refer to ascarids found in equids.
Reproduction
With a mean body size of 370 mm2, P. equorum is one of the largest parasitic
nematodes [54]. Like most nematodes, P. equorum is dioecious and sexually dimorphic.
Mature females are typically larger than males, and can grow to over 25 cm in length.
Males can also be distinguished from females by their curved tail [55]. Internally, male
P. equorum have a long, coiled reproductive system, consisting of the testis, seminal
vesicle, and vas deferens [56]. The copulatory spicules are located within the cloaca of
the male worm, and are used to fertilize female oocytes through the discharge of round,
amoeboid-type sperm [56]. The female worm has two long ovaries that extend to
oviducts and then connect to uteri. The uteri meet at the vagina, which leads to the
vulva, or genital pore, about a third of the way from the anterior end of the worm [56].
Immediately after fertilization occurs in the uteri, the innermost layers of the egg shell
begin to form [56]. As fertilized eggs progress down the uterus, they gain a sticky,
proteinaceous outer coat from the uterine secretions [23]. The eggs are then passed
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through the vulva into the digesta of the small intestine of the equid. Eggs are clear in
color within the uteri, but once passed in the feces, they gain a brown coloration.
Parascaris equorum eggs are spherical and approximately 90-100 µm in diameter
[57]. In general, ascarid eggs have four layers; (1) an inner lipid layer, (2) a tough
chitinous layer 3 to 4 microns thick [58], (3) a vitelline layer, and (4) a mammilated
mucopolysaccharide/protein uterine layer [56, 59]. The chitinous layer is the thickest
portion of the shell, and functions to provide strength [59]. The protein coat presents a
sticky surface that allows the eggs to attach to objects and enhance spread and
transmission. The shell has been shown to provide protection against harmful solutions,
including formalin, sulfuric acid, and hydrochloric acid [23]. However, there is some
permeability of the shell. Ascarid eggs exposed to low humidity can slowly lose water
[59], and embryonation of eggs is an aerobic process, requiring permeability of the shell
to oxygen and carbon dioxide [23]. Permeability of the shell increases at higher
temperatures [59].
The resistant shell allows P. equorum eggs to remain viable for long periods of
time in the environment. In order to maximize chances of successfully infecting a host,
ascarid eggs do not hatch in the environment. Instead, they are prompted to hatch by
conditions of the gastrointestinal tract. These conditions experimentally determined
with A. lumbricoides include temperature of 37 ˚C, neutral pH, and the presence of
carbon dioxide [60]. Upon hatching of A. lumbricoides or A. suum, there is an increase in
the permeability of the lipid layer of the shell [61]. Trehalose from the perivitelline fluid
within the egg begins to leak out, reducing osmotic pressure and promoting increased
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movement of the larvae [60, 61]. It is also thought that enzymes may play a role in the
process, as proteases [62] and chitinases [63] have been identified in hatching fluid. It
has also been hypothesized that the operculum-like region of A. suum eggs [64] may be
more vulnerable to enzymes [61], although P. equorum and B. procyonis eggs do not
appear to have this region [64]. Hatching of P. equorum does not appear to have been
studied or performed in-vitro, but it has been studied in other species. The final stage
described in the hatching of nematodes is eclosion, where a larva explores the egg,
presses against the shell with the cephalic region, and some non-ascarid species use
stylet thrusts to penetrate the shell [61].
Body Structure and Locomotion
The exterior of the ascarid is made of a durable 3-4 layered cuticle secreted by
the epidermis [65]. Ascarid cuticles have large transverse grooves called annulae, which
assist the body in flexing for locomotion [65]. The surface of the cuticle is made up
mostly of glycoproteins (proteins containing sugar chains) [65]. These surface
glyocoproteins appear to be shed readily by T. canis larvae, possibly to assist in evasion
of the host’s adaptive immune response [65]. Labeled lectins (proteins that bind to
carbohydrate groups) have been used to identify carbohydrates on the cuticle of larval
A. suum [66]. Larval stages (L2, L3, L4) differed in cuticular carbohydrates present [66].
These carbohydrates appeared to be a structural component of the surface of the
cuticle, as A. suum larvae did not appear to shed the carbohydrates at any time other
than molting [66]. In the deeper layers of the cuticle, the main components are
collagen-like proteins [65].
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The epidermis and the somatic muscle cells lie below the nematode cuticle. The
somatic muscles run longitudinally, and have dorsal and ventral halves that are
controlled by two separate nerve cords [67]. This allows for nematodes to swim by
undulating in sinusoid-type waves [68]. Nematodes are also pseudocoelomates, and
thus have a fluid-filled central cavity that supports the body by acting as a hydrostatic
skeleton [56], while also circulating fluid throughout the body [69].
Feeding
The anterior of P. equorum has a mouth with three prominent labia [55]. Each
labium is lined with tiny tooth-like projections called denticles [55]. The exact function
of the denticles is unknown, although in A. suum, they have been shown to wear over
time as the parasites age [70]. The mouth opens into the buccal cavity, leading to the
pharynx, intestine, rectum, and then the anus in the female or cloaca in the male [71].
Adult P. equorum are anaerobic and feed by swimming freely in the small intestine,
using pharyngeal muscles to pump host digesta through the mouth [23, 72]. The worms
do not appear to feed by absorption of nutrients through the cuticle, as efforts to view
cuticle absorption with labeled isotope or glucose have been unsuccessful [23]. The
ascarid intestine also appears capable of digestion without necessity for cuticular
absorption. Multiple digestive enzymes have been identified in the intestine of A.
lumbricoides [23], and the luminal surface of the intestine is lined in microvilli [72].
Parascaris equorum larvae do not begin feeding until they hatch in the small
intestine of the equid. The exact feeding mechanism of larvae during migration is
unknown [72]; however, larvae of other ascarid species, such as A. suum [73-75], A.
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lumbricoides [75], T. canis [76], B. procyonis [77], and Toxocara vitulorum (the cattle or
buffalo ascarid) [78], have been maintained in cell culture media for multiple weeks. In
A. suum, larvae were grown to maturity in vitro [79]. Thus, it appears that some, if not
all, nutritional requirements can be met using cell culture media.
Excretion/Secretion
The intestine of mature A. lumbricoides is emptied every 3 to 4 minutes,
although some digesta remains, probably for absorption through the microvilli [72].
Excretion in nematodes occurs through contraction and relaxation of body wall muscle
and intestinal muscle [72]. Ascarids also produce secretions, but difficulties in separating
and characterizing excretions and secretions has led to common use of the term
“excretory-secretory products” [69]. In other nematodes, enzyme secretions have been
shown to assist worms in migration by cleaving molecules in different cell types. For
example, hookworms have been shown to secrete hyaluronidase, which can cleave
hyaluronic acid, a major component of the epidermis [80]. Similarly, soybean cyst
nematodes have been shown to secrete enzymes that hydrolyse cellulose [81].
Secretions have also been shown to have a variety of immunomodulatory effects. Firstinstar cattle grub larvae produce a serine protease that can cleave bovine IgG [82]. A
cysteine protease inhibitor produced by filarial nematodes was shown to decrease T-cell
proliferation and upregulate production of interleukin-10 (IL-10), an anti-inflammatory
cytokine [83]. Many animal-parasitic nematodes secrete acetylcholinesterase [84],
which has been hypothesized to prevent worm expulsion by blocking processes of
innate immunity in the host’s intestine [85]. Other functions of ESA include modification
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of host cells and gene expression to improve feeding sites or provide a protective
environment [69].
Secreted factors of larval P. equorum have not been studied, but ESA have been
identified for larval A. suum. This parasite secretes serine proteases (chemotrypsin,
trypsin, and elastase) during L2, L3, and L4 stages [86], which could assist larvae during
migration through host tissue. Ascaris suum larvae appear to produce aminopeptidase
and cysteine proteases while molting from the L3 to L4 stage [87]. Excretory-secretory
antigens of larval T. canis have been well-characterized because of the zoonotic
potential of this species, and secreted lectins, mucins, and enzymes have been identified
[88]. A major glycoprotein ESA of larval T. canis, TES-120, is also the main component of
the surface of the cuticle [89, 90]. Shedding of this glycoprotein may play a role in
evasion of host immune response. Antibodies against T. canis larval ESA have been
shown to bind to the intact cuticle of larvae [91]. Lectins (C-type) have been identified in
larval T. canis ESA [92], including TES-70, which was shown to bind selectively to canine
cells [93]. Protease inhibitors from homogenized adult P. equorum have shown activity
against bovine trypsin and chymotrypsin, and one protease inhibitor demonstrated
activity against porcine elastase [94]. Extracts from mature A. suum and A. lumbricoides
were found to contain trypsin inhibitors, which may help them to survive in the host’s
gastrointestinal tract [95].
Behavior
Behavior of nematodes is controlled by the cranial ganglia (feeding) and perianal
ganglia (mating) [67]. Nematodes also have sense organs for detection of stimuli. Sense
15

organs include chemoreceptors, mechanoreceptors, thermoreceptors, and even
photoreceptors in some cases (mostly in marine nematodes) [96]. Nematodes can
communicate with one-another through secretion of pheromones. Most pheromone
work has been done using C. elegans, and these nematodes have been found to
communicate information about population density and mate-finding [69].
Pathology and Clinical Signs
Pathologies due to P. equorum can occur during different stages of the parasite’s
life cycle. A full day after artificial infection, many eosinophils and agranulocytes are
present in the jejunum of the small intestine, along with ascarid larvae [16]. Parascaris
equorum larvae do not seem to cause noticeable damage to the wall of the small
intestine; lesions in the small intestine have been described as rare [97].
While migrating through the liver, larvae are estimated to range in size from
0.580 to 0.963 mm long [15]. Migration of these larvae causes liver pathologies around
3-14 days after artificial infection [98, 99]. Petechial hemorrhages (small dark spots
caused by broken capillaries), edema, and scattered necrotic foci containing
mononuclear cells, neutrophils, and eosinophils are found at this time [16]. In one
study, necrotic foci were only found in older foals (6-12 months) inoculated with one
large (8,000 eggs) dose [99]. Necrotic foci have been proposed to be areas formed
around dead ascarid larvae [99], and dead larvae have been found in these areas [16].
Hematology results showed eosinophilia and leukopenia in foals 9 days post-inoculation
with 100,000 eggs [16], but eosinophilia appeared to be limited to foals receiving large
single doses or repeated low doses (50 eggs twice weekly) of eggs [100]. White lesions
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1-3 mm in diameter also appeared 7-30 days after inoculation [99]. These were more
common in animals inoculated with large (8,000 eggs) doses rather than small trickle
inoculations [99]. The hepatic lymph nodes were also enlarged [16] and there were
narrow tracts in the liver containing neutrophils, eosinophils, and macrophages [101].
By 16-23 days after infection, chronic necrotic lesions could still be found in the liver
[16], and by day 30, there were still fibrotic lesions present [99].
The migration of P. equorum through the lungs produces pathologies and clinical
signs of respiratory disease. During the lung migratory phase, young foals (those less
than 6 months of age) display respiratory signs such as coughing, frothy white mucus in
the trachea, and thick nasal discharge [38]. Yearlings naïve to P. equorum develop more
severe respiratory symptoms upon first infection, such as frequent coughing,
depression, and increased density of the lobes of the lungs as seen via radiographs [38].
Yearlings also exhibited anorexia, depression, and weight loss at this time, unlike the
younger foals [17]. The severe respiratory illness displayed by these animals between
days 16-23 indicates that they were more intensely affected during larval migration
through the lungs. While migrating through the lungs, larvae range in size from 0.867
mm to 2.436 mm [15]. Damage to the lungs immediately following migration includes
small lesions showing edema, hemorrhage, and necrosis, along with the presence of
numerous eosinophils [16]. In artificially infected foals, green or grey subpleural nodules
around 5 mm in diameter were present on all lobes, and over time, some nodules even
became calcified [100]. Hyalinization of the alveoli also occurs, and on day 23 after
infection, some alveoli displayed hemorrhaging and contained larvae [16]. There were
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also granulomas containing eosinophils, neutrophils, and mononuclear cells in other
areas of the lungs [16]. The lungs of infected foals displayed pneumonic areas that
appeared red and collapsed [100].
On day 42 after infection, larvae were again found in the villi of the small
intestine [16]. The mucosa and submucosa of the small intestine displayed edema, and
contained amplified numbers of eosinophils, mononuclear cells, and plasma cells [16].
The return of larvae to the small intestine concludes the migratory phase of the
parasite. However, in foals with natural infections, it is likely that ascarids in multiple
stages are all present within the host at the same time.
Once ascarids reach the small intestine and mature, there are new concerns and
clinical signs. After 50 days post-inoculation, foals exhibited weight loss and depression
[17]. Eventually, these foals became emaciated and appeared to have stunted growth
[97]. As these foals had been dosed initially with 8,000 eggs, clinical signs observed
during most natural infections should be less exaggerated. Infected yearlings did not
exhibit any clinical signs at this time [17]. Serum and total body albumin were
numerically lower in P. equorum infected foals than in controls, although only four
animals were compared [102]. As there was no increase in albumin catabolism in the
infected animals [102], it appears that the lower albumin levels were due to decreased
synthesis. Albumin synthesis is dependent on nutritional intake; starvation leads to low
albumin production, and a lack of protein in the diet leads to an even greater reduction
[103]. It seems likely that parasites were consuming some of the foals’ nutrients,
although the small number of animals in this study prohibited statistical comparisons,
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and the intake for infected foals was numerically lower than the intake for controls
[102].
Although vital signs are often used to identify equine health problems,
temperature of foals infected with ascarids is expected to be within the normal range
[17]. Temperature does not seem to be affected by ascarid infection, as both foals and
yearlings maintained normal temperatures throughout migratory and patent infection
stages [17]. Other vital signs were not examined in these studies.
A major concern with infections of ascarids in the small intestine is colic or
intestinal rupture. Large ascarid infections can cause acute non-strangulating intestinal
obstruction [20]. Although these consequences are severe, ascarid impaction accounts
for only 0.4% of surgical colic cases involving horses less than one year of age [104]. In
two studies, the median age of equines with ascarid impaction was 5 months, and the
majority of cases occurred in the fall (in the northern hemisphere) [104, 105]. This type
of colic may be suspected when there are abnormalities in abdominal fluid, abdominal
distention, and persistent pain [20], and irregularities may be detected by ultrasound
[104]. During surgery, ascarids can be visualized and felt through the intestinal wall, and
can removed by small intestine enterotomy [20], milking of the small intestine into the
cecum using lubricant, or resection of the impacted segment [106]. The prognosis for
surgical treatment of foals or young horses with ascarid impaction can be poor,
especially when certain procedures are used. In one study, all foals (7/7) treated with
enterotomy died or were euthanized [105], and another study found that horses that
underwent enterotomy were less likely to survive to discharge [106]. Survival of greater
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than one year post-surgery has been calculated at 10% [105], 24% [104], and 60% [106].
The difference in percentages may be because the study which calculated long-term
survival at 60% used a larger variety of surgical methods, as well as more recent records
[106]. This study found better prognosis for foals treated by milking of the small
intestine, as all of these horses survived [106]. The change in techniques may improve
the prognosis of horses with ascarid impaction, but it is still important to take
preventative measures.
The occurrence of intestinal impaction with roundworms has been associated
with recent anthelmintic use. This association between has been documented in
children with A. lumbricoides infections [107]. In horses, studies have reported that 72%
[104] to 80% [106] of horses admitted for ascarid-related colic had received
anthelmintic treatment less than 24 hours before the appearance of clinical signs.
Another study reported that 58% of horses had been treated within 6 days of ascaridrelated colic [105]. The most common anthelmintics used were ivermectin and pyrantel
pamoate [104, 105]. Dead or paralyzed worms may form a bolus and block the intestine
[20], so some researchers believe that it may be prudent to use anthelmintics with a
slower effect, such as fenbendazole, when foals are thought to have heavy ascarid
burdens [108]. These risks of intestinal obstruction in foals increase the importance of
accurate and timely diagnosis.
Diagnosis
Diagnosis of P. equorum is primarily conducted using copromicroscopic methods,
including qualitative fecal flotations or the quantitative FEC. There are several different
20

methods used to conduct fecal flotations or FECs. All of these methods use some type of
flotation solution that is dense enough to separate parasite eggs from debris in the
feces, and float eggs to the top of solution for collection and examination.
The specific gravity of P. equorum eggs has been reported at 1.0969 [109]. In
order to recover both strongyle-type and P. equorum eggs from horse feces, the specific
gravity of the flotation solution should be between 1.25-1.38 [109, 110]. At lower
specific gravities, strongyle-type eggs may still be recovered, but the solution will not be
dense enough to float the heavier P. equorum eggs [110]. Flotation solutions used
include sodium nitrate, sucrose, sodium sulfate, zinc sulfate, magnesium sulfate, or
sodium chloride [110, 111]. In some procedures, fecal material is poured through a
strainer to remove large pieces of fecal debris. At 500, 350, and 250 µm mesh sizes, this
has been shown to have no effect on the number of P. equorum eggs recovered [110]. A
variety of techniques and flotation solutions can be used, but fecal tests can be broken
down into two major categories: qualitative or quantitative.
The qualitative fecal flotation generally entails modifications of the Willis
method, first described in 1921 [112]. The initial steps of the fecal flotation involve
mixing of fecal material and flotation solution and pouring the mixture into a tube. In
some cases, the feces may be mixed with water instead of flotation solution, passed
through a strainer, and then centrifuged, decanted, mixed with flotation solution, and
centrifuged once more to float the eggs [113, 114]. The final steps involve placing a
coverslip on top of the tube to capture the eggs. The coverslip is then placed on a
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microscope slide and examined under the microscope for the presence of absence of
parasite eggs. Although the test is qualitative, some researchers have been known to
assign a score or provide a rating to describe the number of eggs present on the slide
[111]. However, this test cannot be used a quantitative measure for treatment decisions
or to evaluate the efficacy of dewormers [111]. Despite the fact that an exact count is
not performed, the fecal flotation does have some advantages. Only one gram of feces
is required [111], which is advantageous when the quantity of fecal matter is limited
(such as with young foals). The fecal flotation is also purported to be more sensitive
than fecal egg count methods [111, 114, 115].
There are three major quantitative FEC categories for diagnosis of equine
parasites: the modified McMaster, the modified Stoll, and the Cornell-Wisconsin
method. All three stem from initial work performed by Stoll in 1923 [116]. There are
multiple variations found within the modified McMaster and modified Stoll methods.
Additionally, new methods with altered McMaster-type chambers have recently been
developed [117, 118].
Depending on the particular method used, the amount of feces needed for a
modified McMaster test generally ranges from 1-4 g [119]. Feces may be mixed with
water and centrifuged prior to decanting and mixing with flotation solution, or they may
be mixed directly with flotation solution [119]. With any of these techniques, a
subsample of the flotation/fecal mixture is pipetted into two chambers of a McMaster
slide, and the number of eggs present are counted under a microscope, and multiplied
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by a coefficient specific to the modification used [119]. In the United States, the most
common procedure for testing horses is to use 4 g feces and 26 ml flotation solution,
count the eggs in both chambers of the slide (0.3 ml total), and multiply that number by
25 to get the EPG [57]. One advantage of the modified McMaster is that, depending on
the method used, a centrifuge may not be required. This makes FEC testing faster and
more available to individuals who do not have expensive laboratory equipment.
The modified Stoll technique differs primarily from the modified McMaster in
that a centrifuge is always required, and traditional microscope slides and coverslips are
used in place of the McMaster slides. The modified Stoll involves combining 5-10 g of
fecal matter flotation with flotation solution (or water, then combining a subsample
with flotation solution), and centrifuging once with a coverslip [46, 57, 120, 121]. The
number of eggs on the cover slip are counted and multiplied by a coefficient particular
to the method used. For example, if 5 g of feces are mixed with 45 ml water (or 10 g
feces mixed with 90 ml water), and 1 ml of this solution (0.1 g feces) is mixed with
flotation solution in a test tube, the number of eggs counted on the slide will be
multiplied by 10 to get the EPG [46, 121]. The Cornell-Wisconsin method is another
variation of the modified Stoll technique, and differs in that it requires centrifuging each
entire sample twice (once after mixing 1-5 g feces in water and straining, and again after
decanting and mixing feces in flotation solution) [57, 121, 122].
As it is typically used, the modified McMaster test has a detection limit of 25-50
EPG, with better detection limits obtained with larger fecal samples [57]. New variations
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of the modified McMaster, such as FECPAK or FLOTAC use altered counting chambers
and feature improved sensitivity [117, 118]. Traditionally, for FEC tests where test
sensitivity is important, the modified Stoll or Cornell-Wisconsin methods have been
used. The modified Stoll has a detection limit of 5 EPG, and the Cornell-Wisconsin
method is even more sensitive, at a detection limit of as low as 1 EPG [57]. These
detection limits were developed using eggs from parasites other than P. equorum.
Although the FEC offers a non-invasive and relatively cost-effective method of
parasite diagnosis, the test has several limitations. The performance of the modified
Stoll technique in diagnosis of P. equorum infections in the small intestine has been
examined and found to have an estimated specificity of 0.94 [37]. This indicates that
within the population examined, the test performed well at correctly diagnosing
uninfected horses. Sensitivity was estimated at 0.72, so the test did not perform as well
at correctly identifying infected horses [37]. One explanation is that the FEC only
accounts for mature egg-laying female parasites. An equid with migrating or immature
adult ascarids would yield a false negative result through the FEC during the 3-month
period in the life cycle before patent shedding occurs [38]. Likelihood ratios calculated in
this study indicated that a horse with a positive result on the test is likely to have a P.
equorum infection in the small intestine (12.11), but a horse with a negative result on
the test is not as likely to be uninfected (0.3) [37]. As this study examined P. equorum
infections in the small intestine, the likelihood ratio for a negative result could be
expected to be closer to 1 if migratory larvae were accounted for.
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These data were also tested for a linear correlation of the modified Stoll FEC
results and P. equorum intestinal worm burden. However, the correlation was found to
be poor (r<30) [37]. It is possible that other non-linear correlations between P. equorum
FEC results and worm burden exist, but these have yet to be described. A linear
correlation between worm burden and EPG in children with A. lumbricoides infection
also could not be found [49]. Interestingly, the average egg output per female worm
was found to be lower in children with high numbers of female worms [49]. An equine
study found that when larger P. equorum egg inoculations are given to foals, there are
more worms in the small intestine, yet the worms are smaller in size [100]. Smaller
worms may have lower fecundity than larger worms. This has been shown to be the
case with other ascarid species: mean weight of female A. lumbricoides is positively
associated with egg output [123]. This may make it impossible to estimate worm burden
solely through the FEC.
In children with A. lumbricoides infections, EPG were found to fluctuate by day,
and were thought to be affected by the volume of feces produced [49]. Water content
may also affect EPG, as drier samples are expected to contain more fecal material per
gram [111]. Variation of EPG within each fecal sample has been found to occur in
children with A. lumbricoides infections [49], and horses with strongyle-type eggs [124].
Variation within each equine sample was more marked in samples with low (<50) EPG
values, as there may be fewer worms in these horses and more clumping of eggs [124].
Although there are issues with variation in FEC results and identification of early stages
of disease, the FEC remains the primary tool for diagnosis of P. equorum infections.
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Epidemiology
As mentioned previously, P. equorum is ubiquitous throughout the world, and
has been found on all continents inhabited by equids [4, 5, 8, 10, 11]. There is some
evidence that parasite body size correlates with prevalence, and may be partially due to
the greater fecundity of larger nematodes [54]. In any case, P. equorum is a large
parasite, with high prevalence of infection in young animals. In addition to horses, P.
equorum infects other equids, including zebras [12], Przewalski’s horses [12], donkeys
[8, 10], and mules [10]. The mode of transmission and prevalence of this parasite make
it difficult to control, although it appears that there are ways to minimize risk of
infection.
Transmission of P. equorum begins when a horse with a mature infection passes
eggs in fecal matter, and the eggs have sufficient time and environmental conditions to
embryonate (typically 10 days at temperatures of 25-27 ˚C, or longer at lower
temperatures) [23, 38]. Parascaris equorum eggs are different from those of some other
parasites, such as strongyles, in that they do not hatch in the environment. While
strongyle larvae hatch in the environment and are able to migrate short distances [125,
126], ascarid eggs naturally hatch only within the host [23, 38]. This increases the
importance of the structure of the egg for protection and transmission. The multilayered shell provides protection [23], allowing P. equorum eggs to remain viable for at
least 18 months to 3 years [21, 22], although the eggs can probably survive even longer.
Eggs have been shown to survive temperatures ranging from -20 ⁰C to 60 ⁰C [25],
allowing ascarid eggs to be transmitted across generations of foals. Within the egg,
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trehalose content may help to protect the egg from dessication or freezing [61].
Because P. equorum are unable to actively migrate in the environment, they rely on
other methods for dispersal. The sticky outer proteinaceous coat of the eggs allows
them to cling to surfaces and be transported from one area to another [23].
There are several risk factors that have been linked to P. equorum infection.
Young age is probably the most commonly described risk factor. One study of 2000
German horses of varying ages found that only foals and weanlings were positive for
ascarids by FEC [7]. An Australian study of 150 necropsied horses, and a Kentucky study
of 350 necropsied horses had comparable results, with only horses 2 years of age or
younger positive for ascarids in the small intestine [11, 127]. A Spanish coprological
study found the highest prevalence of ascarid infection (22%) to occur in horses younger
than 3 years of age [128]. In another German coprological study, 33% of foals and 6% of
yearlings were positively diagnosed for ascarids [129]. Higher prevalence of eggs in
feces was found in French 3-4 month old foals when compared with 8-9 month old foals
[130]. In central Kentucky, 22% of foals aged 10-223 days were recorded as having
ascarids following a series of fecal egg counts [4], while another study in the same area
found 43% of foals 2-7 months old were positive for P. equorum in the small intestine by
necropsy [131]. In Kentucky, positive foals were found on 86% of Thoroughbred farms
surveyed [4]. Conversely, one study on horses in Lesotho, a small country bordering
South Africa, found no association between age and infection, and reported an overall
coprological prevalence of 21.6% [132]. The authors proposed that the usual pattern of
development of immunity to P. equorum may diverge in developing countries [132].
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Although young horses are the typical host for mature P. equorum, patent
infections can still be found in mature animals and other types of equids. In Greece and
Macedonia, 2% of “riding” horses and 1.3% of “working” horses were coprologically
positive for P. equorum [6]. In some areas of the world, prevalence reports in mature
horses appear to be much higher. One study found P. equorum eggs in feces of 16.3% of
Ethiopian horses older than 8 years of age [133], while another study positively
diagnosed 22% of Pakistani horses over the age of 2 [10]. It is difficult to discern why
prevalence is higher in these areas, but it is possible that management factors may play
a role. In Ethiopia, P. equorum infections in mature animals appeared to be more
common in donkeys than in horses, as 50.1% of donkeys over the age of 8 had patent
infections [133]. In contrast to these results, a study of equids in Pakistan found similar
prevalence in horses (22%), mules (16%), and donkeys (19%) over the age of 2 [10]. In
animals younger than 2 years, prevalence was as high as 64% for horses, 56% for mules,
and 52% for donkeys [10]. It is possible that the high prevalence of ascarids in donkeys
and mules may be due more to management than to genetics. In Greece, out of 37
donkeys and 37 mules, none were found to be shedding ascarid eggs (ages not
described) [6]. Ascarid prevalence also appears high in other types of equids. A study
monitoring parasites in two wildlife parks in Germany found P. equorum eggs in 39.2%
of Chapman zebra fecal samples, and in 11.2% of samples from a breeding herd of
Przewalksi’s horses, but the exact ages of the animals were not specified [12]. These
animals had also not been dewormed except in the case of “massive egg excretion” or
clinical disease [12].
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It is anticipated that some variation in prevalence reports may occur not just by
geographic location, but also by the method used. As previously noted, there is variation
in the sensitivity of the FEC test depending upon the particular technique used [57].
Furthermore, FEC or necropsy did not account for migrating larvae in these studies, so it
is expected that some infections were missed, and actual prevalence is higher than
described. For example, one German study found 3% prevalence of P. equorum by FEC,
and 8.8% prevalence of P. equorum in the small intestine by necropsy on the same
horses at the same time [134]. Of horses with small worm burdens (1-10 worms), only
16.7% were diagnosed as positive through modified McMaster FEC (detection limit 10
EPG), while horses with larger worm burdens were more likely to be correctly diagnosed
by the FEC [134].
In addition to age, other factors have been evaluated for association with P.
equorum prevalence in equines. Sex is one factor that has been assessed in multiple
studies, with mixed results. One study found that males were more likely to be
diagnosed as positive through FEC or necropsy [134], while another stated that females
were more likely to shed eggs [128], and yet another found no effect [135]. However,
the study that found females more likely to shed eggs also stated that males were more
likely to have higher EPG counts [128]. One study found that geldings were less likely to
be infected than intact male or female animals [11], but this was likely confounded by
an association with age.
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Breed is another factor that has been examined. In one Spanish study, horses
designated as English Pure Breed were more likely to be shedding P. equorum eggs
when compared to horses designated as Spanish Sport Horse, Spanish Pure Breed, or
Pura Galega Raza [128]. An Australian study found no difference in P. equorum
prevelance at necropsy between Thoroughbreds and “hacks” [11]. A Polish study found
no difference in prevalence between 9 breeds [135], and a French study found no
difference between Thoroughbreds and French Trotters [130]. It is possible that some
of the differences in prevalence found by breed may occur because of management
practices on farms catering to various breeds.
As one might expect, manure management and hygiene practices are related to
the prevalence of P. equorum infections. There appear to be differences in the
prevalence of P. equorum by farm. A Kentucky study found prevalence by farm to range
from 0% to 64% [114], and a French study found prevalence by farm to range from 6.9%
to 76.2% [130]. Some management practices could actually increase the spread and
transmission of ascarid eggs. For example, foals on stud farms where manure was used
to fertilize pastures had 44 times the odds of shedding P. equorum eggs when compared
to stud farms where other types of fertilizer were used [7]. Similarly, regular removal of
all fecal material from stalls is important in reducing transmission of P. equorum. Horses
on deep litter bedding, where only surface waste is removed, were found to have 3.35
times the odds of shedding ascarid eggs, when compared to horses in stalls that were
routinely cleaned [7]. One study found that housing (stall, pasture, or several paddock
types) was not associated with P. equorum egg shedding, nor was farm type (stable,
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stud farm, riding club, or ordinary farm) [135]. The authors of this study attributed the
lack of association to low statistical power due to the smaller number of horses with P.
equorum infection compared to strongyle infection [135].
Prevalence of P. equorum in regards to temperature, rainfall, and season has
also been studied. Rainfall and temperature in Poland were found to be positively
correlated with P. equorum infection [135]. This meshes well with the life cycle of P.
equorum, as warmer temperatures would help with larvation of the eggs. Rainfall could
possibly help with dispersal of eggs, or this correlation may have resulted because of the
association between rainfall and temperature in Poland [135]. Additionally, eggs have
been shown to larvate only at relative humidity close to 100% [23]. Conversely, a USDA
study found that the number of horses shedding ascarid eggs more than doubled in the
winter when compared to the summer [136], although an Australian study found no
effect [11].
Another factor associated with P. equorum infection was type of deworming
drug used. Deworming with ivermectin was positively associated with mean EPG,
although ivermectin was much more commonly used than the other deworming drugs
[135]. This agrees with research indicating parasite resistance to macrocyclic lactones
[34], and emphasizes the importance of minimizing potential for infection.
Prevention
Prevention of ascarid infection should be of concern to those who own young
equids. Because of the durability of the egg and its ability to remain viable for years [21,
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23], it may be difficult, if not possible, to completely remove the threat of P. equorum
infection. Regardless, certain measures can be taken to reduce the viability, spread, and
transmission of the parasite eggs and decrease the risk of heavy infection.
As noted previously, manure management practices, such as spreading fresh
manure back on pasture and using deep litter bedding have been linked to P. equorum
infection [7]. Another study found contradictory results: removal of feces from pasture
and “resting” of pasture were associated with positive FEC [137]. No explanation was
proposed, but it is possible that there were other, unmeasured confounding factors
leading to these results; for example, pasture size. Another study comparing
management systems for donkeys in South Africa found the highest EPG results for
donkeys confined to small areas around the owner’s house, when compared with those
allowed to roam their village or graze on pasture [138]. Grazing donkeys had the lowest
mean EPG (0) [138]. It is possible that donkeys allowed to roam or graze larger areas
may have been choosier in their grazing, and less likely to contact eggs in fecal material.
However, these data were not adjusted for age or other factors, and grazing donkeys
were from a different geographical area than donkeys under some of the other
management systems. Although there are some conflicting results about practices
related to housing and grazing systems and more data is needed, it seems prudent to
employ hygienic practices for cleaning and disposal/treatment of manure.
One way to treat manure prior to use as fertilizer is by composting. Parascaris
equorum eggs become unviable at temperatures of 45 ˚C for one day [24], or at
temperatures of 60 ˚C or higher for one minute [25]. One study found that within a
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windrow compost pile, mean minimum and maximum temperatures ranged from 37.9
˚C to 58.3 ˚C, respectively [26]. Furthermore, location in the manure pile may impede
embryonation of ascarid eggs, as they require aerobic conditions to larvate [23]. After
only 8 days within the pile, mean percent P. equorum egg viability was 0 for eggs
permanently located within the pile, and for those alternating by day either inside or on
top of the pile [26]. The effect of temperature on eggs that have already larvated does
not appear to have been examined, but it is probable that high temperatures would
destroy larvae within the eggs. These studies indicate that composting is an effective
way to render freshly passed eggs unviable [26].
Another possible method of environmental management is paddock soil type.
One study examined sacrifice-lot type paddocks used for multiple years for the presence
of ascarid eggs in soil. The upper portion of sand/gravel paddock surfaces was found to
have fewer eggs per 100 cm3 when compared to clayey or morainic soil, although the
actual number of eggs shed initially in each paddock could not be estimated [22].
Sandy/gravel soil or larger particle size may help rainwater to wash eggs from the
surface of the soil, where horses are likely to ingest the eggs [22]. Egg contamination
appears to be high in areas frequently used by young horses. Another study found a
mean of 30 EPG in soil of a drylot used to house weanlings, but did not describe the soil
type [108]. For eggs that have already been spread from manure piles to the soil or to
objects or stall areas, there may be some options for chemical treatment.
Early work with disinfectants found P. equorum eggs to be fairly resistant to
chemical treatment [23]. The use of Lysol or phenolic compounds has been suggested
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for disinfecting stalls, but was not tested by these authors [97]. One study found Amphyl
aerosol spray (active ingredients alkyl dimethyl benzyl ammonium saccharinate and
ethanol) to effectively prevent embryonation, while treatment with Lysol did not show
practical significance [139]. Four days after treatment with 2 ml of disinfectant, none of
the eggs treated with Amphyl aerosol spray were embryonating [139]. Amphyl aerosol
spray could be recommended for disinfecting barn tools and small objects, but may not
be cost-effective or practical for treatment of larger areas. Similarly, A. lumbricoides
eggs were tested with 16 different disinfectant products, and only ortho-benzyl-parachlorophenol was effective at preventing embryonation under all dilutions and times
tested [98]. Another study using T. canis eggs found that when eggs were incubated in
70% ethanol for 24 days, 0% of eggs developed to the infective L2 stage [140]. Sodium
hypochlorite (2%) did not prevent infectivity, but showed some efficacy, as only 8% of
eggs developed to the L2 stage [140]. However, the extent of treatment in this study
does not simulate practical application of the products. Additional work with
disinfectants is needed to identify practical methods for disinfecting large areas used by
young horses, and help reduce the need for treatment.
Treatment
Horse owners in North America have some options for commercially available
anthelmintics for treatment of P. equorum infections. The drug classes typically used
today include the benzimidazoles (fenbendazole and oxibendazole), the
tetrahydropyrimidines (pyrantel pamoate and pyrantel tartrate), and the macrocyclic
lactones (ivermectin and moxidectin). All of these classes were originally marketed as
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effective against adult P. equorum and L4 stages, although macrocyclic lactones are
advertised as effective for L3 stages as well [141].
The first of these drug classes to be introduced on the market were the
benzimidazoles, which became widely used beginning in the 1960’s [142]. The
benzimidazoles have a wide margin of safety [143], and work by disrupting the energy
metabolism of the parasites. This happens when the drug binds to the β-tubulin subunit
of the ascarid, preventing microtubule assembly [143]. When nematodes are unable to
assemble microtubules, they are unable to undergo cellular division or transport
nutrients [143]. This effectively starves the nematodes, and most die and are expelled
within 3 days of treatment [143]. This mode of action provides the benzimidazoles with
ovicidal action [144], which the other dewormer classes do not have.
Benzimidazole compounds, including fenbendazole and oxibendazole, are
effective in treating ascarid infections at a dosage of 10 mg/kg body weight [27]. For
other parasites, such as susceptible cyathostomes, large strongyles, and pinworms, the
dosage needed for treatment is 5 mg/kg body weight [145]. The higher dosage required
to kill P. equorum makes it the dose-limiting parasite for most anthelmintics [145]. Doselimiting parasites are thought to be more prone to developing resistance to deworming
drugs [145]; however, P. equorum resistance to benzimidazole compounds has not yet
been confirmed through published studies. One case study documented intestinal
rupture caused by P. equorum one month after deworming with fenbendazole, although
the horse was dosed at 7.5 mg/kg [28]. Additionally, resistance to fenbendazole has
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been suspected by veterinarians in Kentucky [29], but further evidence is needed before
resistance to this drug is confirmed.
Of the tetrahydropyrimidines, pyrantel pamoate was introduced in the 1970’s,
and pyrantel tartrate was first marketed in 1990 as a daily anthelmintic treatment [142].
These drugs also have a wide margin of safety, as long as they are not administered at
the same time as other drugs with a similar a mechanism of action [143]. The
mechanism of action for pyrantel is as a depolarizing neuromuscular blocker [143]. This
occurs because the drug mimics the action of acetylcholine [143], a neurotransmitter
that causes muscle contraction. The muscle contractions induced by these drugs are
sustained, so the worms become paralyzed [143] and can no longer swim or feed. The
efficacy of these drugs is now in question, as multiple studies report P. equorum
resistance to pyrantel [30-32].
The macrocyclic lactones are the newest of the drug classes marketed for P.
equorum treatment in North America. Ivermectin was first introduced in the early
1980’s [142], and moxidectin in the late 1990’s [142]. Macrocyclic lactones work by
binding to or inducing binding at gamma-aminobutyric (GABA-A) mediated and
glutamate-gated types of ligand-gated chloride channels [143, 146]. Opening of these
channels leads to an influx of chloride ions, causing inhibition of nerves and flaccid
paralysis [143, 146]. This leads to starvation and death of the parasites, similar to the
tetrahydropyrimidine mechanism. Although the macrocyclic lactones are still considered
safe, the use of moxidectin in foals less than 6 months of age is contraindicated because
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of the possibility of moxidectin toxicity [147]. Mammals do not have glutamate-gated
chloride channels, but ivermectin can open GABA chloride channels at overdose levels
[143]. Numerous studies have documented resistance of P. equorum to the macrocyclic
lactones [30, 32-36]. Treatment with ivermectin has even been associated with having
higher mean P. equorum EPG values, although the values were not of practical
significance. Because of the impaired efficacy of two of the three major classes of
deworming drugs, new strategies to monitor and prevent the development of resistance
have been developed.
There are several explanations as to why anthelmintic resistance is becoming so
prevalent in P. equorum. Anthelmintic resistant genes could be novel or pre-date the
development of anthelmintics [148]. Mutations for anthelmintic resistance in P.
equorum have the potential to spread between populations. A study on the population
genetics of P. equorum found low genetic diversity among worms from Sweden,
Norway, Iceland, Germany, Brazil, and the US (Kentucky) [53]. As the global population
appears homogenous, the authors suspect that the level of gene flow caused by
shipment of horses is high enough to rapidly spread new mutations [53]. The issue with
new alleles for drug resistance comes about when these alleles are selected for [149].
When anthelmintic treatment is administered repeatedly, this is thought to put
selection pressure on the nematode populations, and hasten the development of
resistant populations [149]. There are also other factors, such as stocking density or
timing of treatment, which could increase the frequency of resistant alleles [149].
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The use of selective deworming, or the treatment of only individuals with higher
levels of egg shedding, has been advocated to slow the development of resistance by
providing refugia [142, 150-152]. The idea behind this type of deworming program is
that by leaving some animals untreated, anthelmintic-susceptible alleles will be
maintained in the population [152]. Although selective deworming has been advocated
for cyathostomes, it is recommended to treat all foals on a scheduled treatment plan
because of the higher parasite loads experienced at this age [150]. If foals must be
treated regularly, the selective deworming technique will not be of use in preserving the
effectiveness of anthelmintics against ascarids. This increases the importance of
tracking the spread of resistance to deworming drugs.
The presence of anthelmintic resistant nematodes in equine populations is
monitored through the fecal egg count reduction test (FECRT). Although the FECRT is
more commonly used to test for anthelmintic resistance of cyathostomes, it is also
advocated for monitoring anthelmintic resistance of P. equorum [150]. The steps of the
FECRT as it was originally developed for sheep involve (1) a washout period for the
effects of previous anthelmintic treatment, (2) classifying a control group and
experimental group, (3) conducting pre-treatment FEC and (4) 7-10 day post-treatment
FEC tests, then (5) calculating results [153]. Sheep group mean FECs of at least 150 EPG
were required for proceeding with the FECRT. The calculations involved the mean EPG,
the percent reduction of eggs, and the 95% confidence interval [153]. The original cutoff
level for anthelmintic efficacy was a 95% reduction in the mean number of eggs, when
compared with the control group, combined with a 95% confidence interval that did not
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extend below 90% [153]. Others have used the FECRT at different cutoff levels; generally
between 80%-95%, with differences by anthelmintic [142, 150, 151]. As farms with
equines may not have large numbers of animals with high egg counts, the use of each
animal as its own control is accepted [154]. For documenting P. equorum resistance, it
has been suggested to wait 14-21 days before taking the second fecal sample after
anthelmintic treatment [145]. Although the FECRT is relatively cheap and easy to
perform, there are some issues with the test. The FECRT was originally designed using
the modified McMaster technique [153], but the test could have greater or lower
sensitivity depending on the FEC technique used. Tracking the spread of resistance may
be hampered by the variability of methodology and inconsistencies in interpretation.
Furthermore, the FECRT test measures a reduction in eggs laid by female worms, and so
may not be an accurate depiction of the reduction of the total number of adult worms.
As this is the only method used to classify anthelmintic resistance of P. equorum, there
also is no way to examine efficacy of anthelmintics against larvae (except through
necropsy). Surveillance of anthelmintic resistance could be improved by development of
new diagnostic tools with the capacity to quantify current P. equorum infection.
However, it would first be necessary to obtain additional knowledge of the equine
immunoglobulin response to P. equorum.
Immunoglobulin Types and Levels in the Young Horse
In order to understand the humoral equine immune response to parasites, some
background information on immunoglobulin types and levels in the young horse is
necessary. Immunoglobulins are antibodies produced by B-cells in order to bind
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antigens and protect against infection [155]. Depending on the structure of the heavy
chains in the immunoglobulin molecule, immunoglobulins can be broken down into
several classes, each with a different function. Immunoglobulin classes produced by
horses include immunoglobulin A (IgA), immunoglobulin D (IgD), immunoglobulin E
(IgE), immunoglobulin G (IgG), and immunoglobulin M (IgM) [156]. Several equine
studies have serologically examined IgG, IgE, and IgM isotypes in relation to foal
immunity and parasite infection or Th2 type response. These immunoglobulins will be
the focus here [157-161].
Horses have multiple types of IgG; seven heavy chain genes have been
discovered, which is more than has been found in any other mammalian species [156].
The seven isotypes include IgG1, IgG2, IgG3, IgG4, IgG5 , IgG6, and IgG7 [156]. Formerly,
IgG3 and IgG5 were classified together as one isotype called IgG(T), until affinity
chromatography [162] and gene sequencing [163] showed IgG(T) to be two separate
isotypes. Additionally, when goat anti-horse IgG(T) polyclonal antibodies were tested
against each of the seven isotypes, they were found to react most strongly to IgG5, but
also reacted to IgG2 and IgG3 . However, many commercial producers of anti-equine
immunoglobulins continue to produce “IgG(T).”
The newborn foal does not receive IgG or other immunoglobulins from the mare
in utero. Equines have a diffuse epitheliochorial placenta [164]. Immunoglobulin
molecules cannot pass from mare to foal through this type of placenta [164]. Rather,
immunoglobulins (IgG, IgG(T), IgE, IgM, and IgA) are first passed from mare to foal via
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colostrum [165-167]. Colostrum is routinely tested for IgG using a colostrometer or
sugar refractometer prior to allowing the newborn to nurse, with 5000 mg/dl being
considered “adequate”[168]. To ensure a healthy immune system, it is recommended
that foal sera contain at least 800 mg IgG/dl by 6-9 hours after intake of colostrum
[169]. Failure of passive transfer of IgG is associated with increased risk of severe
bacterial disease [170], so it is recommended to treat foals experiencing failure of
passive transfer through plasma transfusion [170]. The most common cause of failure
of passive transfer is loss of colostrum due to premature lactation [171].
In the young horse, levels of immunoglobulins seem to vary by age, and
endogenous production of immunoglobulins appears to be limited for very young foals.
One day after birth, levels of serum IgG and IgG(T) are equal to adult horses [172]. From
the day after birth until one month of age, levels of IgG and IgG(T) drop sharply [172,
173]. This is proposed to be due to catabolism of maternal antibody and possibly
because of dilution of antibody due to increasing plasma volume from foal growth [173].
The half-life of foal serum IgG has been estimated at 18-23 days, with shorter half-life
being associated with higher serum antibody concentrations [173]. Another study
estimated the half-life of IgG(T) at 35 days [174]. In foals born to dams hyperimmunized
with Clostridium welchii antitoxin, maternal IgG antibody persisted in the foals until
around 4 months, when levels fell to negligible amounts [173].
Maternal antibody transfer is thought to protect foals during a period of time
when endogenous antibody production is just beginning or still very low. The expression
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of RAG-1 and RAG-2, which are genes necessary to produce mature B-cells and T-cells,
are limited in foals younger than 3 months of age [175]. Because mature B-cells are
necessary for the production of immunoglobulins, low RAG-1 and RAG-2 expression may
be a factor leading to the low serum immunoglobulin levels in the 1-month-old foals.
However, it appears as though endogenous antibody production can still occur in very
young foals. Between 1 and 3 months of age, serum IgG and IgG(T) levels in foals begin
to rise [172, 173]. Another study found a more delayed but similar pattern, with the
lowest serum IgG and IgG(T) concentrations at 1-2 months of age, with an increase
around 3-4 months of age [176]. Furthermore, foals deprived of colostrum and milk and
instead fed a milk substitute were shown to begin serum IgG production around 2
weeks [173]. By 1 month of age, the IgG levels of these foals had surpassed the IgG
levels of foals with adequate passive transfer that received colostrum and were kept
with their dams [173]. Around 8 months of age serum IgG(T) levels have been shown to
increase rapidly in Fjords, Dole horses, and Shetland ponies, while there was more of a
plateau for Thoroughbreds [172, 176]. Serum IgG(T) was higher in 2-year-old horses
than in adults, and so it appears to be important in young horses [172]. Serum IgG(T)
levels were also higher in 2-4 year old Shetland ponies than in 2-3 year old
Thoroughbred racehorses [176]. This could have been due to genetic differences or to
management practices, as the ponies were on pasture and the Thoroughbreds would
have been stalled, had higher levels of exercise, and were fed a high concentrate diet
[176].
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Functions of the different IgG isotypes and their significance in young horses are
still being determined. There are some indications that the IgG1, IgG3, IgG4, and IgG7
isotypes appear to be important for effector function, and thus, for elimination of
intracellular pathogens [177]. Some studies have indicated that certain immunoglobulin
classes or isotypes may be associated with Th2 responses, which are commonly
associated with parasitic infections as well as allergic responses [178]. Evidence points
to a Th2 response for IgG(T), as it has been associated with response to allergens and
parasites. Equine serum IgG1 and IgG(T) have been shown to bind to allergens from
biting midges [157]. In weanlings infected with trickle doses of Strongylus vulgaris,
serum levels of IgG(T) were found to increase, while levels of other IgG isotypes
remained constant [161]. Correspondingly, IgG(T) performed better than other IgG
subtypes in serological diagnosis of S. vulgaris infection [179]. Another study found an
enzyme-linked immunosorbent assay (ELISA) for detection of IgG(T) better able to
diagnose high levels of equine Anoplocephala perfoliata infections when compared with
IgG [158]. Additionally, in adult ponies, IgG was found in serum at a mean
concentration of 1334 mg/100 ml, and IgG(T) at 821 mg/100ml, which were much
higher than any other immunoglobulin types [180]. The high levels of IgG(T) in the
serum and its association with Th2 type responses make IgG(T) a good candidate for
serological testing.
Immunoglobulin E is another immunoglobulin class associated with parasite
infection and type I allergic diseases [178]. This immunoglobulin is less commonly found
in circulation, as it is produced in smaller quantities and quickly binds to receptors on
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mast cells, basophils, and eosinophils [155]. Although IgE is associated with parasite
infection, detection of this isotype may be limited during the age when foals are most
likely to be infected with ascarids. One study found that serum IgE peaked 2-5 days after
foals received colostrum, and then disappeared by 3-4 months of age, indicating that IgE
was transferred from mare to foal via colostrum [166]. Passively transferred maternal
IgE also can bind to foal peripheral blood leukocytes, and bound IgE was found at high
levels at days 2-5, and decreased to undetectable levels by 2 months of age [166]. This
immunoglobulin isotype has the shortest half life; it has been estimated at 2 days in
other species [181]. Serum levels of IgE in foals were not detectable again until 9-11
months of age, and these horses did not have adult levels until 18 months of age [166].
Serum IgE levels in adult horses have been found to be up to 1000 times higher than IgE
levels found in human serum [182], which has been proposed to be caused by the lack
of parasitism in humans living in westernized countries. The relatively high IgE levels in
equine serum and the association of IgE with parasitism may also make IgE worth
examining using a western blot test for P. equorum, although levels in the young foal
may be too low for detection.
Another immunoglobulin type that could be worth examining for use in
serological diagnosis is IgM. This is the first kind of antibody to be produced in any
immune response, and it provides protection before the period when somatic
hypermutation and isotype switching for production of other antibody types are
underway [155]. Serum IgM concentration patterns in foals appear similar to those
found for IgG, with some differences. Levels of IgM in day old foals were similar to those
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found in adults [176]. Levels declined quickly and were at their lowest at one month of
age [176]. However, endogenous production of IgM appeared to reach adult levels
faster than the other immunoglobulin isotypes. Levels higher than those present at one
day of age were produced by around 2 months for Shetland ponies, and 5 months for
Thoroughbreds [176]. In serum, IgM is found in higher concentrations than IgE, but
lower than IgG [166, 183]. For example, in day old foals, the concentration of IgM in
plasma was about 1/13th of the IgG concentration present. Immunoglobulin M is known
to bind to antigens from parasites, such as Toxoplasma gondii [184]. The diagnostic test
for this parasite also uses antibody tests for IgM in conjunction with tests for IgG so that
new infections can be distinguished from previous infections [184, 185]. Nonetheless,
this technique is not thought to be effective for T. canis, as IgM is produced for a longer
duration after initial infection with this species [185].
The Immune Response to P. equorum and other Parasites
The development of immunity in the horse differs depending on the type of
parasite. Strongyle infections appear to lead to incomplete immunity, with the majority
of older horses still susceptible to infection, although with fewer parasites when
compared with younger horses [7]. In contrast, the development of immunity to P.
equorum occurs rapidly at a young age, and adult parasites are typically not found in
older horses [7, 42, 186]. Parascaris equorum egg shedding typically begins when the
foal is around 3 months of age, and maximum egg shedding occurs around 5 months of
age, after which time egg shedding decreases [186]. Another study measuring worm
burden found the highest number of both immature and mature P. equorum in foals 3
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months of age [3]. After 3-5 months of age, worm burdens decreased monthly to nearly
zero by 10 months of age. Epidemiological studies have found foals and yearlings to be
more likely to shed ascarid eggs when compared with older individuals [7, 136].
Interestingly, immunity appears to develop by around 6 months of age, even for
P. equorum naïve foals [38, 186]. When 6-12 month old ponies (reared parasite-free)
were experimentally infected with larvated P. equorum eggs, those ponies had lower
numbers of parasites in the small intestine when compared with parasite-free 2-4 weekold pony foals [186]. Additionally, other researchers, as cited by Clayton and Duncan
(1979) tried to induce a patent P. equorum infection in adult horses, with unsuccessful
results [13, 14]
Another phenomenon has been observed in horses naïve to ascarids. As might
be expected, older foals (8-10 months) naïve to P. equorum that become infected show
more severe respiratory and systemic signs when compared to younger infected foals
[186]. These foals show increased density on thoracic radiographs, indicating the
intensity of the immune response to migrating larvae [38]. However, larvae do not seem
to be able to reach maturity in naïve older horses. In a study using naïve 6-12 month-old
horses, when compared with younger foals, few larvae were able to complete the cycle
back to the small intestine [186]. This signifies potential for a strong primary
immunologic response in the liver and lungs, despite not having encountered the
parasite previously.
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The secondary immune response may be important to developing immunity to
ascarids and other equine parasites. One study found that administration of attenuated
(irradiated) P. equorum eggs to foals prior to artificial infection with viable eggs
decreased worm burden in those foals when compared with controls [47]. Similarly,
when weanlings were administered a challenge dose of S. vulgaris larvae, those who
had previously been given trickle doses of S. vulgaris survived, while control ponies
naïve to S. vulgaris did not [161]. This signifies the importance of multiple small
exposures for production of immunity. Another study compared foals that had been
raised parasite-free and those raised naturally [186]. After the naturally raised foals
were dewormed, both groups were inoculated with 8,000 P. equorum eggs [186]. No
differences were found in the number of parasites in the small intestine upon necropsy,
so age may be more of a factor than previous exposure for the development of
immunity [186].
Ascarid infection in horses has also been associated with a change in cellmediated immunity. From 10 to 40 days following ascarid infection, the number of
eosinophils in the foal’s blood rises in proportion to the intensity of the infection [38].
This corresponds with pulmonary eosinophilia during the migration of the ascarid [38].
Eosinophilia has also been implicated with infection of other equine parasites. Pony
foals infected with S. vulgaris were found to have higher eosinophil levels compared
with uninfected ponies, and eosinophil levels decreased following treatment with
ivermectin [187]. Eosinophils appear to assist in host defense through the expulsion of
cytotoxic granules, presentation of parasite antigen to T-cells, and production of
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interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-5 (IL-5), cytokines that are associated
with parasite infection and Th2 immune response [188].
The humoral immune response of horses to ascarids has been the topic of
limited study. Early immunological testing found a continual increase in the level of
serum precipitin titers (indicating increased antibodies) against whole worm antigen
during the development of immunity to P. equorum in foals and yearlings [47].
Interestingly, the dams were also tested and had high serum precipitin titers throughout
the year, even though they were negative for ascarid eggs in the feces [47]. This was
thought to have occurred because of the daily challenge of grazing on pastures
populated by foals [47]. However, the exact mechanism leading to the development of
immunity in mature horses is currently unknown.
Basic immunologic mechanisms of defense have been described for other
parasite species. The primary mechanism of defense against parasites is a Th2 CD4 T-cell
response, whereas an ineffective Th1 CD4 T-cell response leads to inflammation, tissue
damage, and worm survival [155, 189]. The chain of events leading to a Th2-type
response involves the presentation of parasite products by dendritic cells (although
dendritic cells are not always required for this type of response), which prompt naïve Tcells to become Th2-type T cells [155, 190]. These cells produce cytokines such as IL-4,
IL-5, IL-10, and IL-13 that help to upregulate of IgE production and recruit mast cells and
eosinophils [88, 155].
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The initial development of resistance may be marked by expulsion of parasites.
When large numbers of P. equorum are present in the small intestine, an immunological
reaction may occur to expel the worms [97]. In A. suum, larval expulsion has been
shown to occur after different dosage levels when larvae complete their migration and
return to the small intestine 21 days post-inoculation [191]. This process occurs in
conjunction with increases in mucosal jejunum A. suum-specific IgA, and serum IgM,
IgG1, and IgA specific to L3 ESA [191]. Maximal levels for serum IgM were found on day
14 post-inoculation, whereas maximal levels for serum IgG1 were found on day 21
[191]. An increase in eosinophils was found after the expulsion process had occurred,
and there was no change in IgG2 or mucosal mast cell numbers [191]. In uninfected and
infected children, there did not appear to be a difference in response of IgG, IgG
subtype, IgM, or IgA to three different A. lumbricoides antigens [192]. With one of the
antigens, infected children had significantly higher IgE response, so IgE may be
important for immunity to A. lumbricoides [192]. In other parasite infections, IgE has
been shown to bind to mast cells and become activated by parasite antigen, causing
release of histamine, and subsequent expulsion of worms through contraction of the
small intestine [155, 189]. In human T. canis infections, parasite ESA appear to prompt a
Th2 response [193]. The primary antibody generated against these ESA seems to be
IgG1, with substantial levels of IgM and IgE also produced [88]. Host production of these
parasite-specific antibodies forms the basis for development of diagnostic tools.
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Immunological Diagnostics for Ascarid Infections
Immunological diagnostic tools are presently available for several ascarid
species. Whole worm antigen was once the focus of diagnostic test development until
the late 1970’s when De Savigny described procedures for the culture of T. canis larvae,
ESA collection, and use of ESA in diagnostic testing [76, 194]. Diagnosis of T. canis larval
migrans in humans is now conducted using a commercial ELISA kit, or through western
blotting for identification of low molecular weight proteins [88]. Toxocara cati infections
can be diagnosed through the same tests, as T. canis and T. cati ESA are cross-reactive
[195]. Recombinant proteins have also been created to try to improve the performance
of these tests and reduce cross-reactivity with other species [88]. Most tests for T. canis
larval migrans assess total IgG, although one test saw increased specificity and
decreased sensitivity by measuring IgG4 [196]. Serological diagnosis of T. canis is also
possible in dogs. A test for T. canis infection in dogs and puppies was developed to
measure circulating ESA [197]. This sandwich ELISA had a positive correlation between
circulating T. canis antigens and worm burden, and found the highest ESA levels in onemonth-old puppies [197].
Excretory-secretory antigens, whole worm antigens, and adult worm body fluid
of A. suum have been examined through SDS-PAGE and western blotting [75, 198].
Ascaris suum larval ESA exhibit a great deal of homology with A. lumbricoides and T.
canis ESA, but the antigens can still be distinguished by SDS-PAGE or western blot profile
[75, 199]. An ELISA for A. suum using a protein purified from adult worm body fluid has
shown high sensitivity and specificity, and improved results over the FEC [200]. ELISAs
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have been used to detect IgG4 responses to ESA or somatic proteins from adult Ascaris
lumbricoides [201, 202]. Diagnostic tests for B. procyonis larval migrans in humans have
also been developed. These include western blot assays and ELISAs to detect IgG using
crude ESA [203] and recombinant antigen [204]. The recombinant antigen ELISA showed
improved sensitivity and specificity over the crude ESA ELISA, along with reduced
Toxocara cross-reactivity [204]. The number of diagnostic tests developed for other
ascarid species indicates strong potential for serological diagnosis of P. equorum in
horses.
The current methods of P. equorum diagnosis in horses are lacking in that they
do not allow for detection of migratory larvae and do not correlate with worm burden
[37]. Methods of prevention can be difficult for horse owners to implement, and the
efficacy of treatment is now questionable. As heavy P. equorum burdens can lead to
clinical signs and pathological effects, it is essential to learn more about equine
immunity to this parasite and develop new tools for monitoring infection.
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CHAPTER 4: IN VITRO CULTURE OF PARASCARIS EQUORUM AND PRELIMINARY
INVESTIGATION OF LARVAL EXCRETORY-SECRETORY ANTIGENS
Introduction
Parascaris equorum is a roundworm parasite found ubiquitously in young equids.
Infection with this parasite begins when larvated eggs are ingested. The larvae hatch in
the host’s small intestine, migrate through the liver and lungs, and return to the small
intestine once more to mature and reproduce [15, 16]. It is at the reproductive stage of
the life cycle, 10-15 weeks after initial infection [15, 17, 46, 47], when diagnosis can be
made using coprological methods. However, this parasite is known to cause damage to
the liver and lungs, along with respiratory symptoms during the migrational phase of the
life cycle [16, 17, 99]. Because of the delay in diagnosis by coprological methods, early
infections in foals may go undetected or clinical signs may be misdiagnosed. This
emphasizes the importance of developing new diagnostic tools for P. equorum infection.
Diagnostic tests for other ascarid species have been investigated using larval
excretory-secretory antigens (ESA). The ESA produced by ascarids are thought to serve a
variety of purposes, including migration through host tissue [86, 87], molting [87],
survival within the host’s digestive tract [95], and evasion of host immune response
[93]. The ESA produced by other ascarid parasites, such as Toxocara canis [205, 206],
Toxocara cati [195], Ascaris suum [75, 205, 207-209], Ascaris lumbricoides [75, 209],
Baylisascaris procyonis [77, 203], and Toxocara vitulorum [210] have been
characterized, but there is no known work describing the ESA of P. equorum. Two
protease inhibitors have been identified from homogenized whole adult P. equorum
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(after removal of body fluid). Both showed activity against bovine trypsin and bovine
chymotrypsin, and one protease inhibitor showed activity against porcine elastase [94].
Although the proteases were not from the appropriate host species, it still appears that
P. equorum may produce protease inhibitors to block the action of digestive enzymes
and survive in the gastrointestinal tract of the horse. A description of the ESA produced
by P. equorum larvae would be the first step in identifying potential antigens of
importance for diagnostic testing. Comparison of ESA produced by P. equorum L2/L3
and L5 stages may also be of interest, as these stages could produce different antigens
to assist with the functions of migration versus survival in the gastrointestinal tract.
Separation and visualization of these proteins would also lead the way for future
analyses to categorize these proteins and their functions.
In-vitro larval culture has been conducted for the collection of ESA produced by
other ascarid species [75-77]. The literature does not indicate any hatching or culture
attempts for P. equorum larvae. Thus, there are no published culture methods particular
to this parasite, nor estimates of larval size upon hatching, larval mortality in culture,
changes in larval stage in culture, or estimates for antigen production. Such information
would be of use for those attempting to collect ESA for characterization or diagnostic
purposes.
The specific objectives of this study were to (1) hatch and maintain P. equorum
and B. procyonis larvae in culture for collection of ESA, (2) compare ESA produced by B.
procyonis and P. equorum using sodium dodecyl sulfate polyacrylamide gel
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electrophoresis (SDS-PAGE) and silver stain, and (3) identify antigens specific to P.
equorum larvae through western blot analyses using sera from animals with P. equorum,
B. procyonis, or T. canis inoculations, immunizations, and natural infections. Sera used
for western blot analyses was obtained from P. equorum naturally infected horses, T.
canis naturally infected dogs, rabbits inoculated with B. procyonis or T. canis eggs, and
rabbits immunized with P. equorum or B. procyonis ESA collected from larval culture.
Baylisascaris procyonis and T. canis were examined because of the close proximity in
which horses, cats and dogs, and raccoons often live. One review cited the use of hay,
straw, or animal feed as a major factor associated with B. procyonis infection [211].
Although not documented, it is possible that a horse could mount an antibody response
against migratory T. canis or B. procyonis larvae after ingestion of eggs, causing a false
positive result on the western blot test. Studies comparing other ascarid species have
found similarities in ESA and cross-reactivity on serological analyses [75, 77, 199, 203,
205, 212]. Toxocara cati was not examined because of the degree of ESA similarity with
T. canis [185]. As other ascarid species were expected to have a higher potential for
cross-reactivity with P. equorum ESA when compared with other equine parasites,
comparisons with B. procyonis and T. canis were emphasized here.
Materials and Methods
Antibody collection protocols for immunized rabbits were approved by the
Institutional Animal Care and Use Committee at Bethyl Laboratories (20-2011-EM). All
sampling procedures were approved (2012-0924) by the University of Kentucky
Institutional Animal Care and Use Committee.
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Parasite Egg Collection
Mature P. equorum specimens were collected from the small intestines of five
necropsied foals from the University of Kentucky Veterinary Science Department farm,
and from 15 foal necropsy submissions to the University of Kentucky Veterinary
Diagnostic Laboratory. Mature B. procyonis specimens were collected from the small
intestines of 11 raccoons trapped in Kentucky’s Whitley, Bell, or Knox counties between
the months of November and February. Additional B. procyonis were collected from 16
raccoons collected by a wildlife control company based in Lexington, Kentucky between
the months of February and June. Raccoons had been kept at -20 ˚C for approximately
one month prior to worm collection.
Adult worms were maintained in 0.5% formalin, 0.85% saline at 4 ˚C until
dissection. Prior to dissection, female worms were surface-decontaminated in 10%
formalin, and rinsed in distilled water. Worms were dissected in distilled water, and the
vagina and first 1-2 centimeters of the uterus were removed. Eggs were released from
uteri in solution (0.1% formalin, 0.85% saline) using a Tenbroek homogenizer. Eggs were
then embryonated in 0.1% formalin, 0.85% saline at room temperature and an egg
density of ≤25 eggs per μl. Eggs were checked weekly for larvation, and after 3-5 weeks,
eggs were either hatched immediately or stored at 4 ˚C until hatching. The thickness of
the chitinous layer of the shell for B. procyonis and P. equorum was compared using the
measurement tool on Adobe Photoshop 7.0 (Adobe Systems Incorporated, San Jose,
CA).
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Larval ESA Collection
Eggs that had been stored at 4 ˚C were maintained at room temperature for two
days prior to hatching. Eggs were washed three times in 0.85% NaCl via centrifugation
for one minute at 200 x g to remove formalin. Eggs were decorticated by adding 5.25%
sodium hypochlorite in a 1:1 solution, and rocking on an orbital rocker until the majority
of the chitinous layer of the eggs had been removed. For P. equorum, the eggs were
washed 10 times in 0.85% NaCl, and stored at room temperature for one week. After
one week, the washing steps were repeated, with a 1-2 minute bleaching step to
eliminate any bacteria present. For B. procyonis eggs, which were less resilient, the
washing and bleaching steps were only conducted once, proceeding to hatching on the
same day. After washing in 0.85% NaCl, eggs were washed twice in warm (37 ˚C) Hank’s
Balanced Salt Solution (HBSS) without phenol red (Thermo Scientific, Waltham, MA). On
the last wash, 10 μl triple antibiotic solution (penicillin 10,000 IU/ml, streptomycin 10
mg/ml, amphotericin B 25 μg/ml; MP Biomedicals, Santa Ana, CA) was added per ml
HBSS. Eggs in HBSS and antibiotic solution were hatched with mechanical disruption
using a stir bar and glass beads (3 mm and 5 mm in diameter). Hatching solution was
transferred to a Baermann apparatus according to the method of Urban et al. [213].
Larvae were collected from the Baermann apparatus four hours later. Larvae were then
washed in warm (37 ˚C) Dulbecco’s Phosphate Buffered Saline (Thermo Scientific,
Waltham, MA) by centrifuging 8 times at 200 x g for one minute each time, followed by
two washes with warm (37 ˚C) RPMI-1640 (with L-glutamine and phenol red; Thermo
Scientific, Waltham, MA). RPMI-1640 was added as necessary to make a larval
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concentration of 10,000 larvae per ml solution. Protease inhibitor cocktail (described
below) and triple antibiotic solution (penicillin 10,000 IU/ml, streptomycin 10 mg/ml,
amphotericin B 25 μg/ml; MP Biomedicals, Santa Ana, CA) were added to RPMI-1640 to
make a 1x concentration of each, and 2-4 ml of the resulting larval solution were
transferred to individual 50 ml culture flasks (Research Products International
Corporation, Mount Prospect, IL). The type of protease inhibitor cocktail (PIC) used was
changed between P. equorum culture batches to attempt to decrease mortality, and
included a protease inhibitor cocktail with EDTA (AEBSF, aprotinin, bestatin, EDTA, E-64,
leupeptin; Sigma-Aldrich, St. Louis, MO), a protease/phosphatase inhibitor cocktail
(sodium fluoride, sodium orthovanadate, b-glycerophosphate, sodium pyrophosphate,
aprotinin, bestatin, leupeptin; Thermo Scientific, Waltham, MA), and a protease
inhibitor cocktail without EDTA (AEBSF, aprotinin, bestatin, E-64, leupeptin and
pepstatin A in DMSO; Thermo Scientific, Waltham, MA). Only one type of protease
inhibitor (AEBSF, aprotinin, bestatin, E-64, leupeptin and pepstatin A in DMSO; Thermo
Scientific, Waltham, MA) was used for the culture of B. procyonis.
Larvae were incubated in medium at 37 ˚C and 5% CO2. Media were changed
every 4 days and used media were filtered using 0.2 µm syringe filters (Corning,
Tewksbury, MA). Filtered media were then dialyzed (SnakeSkin Dialysis Tubing, 3.5
MWCO, Thermo Scientific, Waltham, MA) at 4 ˚C against 0.1M ammonium bicarbonate.
Dialyzed media were then frozen at -20 ˚C and subsequently lyophilized to concentrate
protein. Lyophilized media were resuspended in 0.1M ammonium bicarbonate and
pooled between culture batches and weeks of collection for the same species. Protein
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concentrations were estimated using the Pierce BCA Protein Assay (Thermo Scientific,
Waltham, MA) according to the manufacturer’s directions. Protein in solution was then
aliquotted and stored at -20 ˚C.
Larval mortality was monitored weekly by gently shaking the culture flasks,
removing a 5 μl subsample from each flask, and viewing larvae by microscopy. Day 0
samples were obtained before the larvae were separated into flasks; therefore, the
number of samples taken on day 0 was less than on subsequent days. Cultures were
terminated when larval mortality reached 60% or greater, or if bacterial contamination
was noted. Weekly measurements of five randomly selected larvae from each flask were
also taken using an eyepiece micrometer. Larval length and width at the widest part
(approximately 1/3 of the way from the anterior end) were estimated. Sizes for a total
of 10 B. procyonis larvae were obtained weekly, and all were from the same culture
batch. Sizes for a total of 25 P. equorum larvae were obtained weekly, and were
collected from multiple culture batches.
Immature Adult P. equorum ESA Collection
At necropsy, two live immature adult L5 P.equorum (approximately 5
centimeters in length) were collected from the small intestine of a yearling from the
University of Kentucky Veterinary Science Department farm, and transported in
phosphate buffered saline (PBS). The ascarids were washed in warm (37 ˚C) phosphate
buffered saline (PBS) on an orbital rocker 8 times for 2 minutes each time for
decontamination. The worms were washed twice in RPMI-1640 (Thermo Scientific,
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Waltham, MA) medium with triple antibiotic solution (penicillin 10,000 IU/ml,
streptomycin 10 mg/ml, amphotericin B 25 μg/ml; MP Biomedicals, Santa Ana, CA) and
then maintained individually in 50 ml culture flasks (Research Products International
Corporation, Mount Prospect, IL) in RPMI-1640, triple antibiotic solution, and protease
inhibitor cocktail (AEBSF, aprotinin, bestatin, EDTA, E-64, leupeptin; Sigma-Aldrich, St.
Louis, MO). Media was changed on day 2, day 3, and day 5, upon which cultures were
terminated. Antigen processing procedures were identical to those for larval ESA.
Sera Collection
Sera were collected from animals with artificial or natural infection with P.
equorum, B. procyonis, or T. canis for qualitative examination by western blot.
Polyclonal antibodies were obtained from two rabbits immunized with P.
equorum larval ESA and two rabbits immunized with B. procyonis larval ESA (Bethyl
Laboratories, Montgomery, TX). As the primary focus of this study was on the larval
stages, no anti-sera were produced against immature adult P. equorum. On day 0 each
rabbit was immunized with 100 µg antigen in complete Freund’s adjuvant. Each rabbit
was subsequently immunized with 100 µg (B. procyonis) antigen or 50 µg (P. equorum)
antigen and incomplete Freund’s adjuvant on days 14, 28, 42, and 56. Less P. equorum
protein was used because of the limited availability of this protein. Sera were collected
on day 0 prior to immunization, and on day 63. Sera were stored at 4 ˚C and were
tested several days after receipt.
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Sera from animals infected with T. canis were also collected. Sera remaining
from routine veterinary procedures were obtained from two naturally infected adult
dogs at the Lexington Humane Society and one naturally infected adult dog at a local
veterinary clinic, and were stored at -20 ˚C. Two animals were found to be shedding
eggs in the feces by fecal flotation using sodium nitrate flotation solution (specific
gravity 1.25 to 1.30). One animal had expelled adult worms in feces.
Additional sera were obtained from New Zealand White rabbits (kindly provided
by Drs. Kevin Kazacos and Sriveny Dangoudoubiyam, Purdue University). Sera were
collected from two rabbits pre-inoculation, from two rabbits inoculated with
embryonated T. canis eggs, and from five rabbits inoculated with embryonated B.
procyonis eggs. These sera were used in prior studies [77, 203] and had been stored at 20 ˚C.
Sera were collected from two horses with natural P. equorum infections. Serum
was obtained from an 8 –month-old colt immediately prior to necropsy for a different
study (kindly provided by Drs. Eugene Lyons and Martin Nielsen, University of Kentucky).
Upon necropsy, 54 immature and 18 mature P. equorum were found in the small
intestine. This foal also had a fecal egg count of 40 eggs per gram (EPG), as determined
by a previously described modified Stoll method with a detection limit of 10 EPG [46].
Serum was also obtained from a University of Kentucky (Maine Chance Farm) 3-monthold filly positive for P. equorum eggs in feces, as confirmed by a previously described
fecal flotation method [113]. Blood was collected in a 10 ml serum tube (Vacutainer

62

Serum Plus Tubes; Becton, Dickinson, and Company, Franklin Lakes, NJ) and centrifuged
for 10 minutes at 1000 x g prior to removing and storing serum. Sera were stored at -80
˚C until used for western blotting.
Gel Electrophoresis and Silver Staining
SDS-PAGE was conducted using a 1.5 mm width 4-20% linear gradient gel with a
4% stacking gel. Broad Range Precision Plus Protein Unstained Standards (Bio-Rad,
Hercules, CA) were used in the first lane of the gel (2 µl) to provide a molecular weight
reference. Samples were heat denatured for 5 minutes 95 ˚C in 5x sample buffer (1.5 M
Tris HCl, pH 6.8, with 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.01%
bromophenol blue). Samples included 5 μg each of P. equorum larval ES protein, P.
equorum immature adult ES protein, and B. procyonis larval ES protein. Following gel
electrophoresis, the gel was silver-stained using the manufacturer’s instructions for the
Silver Stain Plus Kit (Bio-Rad, Hercules, CA).
Gel Electrophoresis and Western Blotting
SDS-PAGE was conducted using 0.75 mm 2-D/prep 12% gels with a 4% stacking
gel. Broad Range Precision Plus Protein Unstained Standards (Bio-Rad, Hercules, CA)
were used in the first lane of the gel (2 µl) to provide a molecular weight reference.
Samples were heat denatured for 5 minutes 95 ˚C in 5x sample buffer (1.5 M Tris HCl,
pH 6.8, with 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.01% bromophenol
blue), with an additional 100 µl of 1x sample buffer (62.5 mM Tris HCl, pH 6.8, with 2%
SDS, 10% glycerol, 0.01% β-mercaptoethanol, 0.01% bromophenol blue) to help
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distribute the solution in the large 2-D/prep well. Samples to be run in the large well of
the gel included 4 µg of either B. procyonis larval ESA or P. equorum larval ESA for the
serum from rabbit immunizations or 20 µg of either B. procyonis larval ESA or P.
equorum larval ESA for the serum from rabbit inoculations. An increased amount of
protein was used when blotting sera from rabbit inoculations because these sera had
been stored for longer period of time. After electrophoresis, proteins were
electrophoretically transferred to a 0.45 µm polyvinylidine fluoride (PVDF) membrane
(Westran Clear Signal; GE Healthcare, Piscataway, NJ). Membranes were washed twice
for 5 minutes on an orbital rocker in 1x Tris Buffered Saline with Tween 20 (TBST). Next,
membranes were washed in a 0.1% India Ink solution for 15-20 minutes for visualization
of proteins, and then washed 4 times for 5 minutes each in 1X TBST. Membranes were
air-dried and stored at 4 ˚C for up to 2 weeks. For blotting, membranes were allowed to
equilibrate to room temperature, and then were blocked on an orbital rocker for one
hour in 5% fat-free milk solution prepared in 1x TBST. Membranes were washed an
additional 3 times in 1x TBST prior to clamping into a multiscreen apparatus (MiniPROTEAN II, Bio-Rad, Hercules, CA).
For primary antibody preparation, sera were mixed with blocking buffer in a
1/1250 dilution, except for sera from inoculated rabbits, which were mixed in a 1/500
dilution. Primary antibody incubation was conducted in the multiscreen for 2 hours at
room temperature on a platform rocker at a very slow speed. Samples were vacuumed
from the multiscreen and lanes were washed 6 times with 1x TBST on the platform
rocker for 5 minutes each. Next, secondary antibody was prepared at different dilutions
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in blocking buffer depending on the type of primary antibody. Secondary antibodies
included horseradish peroxidase (HRP) conjugated goat anti-rabbit IgG with heavy and
light chains (H+L) at a 1/50,000 dilution in blocking buffer (Thermo Scientific, Waltham,
MA), goat anti-canine IgG (H+L) at a 1/50,000 dilution (Southern Biotechnology
Associates, Birmingham, AL), and goat anti-horse IgG(T) at a 1/100,000 dilution (AbD
Serotec, Raleigh, NC). Molecular weight standards were incubated with StrepTactin-HRP
(Bio-Rad, Hercules, CA) at a 1/100,000 dilution in blocking buffer. Secondary antibody
incubation was conducted for one hour at room temperature on a platform rocker.
Lanes were then washed 6 times in 1X TBST before using a chemiluminescent kit
according to the manufacturer’s instructions (Amersham ECL Prime; GE Healthcare,
Piscataway, NJ). Antibody recognition was visualized using a FluorChemE imager
(ProteinSimple, Santa Clara, CA). Molecular weights of proteins were estimated using
the AlphaVIEW SA program (Version 3.2.4.0; Cell BioSciences Inc., Santa Clara, CA).
Statistical Analysis
Statistical analysis was conducted using SAS version 9.3 (SAS Institute Inc., Carey,
NC). Differences for B. procyonis prevalence by geographical area were examined using
PROC FREQ. Descriptive statistics for larval mortality and larval sizes were obtained
using the PROC MEANS command, and mean larval sizes were compared by week
between the two species using PROC TTEST (unpaired). In the case of unequal variances,
the Satterthwaite method was used to calculate the p-value. Mean larval sizes for day 0
and day 21 were also compared within species using PROC TTEST (paired). Where
statistical comparisons were made, a p-value of <0.05 was deemed significant.
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Results
Specimen Collection
Of 55 raccoons captured in central Kentucky between February and June, 29.1%
were positive for B. procyonis, with a mean of 3 worms (SD=2.3 worms) in the small
intestine. Of 61 raccoons trapped in southeastern Kentucky between November and
February, 18.0% were positive for B. procyonis, with a mean of 14 worms (SD=9.3) in the
small intestine. There was no statistical difference for prevalence by geographical area
using the chi-square test (p=0.159).
Larval Culture
Larval culture of P. equorum proved challenging, and required a modification in
order to promote sufficient hatching and larval recovery. Without the modification
(proceeding directly from bleaching and washing to hatching), the mean P. equorum
larval recovery percentage was 3.2% (SD= 4.3%) from seven attempts. With the
modification (bleaching and washing, maintaining in saline solution for a week, and then
briefly bleaching and washing again), the mean larval recovery percentage was 48.3%
(SD=21.5%) from seven attempts. Differences in the thickness of the eggshell for B.
procyonis, T. canis, and P. equorum were noted visually (Figure 4.1) and the chitinous
layer shell of P. equorum was found to be 4.7 times thicker than the shell of B.
procyonis.
Percent mortality of P. equorum larvae after hatching also differed by protease
inhibitor (Table 4.1). Due to the high mortality of larvae in cultures containing the PIC
with EDTA (AEBSF, aprotinin, bestatin, EDTA, E-64, leupeptin; Sigma-Aldrich, St. Louis,
66

MO), subsequent culture attempts used two other types of PIC. Cultures of P. equorum
were sustainable for approximately 3 weeks, after which time mortality was too high to
maintain cultures for production of ESA. Baylisascaris procyonis was also maintained for
3 weeks, at which time mean mortality within the six culture flasks reached 77.3%
(SD=17.6%).
Morphological differences were noted for P. equorum larvae when compared
with B. procyonis. At all time points, B. procyonis larvae were wider than P. equorum
larvae (p<0.001) (Table 4.2). While B. procyonis larvae appeared to grow noticeably in
culture, changes in size for P. equorum were not as apparent (Table 4.2). However,
paired t-test results indicated an increase in length and width by both P. equorum and B.
procyonis between day 0 and day 21 (p<0.001). Shedding of the cuticle was also
observed for P. equorum (Figure 4.2) and B. procyonis (Figure 4.3) while in culture.
Parascaris equorum cultured in Thermo Scientific PIC (AEBSF, aprotinin, bestatin,
E-64, leupeptin and pepstatin A in DMSO; Thermo Scientific, Waltham, MA) produced 38
µg protein/10,000 hatched larvae over the course of 21 days. In comparison, B.
procyonis larvae cultured in the same PIC produced 64 µg protein/10,000 hatched larvae
during a 21 day culture period. Immature adult P. equorum produced 93 µg of protein
per worm over the 5 day culture period.
SDS-PAGE
Silver-stained SDS-PAGE results displayed multiple ESA produced by larval P.
equorum, larval B. procyonis, and immature adult P. equorum (Figure 4.4). Proteins that
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were visualized by silver stain ranged in size from an estimated 12-94 kDa for P.
equorum larval ESA, 12-189 kDa for P. equorum immature adult ESA, and 13-244 kDa for
B. procyonis larval ESA. Banding patterns indicate that many proteins of homologous
molecular weights were excreted/secreted by the two species of larvae, but P. equorum
larvae did not appear to produce some of the high molecular weight proteins produced
by B. procyonis larvae and P. equorum immature adults.
Western Blotting
In western blot analysis, the two horses naturally infected with P. equorum had
IgG(T) antibodies that recognized larval P. equorum ESA (Figures 4.5, 4.6, Table 4.3).
Antibody recognition by both horses occurred at approximately 19 kDa, 22 kDa, 26 kDa,
and 34 kDa. Pre-immunization with P. equorum or B. procyonis ESA, rabbits showed
some antibody reactivity at high molecular weights (approximately 90 kDa and 120 kDa)
(Figure 4.5). Pre-inoculation with P. equorum or B. procyonis eggs, rabbits did not
appear to have any IgG antibodies to P. equorum larval ESA (Figure 4.6). Serum from one
rabbit immunized with P. equorum ESA had IgG antibodies that recognized proteins at
19 kDa, 22 kDa, 26 kDa, and 34 kDa (Figure 4.5 and Table 4.3). Serum from rabbits
immunized with B. procyonis ESA recognized only the 26 kDa P. equorum protein, along
with high molecular weight proteins (Figure 4.5 and Table 4.3). Serum from rabbits
inoculated with B. procyonis eggs also recognized the high molecular weight proteins
(Figure 4.6). Similarly, rabbits inoculated with T. canis eggs showed reactivity at these
high molecular weights, along with 22 kDa and 26 kDa, as did one of the dogs with
natural T. canis infection (Figure 4.6 and Table 4.3). One dog did not show any antibody
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reactivity to P. equorum antigens (Figure 4.6), and another recognized only high
molecular weights.
Sera blotted on B. procyonis larval ESA recognized antigens of different
molecular weights. Serum from the P. equorum positive necropsied colt had very faint
reactivity at approximately 52 kDa and 250 kD (Figures 4.7 and 4.8). Serum from the filly
positive for P. equorum eggs in feces faintly recognized ESA at approximately 30 kDa and
34 kDa (Figure 4.7). Rabbits immunized with P. equorum ESA showed antibody reactivity
when the imager exposure time was increased, and recognized antigen at approximately
13 kDa, 40 kDa, 68 kDa and around 250 kDa (Figure 4.7). Serum from one rabbit showed
additional antibody recognition at 33 kDa and 35 kDa. As might be expected, a greater
number of B. procyonis than P. equorum antigens were detected by animals naturally
infected with T. canis, or inoculated with B. procyonis or T. canis eggs (Figures 4.7 and
4.8).
Discussion
Larval Culture
The hatching method originally attempted with P. equorum has been reported to
yield recovery of 80-90% of A. suum larvae [213, 214]. The P. equorum yield obtained by
following this protocol was extremely low. This could be related to the morphology of
the egg shell. In other species, such as A. lumbricoides and A. suum, the chitinous layer
has been reported to be 2 µm [215] or 3-4 µm [58] in thickness. Although
measurements of the egg shells were not taken in this study, the shell of P. equorum

69

was comparatively thicker than that of B. procyonis. Parascaris equorum eggs are also
more spherical when compared to T. canis and B. procyonis eggs, which could
potentially contribute to the strength of the shell. The modification of bleaching and
washing, and then allowing eggs to remain in physiological saline solution may have
increased permeability of the shells. The bleaching time for the second hatching
attempt was very short, and is not expected to have had much effect on further
decreasing the chitinous layer of the shell. For future P. equorum culture attempts, it
may also be worthwhile to examine extensive bleaching times and concentrations above
what are reported for other species. Although the modification of bleaching and
washing twice led to improved yields, these were still lower than what was obtained for
A. suum. Additional investigation is needed to improve hatching yields for P. equorum.
Larval mortality by week for P. equorum and B. procyonis in unsupplemented
media for ESA collection was similar to what has been described in some previous work.
Dangoudoubiyam and Kazacos (personal communication) maintained B. procyonis in
Dulbecco’s modified Eagle’s medium for 3 weeks until mortality reached 50%, while
another researcher was able to maintain B. procyonis larvae in the same medium for 6
weeks [77]. Toxocara vitulorum was reported to survive in RPMI-1640 media in culture
for up to 3 months, but mortality data was not provided [78]. Toxocara canis can be
cultured in Eagle’s minimal essential medium with Hank’s salts for up to 18 months
without significant mortality [76]: this is thought to be because of the ability of T. canis
larvae to remain dormant and encysted in adult female dogs. In the same type of
medium, A. suum has been shown to survive for only 3 weeks without substantial
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mortality [76]. Larval survival for P. equorum was shorter when the protease inhibitor
cocktail containing EDTA was used. Although the same protease inhibitor containing
EDTA did not appear to harm cultures of Strongylus vulgaris (the equine large strongyle)
[179], it appears that it is not a good choice for P. equorum larval culture.
Size differences in culture were noted for B. procyonis and P. equorum. Although
only rough estimates of larval length can be provided due to the methods used in this
study, the estimates for B. procyonis (Table 4.2) were extremely similar to what has
been previously described. Mean lengths of fixed B. procyonis after hatching have been
reported at 278 µm on day 0, 333 µm on day 7, 409 µm on day 14, and 451 µm on day
21 [77]. For P. equorum, lengths of larvae recovered at necropsy have been reported.
On days 1, 3, and 5 after infection, larvae in the stomach, small intestine, and liver were
reported to be 200 µm in length [16]. By day 7, larvae in the liver had increased to 600
µm in length [16]. As our larvae did not reach this size, it appears that development
occurred more slowly in culture than it would have within the host. However, cuticle
shedding was noted for both B. procyonis and P. equorum. Other studies have identified
cuticle shedding and larval growth during culture of A. suum [216] and B. procyonis [77],
while T. canis remained in the L2 stage [76]. If P. equorum cuticle shedding occurs in
culture, it appears that the infective unhatched larva is in the L2 stage. The molt to L3
stage appears to be completed after hatching, and probably prior to or shortly after
reaching the liver.
The amount of protein produced by each species may not be completely
accurate, as the silver-stained gel indicated that the 5 µg sample of B. procyonis ESA
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contains more protein than the P. equorum lanes (Figure 4.4). The BCA kit may have
underestimated production by B. procyonis, or overestimated production by P. equorum
larvae and immature adults. Regardless, it appears that B. procyonis larvae produce a
greater amount of protein in culture than P. equorum. While Boyce and colleagues
estimated that each B. procyonis larva produced 1-3 ng of protein per day for the first 3
weeks in culture [77], we estimate that each P. equorum larva produced 0.18 ng
protein/day, and each B. procyonis larva produced 0.30 ng protein/day. It is possible
that differences in egg storage or culture methods could have affected larval B.
procyonis ability to produce ESA.
SDS-PAGE
SDS-PAGE results indicated that P. equorum larvae and immature adults
excrete/secrete a range of molecules (Figure 4.4). Silver-stain results indicate that P.
equorum larvae produced dominant proteins that were smaller than 100 kDa, with
approximately 13 bands that could be visualized. There were some common bands
among the three parasite types, along with several differences. Differences observed
between P. equorum larvae and immature adults could have been attributed to
variation in individual populations, as other researchers have noted changes in banding
by culture batch [217], or they could have been due to changes in proteins produced by
life stage. Other researchers who examined homogenized whole adult P. equorum worm
identified two broad and unresolved low molecular weight bands (7 and 9 kDa) as
protease inhibitors [94]. Parascaris equorum larvae and immature adults produced
diffuse areas of banding below 10 kDa, but we cannot speculate on the identity or
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function of these proteins. Another study examined somatic antigens of adult P.
equorum, and found a large number of bands ranging in size from below 15 kDa up to
200 kDa [218]. We observed fewer proteins, but it is expected that a smaller number of
proteins would be excreted/secreted than would be contained within the body
structures.
Western Blotting
Silver-stained P. equorum larval proteins at approximately 22 kDa, 26 kDa, and
34 kDa were also recognized by IgG(T) antibodies of both P. equorum infected horses
(Figures 4.4, 4.5, and 4.6). The protein at 19 kDa was not clearly visualized by silverstaining. This indicates that the amount of that protein in the gel may have been too low
to be detected by silver stain, but that protein may elicit a relatively strong immune
response in the host. Of the P. equorum antigens of importance recognized by P.
equorum infected horses, only the 26 kDa band was recognized by the rabbits
immunized with B. procyonis ESA. Of the rabbits immunized with P. equorum ESA, one
rabbit responded similarly to the horses, while the other rabbit responded more like the
rabbits immunized with B. procyonis ESA. This could have been due to the lower amount
of protein used for P. equorum immunizations, or differences in immune response of
the two rabbits. As many of the same antigens were recognized by IgG(T) antibodies of
horses and the IgG antibodies of the immunized rabbit, it appears that the rabbit IgG
isotypes corresponding to equine IgG(T) are the antibodies of major importance. Of the
rabbits inoculated with B. procyonis or T. canis eggs, cross-reactivity with antibodies to
P. equorum was only noted at the 22 kDa and 26 kDa antigens. These results indicate
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that the antigens with the greatest potential for distinguishing the two types of infection
are located at 19 kDa and 34 kDa. Antibody recognition of the higher molecular weight
molecules appears common to all of the sera and P. equorum larval ESA combinations
examined.
Western blots using B. procyonis larval ESA and sera from B. procyonis and T.
canis infected animals indicated that sera were acceptable for use as controls (Figures
4.7 and 4.8). Although our main goal was to examine the diagnostic potential of a
western blot test for P. equorum, these western blots provided new information on the
potential for cross-reactivity when testing for B. procyonis infection. Antibody
recognition of B. procyonis larval ESA was very weak for P. equorum infected horses.
Antibody binding to B. procyonis ESA was also weaker for rabbits immunized with P.
equorum ESA when compared with rabbits immunized with B. procyonis ESA, as might
be expected. Recognition of antigen by P. equorum immunized rabbit sera could only be
visualized by increasing the imager exposure time above what was needed for the B.
procyonis immunized rabbits. Dangoudoubiyam and Kazacos used antibody binding
between 30-45 kDa as criteria to identify infections with B. procyonis [203], and
although weaker, we did identify antibody binding in this region by rabbits immunized
with P. equorum ESA. This suggests that there is potential for cross-reactivity when
using the western blot test for diagnosis of B. procyonis infection. It also appears that
there were differences in ESA produced or collected during our B. procyonis culture
when compared with prior studies, as antigen recognition patterns by rabbits inoculated
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with B. procyonis and T. canis eggs did not provide an exact match for what has been
previously described using the same serum [203].

Specimen Collection
It is worthwhile to report the prevalence of B. procyonis, as ingestion of infective
eggs can lead to larval migrans and health concerns in humans. In the eastern and
midwestern United States, the prevalence of B. procyonis in raccoons has been found to
decrease from north to south, with prevalence as high as 86% in Illinois, decreasing to
0% in Florida and Alabama [211]. The prevalence of B. procyonis in raccoons has been
previously described for western Kentucky, but reports for other areas of Kentucky
could not be found in the literature. One study found a very low prevalence of 3% out of
145 raccoons collected throughout the year in western Kentucky and northern
Tennessee [219]. Another study in western Kentucky found 30% prevalence in 70
raccoons collected between December and May [220], which is similar to the findings
for central Kentucky (29%) in our study. The majority of the positive raccoons from
western Kentucky were from an agricultural region [220]. In midwestern states, B.
procyonis prevalence was found to be higher in rural areas than urban areas [221], and
B. procyonis is also thought to be more common in mountainous areas [211].
Conversely, a study in Georgia found that prevalence was higher in urban/suburban
raccoons, when compared to rural raccoons [222]. The majority of raccoons collected
from central Kentucky were from urban or suburban locations, while the area in
southeastern Kentucky is more rural and mountainous. However, we did not find a
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statistical difference in prevalence between the two locations, and the prevalence in the
urban area was numerically higher. If the parasite is more sparsely distributed in
southern states, P. equorum could be more prevalent in urban areas because raccoon
population densities are also higher in those areas [223], helping to maintain
transmission of the parasite. Also, because B. procyonis is more prevalent in juveniles
than adults, results could differ because of the ages of raccoons sampled, as well as the
time of year of collection [211]. The highest prevalence of B. procyonis appears to occur
in the fall, followed by a rapid decline in the winter months [211]. The raccoons from
southeastern Kentucky were all obtained during trapping season in the winter months;
thus, the prevalence in this region may be higher at other time points throughout the
year.

Conclusion
The results of this study provided new information on the culture and ESA
production of P. equorum larvae, and the potential for IgG/IgG(T) antibody recognition
of P. equorum ESA. Larval culture results indicated that a modified hatching technique
may be required to obtain sufficient numbers of P. equorum for culture, but that
hatching and in-vitro maintenance of this parasite are possible. Excretory-secretory
antigen production of this parasite was low, so larger cultures of this parasite may be
required to obtain adequate antigen for diagnostic testing. Parascaris equorum larvae
appear to molt and grow in culture, indicating that they hatch as the L2 stage. For
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western blotting, antigens with the potential to diagnose P. equorum infection were
identified at 19 kDa and 34 kDa. Some cross-reactivity between species was noted at 22
kDa, 26 kDa, and at high molecular weights. It appears that there may be potential for
diagnosis of P. equorum infection using larval P. equorum ESA.
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Table 4.1. Mean and standard deviation of P. equorum larval mortality percentage by
type of protease inhibitor cocktail.*
Thermo Scientific
Thermo Scientific
Days Post-Hatching
Phosphatase PIC
PIC (without EDTA)
(without EDTA)
0
16.1 (12.6) n=2
8.3 (2.5) n=4
5.5 (2.5) n=3
7
63.7 (16.9) n=3
34.6 (27.9) n=14
24.2 (9.0) n=12
14
71.4
n=1
47.9 (14.7) n=11
41.9 (13.4) n=12
21
76.0 (14.0) n=10
75.3 (7.1) n=12
*The number of culture flasks is represented by “n.” On day 0, samples were taken prior
Sigma-Aldrich PIC
(with EDTA)

to aliquoting into flasks.
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Table 4.2. Mean and standard deviation of lengths and widths of P. equorum and B.
procyonis larvae (µm).
Days PostP.equorum
B. procyonis
P. equorum
B. procyonis
Hatching
Length
Length
Width
Width
0
263 (19)
275 (26)
12* (2)
25* (3)
7
277* (17)
328* (26)
14* (2)
30* (5)
14
274* (20)
367* (73)
15* (4)
37* (11)
21
291* (25)
498* (50)
17* (5)
40* (8)
*Length or width means within a row differ between species, P < 0.05.
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Table 4.3. Number of animals exhibiting antibodies to P. equorum ESA.
Host
Species
Horse
Rabbit
Rabbit
Rabbit
Rabbit
Dog

Molecular Weight
Infection/Injection Type

19 kDa

22 kDa

26 kDa

34 kDa

P. equorum natural infection
P. equorum ESA
B. procyonis ESA
B. procyonis eggs
T. canis eggs
T. canis natural infection

2/2
1/2
0/2
0/5
0/2
0/3

2/2
1/2
0/2
0/2
2/2
1/3

2/2
2/2
2/2
0/2
2/2
1/3

2/2
1/2
0/2
0/2
0/2
0/3
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A

B

C

D

Figure 4.1. Eggs of B. procyonis, T. canis, and P. equorum (not to scale). A: B. procyonis
egg undergoing division. B: T. canis unicellular egg. C: P. equorum unicellular egg. D: P.
equorum egg with outer proteinaceous layer removed and mechanical disruption of
chitinous layer of shell.
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A

B

Figure 4.2. Cuticle shedding by P. equorum larvae, day 21 in culture (A and B). Arrows
indicate the shed cuticle. The larva in photo B shed a thicker cuticle than typically noted
in culture.

82

Figure 4.3. Cuticle shedding by B. procyonis larva, day 14 in culture. The arrow indicates
the shed cuticle.
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Figure 4.4. Silver-stained P. equorum and B. procyonis ESA on a 4-20% gradient gel. Lane
1, molecular weight standards; Lane 2, P. equorum larval ESA; Lane 3, P. equorum
immature adult ESA; Lane 3, B. procyonis larval ESA.

84

Figure 4.5. Western blot of larval P. equorum ESA recognized by P. equorum naturally
infected equine IgG(T) and P. equorum ESA immunized rabbit IgG. Lane 1, molecular
weight standards; Lane 2, colt positive for P. equorum at necropsy, anti-horse IgG(T)
secondary antibody; Lanes 3-6, pre-immunization rabbit sera; Lanes 7-8, rabbits
immunized with B. procyonis ESA (day 63); Lanes 9-10, rabbits immunized with P.
equorum ESA (day 63).
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Figure 4.6. Western blot of larval P. equorum ESA recognized by P. equorum naturally
infected equine IgG(T), B. procyonis or T. canis inoculated rabbit IgG, and T. canis
naturally infected canine IgG. Lane 1, molecular weight standards; Lane 2, colt positive
for P. equorum at necropsy; Lane 3, filly positive for P. equorum eggs in feces; Lanes 4-6,
pre-immunization/inoculation rabbits; Lanes 7-11, rabbits inoculated with B. procyonis
eggs; Lanes 12-13, rabbits inoculated with T. canis eggs; Lanes 14-16, dogs with natural
T. canis infections.
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Figure 4.7. Western blot of larval B. procyonis ESA recognized by P. equorum naturally
infected equine IgG(T) and P. equorum or B. procyonis immunized rabbit IgG. A: Lane 1,
molecular weight standards; Lane 2, colt positive for P. equorum at necropsy; Lane 3,
filly positive for P. equorum eggs in feces; Lanes 4-7, pre-immunization rabbits; Lanes 89, rabbits immunized with P. equorum ESA (day 63). B: Lanes 10-11, rabbits immunized
with B. procyonis ESA (day 63).
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Figure 4.8. Western blot of larval B. procyonis ESA recognized by P.equorum naturally
infected equine IgG(T), B. procyonis or T. canis inoculated rabbit IgG, and T. canis
naturally infected canine IgG. Lane 1, molecular weight standards; Lane 2, colt positive
for P. equorum at necropsy; Lane 3, filly positive for P. equorum eggs in feces; Lanes 4-6,
pre-inoculation/immunization rabbits, Lanes 7-11 rabbits inoculated with B. procyonis
eggs; Lanes 12-13, rabbits inoculated with T. canis eggs; Lanes 14-16, dogs with natural
T. canis infections.
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CHAPTER 5: ANTIBODY RESPONSE OF HORSES TO PARASCARIS EQUORUM EXCRETORYSECRETORY ANTIGENS
Introduction
Parascaris equorum is an ascarid parasite that infects foals and young horses.
This parasite has been found on every continent except Antarctica [5, 6, 8, 10, 11, 131],
and in Kentucky, prevalence in foals by farm has been reported to range from 0% to 64%
[114]. The successful survival of this parasite is at least partially due to the life cycle and
the structure of the egg. Transmission occurs when eggs are shed in the feces of an
infected equid, the eggs larvate, and an equid ingests the infective eggs [38]. The
microscopic eggs of P. equorum have been reported to remain viable for at least 18
months to 3 years [21, 22], making this a difficult parasite to manage. Once infective
eggs are ingested, larvae hatch and migrate from the small intestine through the liver
and lungs, and then return to the small intestine for maturation and reproduction [15,
16]. During the migrational phase of the life cycle, larvae can cause pathologies of the
liver and lungs, along with respiratory symptoms [16, 17, 99]. Diagnosis can be made
using microscopy to check for parasite eggs in feces. However, the appearance of eggs
does not occur until parasites reach the reproductive stage of the life cycle, 10-15 weeks
after initial infection [15, 17, 46, 47]. Thus, prepatent infections cannot currently be
diagnosed. Once larvae return to the small intestine to mature, new issues arise. Large
worm burdens in the small intestine can lead to weight loss, depression, lowered serum
and total body albumin, and even intestinal blockage or rupture [17, 20, 97, 102, 104].
Copromicroscopic methods for detection of the parasite eggs do not provide an
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accurate depiction of the total worm burden in the small intestine [37]. Therefore, it
becomes problematic to use copromicroscopic methods, such as the fecal egg count
(FEC), for making treatment recommendations or evaluating the efficacy of
anthelmintics.
As copromicroscopic methods are currently the only methods available for
diagnosis of P. equorum, the development of new diagnostic tools would be beneficial
to equine health, and could help to improve our knowledge of the host immune
response to this parasite. Serological tests have been developed for diagnosis of other
ascarids or equine parasites, and often utilize excretory-secretory antigens (ESA)
collected from parasites in-vitro [77, 160, 179, 194, 195, 203, 224]. Excretory-secretory
antigens have been used in the development of serological tests for infection or larval
migrans of Toxocara canis [194, 205, 206, 210], Baylisascaris procyonis [77, 203], Ascaris
suum [75, 205, 225, 226], and Ascaris lumbricoides [201, 205].
Tools for serological diagnosis of other equine parasites have been developed
using ESA. For example, a western blot test, and subsequently, an ELISA test have been
developed using ESA from the equine tapeworm, Anoplocephala perfoliata [158, 160].
Diagnostic potential of this test was improved by monitoring for IgG(T) instead of IgG,
and using a recombinant protein based on the 12/13 kDa ESA [158]. In horses, IgG(T)
actually consists of two isotypes (IgG3 and IgG5) that were formerly classified together
as one [162, 163]. These isotypes, together as IgG(T), have also been used for diagnosis
of other equine parasites. Recently, ESA from a large equine strongyle species,
Strongylus vulgaris, were evaluated using a western blot test, and a recombinant
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protein was developed for ELISA use [179]. This study also found that IgG(T) had better
diagnostic accuracy than IgGa or total IgG [179]. These studies indicate the potential for
a new serological tool for diagnosis of P. equorum utilizing ESA.
Sera from two foals with P. equorum infection had been previously examined
and found to contain IgG(T) antibodies that recognized antigens that migrated at
approximately 19 kDa, 22 kDa, 26 kDa, and 34 kDa, indicating the potential for
diagnostic use (Figures 4.5 and 4.6). Other secondary antibody types have not yet been
examined for diagnosis of P. equorum. Although not currently used in other diagnostic
tests for equine parasites, investigation of other immunoglobulin isotypes is warranted.
For example, Immunoglobulin M (IgM) is the first immunoglobulin type produced in
response to infection [155], and antigen binding by IgM is used for diagnosis of
Toxoplasma gondii infection [184]. Immunoglobulin E may also be useful for diagnosis,
as IgE is commonly associated with parasitic disease [178], and serum levels of IgE in
horses are much higher than levels found in human serum [182].
The objectives of this study were to (1) compare IgE, IgM, and IgG(T) antibody
recognition of larval P. equorum ESA using sera from infected horses, (2) test the sera
from a cohort of broodmares and their foals from birth until a period of no egg
shedding, and (3) examine equine controls with monospecific parasite infections to
identify possible cross-reactivity.
Materials and Methods
The University of Kentucky Institutional Animal Care and Use Committee (20120924) approved all procedures used in this study.
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Antigen Collection
Parascaris equorum egg collection, embryonation, and hatching were conducted as
previously described (Chapter 4). Larvae (L2/L3 stages) were maintained in-vitro for
collection of ESA, as described elsewhere (Chapter 4).
Animals and Housing
A total of 18 Thoroughbred broodmares at University of Kentucky’s Maine
Chance Farm (MCF) were used for this study. The mean age of the mares was 8.8 years
(SD=4.4 yr), and the range was 4-20 years. All mares were in foal to Thoroughbred
stallions. Broodmares were kept on pasture for the majority of the year, and were
moved to smaller 5 acre pastures in groups of 4-7 near the foaling barn at least one
month prior to the expected foaling date. Mares were housed in foaling stalls within
several days prior to giving birth. Actual foaling dates were between 2/29/12 and
4/7/12. Mares are designated Mare1-18, and foals are correspondingly designated
Foal1-18, based on the order in which foals were born.
Immediately after giving birth, mare colostrum was checked using a Brix equine
colostrum refractomer (Animal Reproduction Systems, Chino, CA). For four mares
(Mare6, Mare7, Mare10, and Mare11), the colostrum score was at or below 20%
(corresponding to a concentration of approximately 50 g IgG/L or lower), and the foal
was supplemented with banked colostrum from a MCF mare with a good colostrum
score. Serum was collected the day after foaling to check serum IgG levels. Two foals
(Foal5 and Foal16) with failure of passive transfer (IgG <800 mg/dl) were given plasma
provided by a plasma bank (Equine Medical Associates, Lexington, KY). Overall, 12 foals
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received colostrum only from their dam and had adequate passive transfer, while four
foals required supplemental colostrum, and two foals required plasma. Results from all
foals were analyzed.
For the first 1-2 weeks after birth, foals were kept in stalls with their dams at
night and were turned out in small paddocks in individual mare-foal pairs during the
day. Mare and foal pairs were later grouped together in larger pastures and were stalled
only for health care or training. The locations of the fields and groupings changed
several times during the study. Foals were weaned in August or September by gradually
removing mares from each field.
Sera and Fecal Collection Procedures
Blood from each horse was collected (schedule below) in a 10 ml serum tube
(Vacutainer Serum Plus Tubes; Becton, Dickinson, and Company, Franklin Lakes, NJ) and
centrifuged for 10 minutes at 1000 x g prior to removing and storing serum. Sera were
stored at -80 ˚C until used for western blotting.
For MCF broodmares, ≥10 g of feces were collected from a freshly deposited sample
(schedule below). Samples were stored at 4 ˚C and processed within one week after
collection using a modified Stoll FEC method. For this method, 10 g feces were mixed
with 90 ml double distilled water, and a 1 ml subsample was added to a 14 ml conical
tube. Sucrose solution (1.275 specific gravity) was added to the tube. A cover slip was
added and the tube was centrifuged at 200 x g for 10 minutes. Parasite eggs counted by
microscopy were multiplied by 10 to calculate the eggs per gram (EPG).
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For MCF foals, ≥1 g of feces was collected either rectally or from a freshly
deposited sample (schedule below). Samples were stored at 4 ˚C and processed within
one week after collection. Parasite eggs were detected using a previously described
qualitative fecal flotation test [113, 115], using sucrose solution (1.275 specific gravity)
and 1 g of feces. This methodology was chosen because of the small amount of feces
required and the purported high sensitivity of the test [111, 115].
Sera and Fecal Collection Schedule
Sera and manure were collected from MCF mares within one month of expected
foaling date. Mares had not been treated with an anthelmintic for at least 10 weeks
prior to sampling, and were not treated with an anthelmintic for S. westeri after giving
birth, as is the typical procedure at this farm.
Serum was collected from each MCF foal immediately after birth, prior to
suckling. Serum was collected one day after suckling, and then weekly thereafter. As P.
equorum eggs from patent infections were not expected until the foals were at least 1015 weeks of age [15, 17, 46, 47], fecal samples were taken weekly starting on week 8.
Foals were not treated with anthelmintics until the week following the first P. equorum
positive fecal. Once foals were confirmed to be positive for P. equorum through fecal
flotation, they were switched to a monthly fecal and serum sampling schedule. A regular
anthelmintic treatment schedule was then followed in order to maintain the farm’s foal
health care practices and provide realistic results. The schedule was as follows:
fenbendazole (Panacur; Merck Animal Health, Summit, NJ) double dose one week after
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first P. equorum positive fecal, pyrantel pamoate (Durvet, Blue Springs, MO)
approximately one month later, fenbendazole double dose approximately one month
after pyrantel, and ivermectin with praziquantel (Zimectrin Gold; Merial, Duluth, GA) in
November. Foals were sampled every 4-6 weeks, depending on anthelmintic use.
Sampling for each foal ceased when two consecutively negative fecal samples were
obtained. If anthelmintic use was suspected to have affected fecal results, a third fecal
sample was examined 3-6 weeks later. Yearlings remaining on the study were
dewormed with pyrantel in January and ivermectin in March. Two foals did not
complete the study: Foal15 was still shedding ascarid eggs when sold in February 2013,
and Foal13 was still shedding eggs in May 2013.
Additional sera were obtained from another study using mixed-breed foals from
the University of Kentucky Veterinary Science Farm (VSF) for use as positive controls
(courtesy of Drs. Eugene Lyons and Martin Nielsen, University of Kentucky). Sera and
manure were collected from five 3-5 month old VSF foals in July of 2011. Parascaris
equorum results for these foals ranged from 30-820 EPG. Serum from one of these foals
(VSF1) was collected again immediately prior to necropsy, when the horse was 8 months
of age. At necropsy, this horse had 54 immature adult P. equorum and 18 mature P.
equorum in the small intestine, and a FEC of 40 EPG (by modified Stoll method). Sera
from two other foals were collected immediately prior to necropsy. An 11-week-old foal
(VSF2) had 3 migrating P. equorum L4 in the lungs, and 159 L4 and 118 L5 P. equorum in
the small intestine. One 8-week-old foal (VSF3) had 4 migrating P. equorum L4 larvae in
the lungs, and 115 L4 and 31 L5 P. equorum in the small intestine. These foals were from
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a previously characterized herd of macrocyclic lactone naïve horses [227], and the foals
had never been treated with anthelmintics. It is unknown if these foals had adequate
passive transfer of antibodies.
Sera from foals with various parasite infections were obtained for this study
(kindly provided by Dr. Jacqui Matthews, Moredun Research Institute). One specimen
was from pooled sera from a group of ponies that were raised parasite-free. Briefly,
foals were removed from their dams 12 to 18 hours after birth, raised in cages, and fed
formula and pelleted horse feed. These animals were described in more detail in a
previous study [21]. Sera were also acquired from two ponies (numbers 101 and 105)
that were reared indoors with their dams as helminth-naïve. Sera were obtained from
these foals before (0-1 weeks pre-infection) and 13-15 weeks after artificial infection
with cyathostome larvae. These animals were also described in a previous study [228].
Finally, samples were obtained from two ponies that had been raised parasite-free but
were found to be infected with either Strongyloides westeri or P. equorum at necropsy
(M. Chapman, unpublished), as were referenced in another study [218]. These sera were
stored at -20 ˚C prior to use for western blotting.
Western Blotting
Identical western blotting procedures were used to test for IgM, IgE, and IgG(T)
antibodies, with modifications only in primary and secondary antibody dilutions. First,
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to
separate antigen. SDS-PAGE was conducted using 0.75 mm 2-D/prep gels (12% running
and 4% stacking). Parascaris equorum ESA (4 μg) were thawed and combined with 5x
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sample buffer (1.5 M Tris HCl, pH 6.8, with 2% SDS, 10% glycerol, 5% βmercaptoethanol, and 0.01% bromophenol blue), and an additional 100 µl of 1x sample
buffer (62.5 mM Tris HCl, pH 6.8, with 2% SDS, 10% glycerol, 0.01% β-mercaptoethanol,
0.01% bromophenol blue). Samples were then heat denatured for 5 minutes 95 ˚C. A
molecular weight standard (Broad Range Precision Plus Protein Unstained Standards;
Bio-Rad, Hercules, CA) was used in the first lane of each gel (2 µl), and P. equorum larval
ESA were run in the large lane of each gel.
After electrophoresis, proteins were transferred electrophoretically to a 0.45 µm
polyvinylidine difluoride (PVDF) membrane (Westran Clear Signal; GE Healthcare,
Piscataway, NJ). Membranes were washed in 1x Tris Buffered Saline with Tween 20
(TBST) twice for 5 minutes each time on an orbital rocker. Membranes were washed in a
0.1% India Ink solution for 15-20 minutes, washed in 1X TBST 4 times for 5 minutes, and
then were air-dried and stored at 4 ˚C for up to 2 weeks. Membranes were allowed to
equilibrate to room temperature prior to western blotting, and then were blocked on an
orbital rocker for one hour in 5% fat-free milk solution prepared in 1x TBST. Next,
membranes were washed an additional 3 times in 1x TBST prior to securing in a
multiscreen apparatus (Mini-PROTEAN II, Bio-Rad, Hercules, CA).
Primary antibody was prepared at dilutions dependent upon the type of
secondary antibody to be used. For use with anti-equine IgG(T), equine sera were mixed
with blocking buffer in a 1/1250 dilution, or a 1/500 dilution for the banked sera from
the parasite-free and monospecifically infected foals. For use with anti-equine IgM,
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samples were mixed with blocking buffer at a 1/100 dilution. For use with anti-equine
IgE, serum dilutions included 1/1000, 1/500, 1/100, and 1/25. Primary antibody
incubation was conducted in the multiscreen for 2 hours at room temperature on a
platform rocker at low speed. Samples were vacuumed from the multiscreen and lanes
were washed 6 times with 1x TBST on the platform rocker for 5 minutes each. Next,
secondary antibody was prepared in blocking buffer. Secondary antibodies included
horseradish peroxidase (HRP) labeled goat anti-horse IgE at a 1/1000 dilution (Alpha
Diagnostic International, San Antonio, TX), HRP-labeled goat anti-horse IgM at a 1/2000
dilution (Bethyl Laboratories, Montgomery, TX), HRP-labeled goat anti-horse IgG(T) at a
1/50,000 dilution for banked monospecific infection or parasite-free control sera, and at
a 1/100,000 dilution for all other samples (AbD Serotec, Raleigh, NC). Molecular weight
standards were incubated with StrepTactin-HRP (Bio-Rad, Hercules, CA) at a 1/100,000
dilution in blocking buffer. Secondary antibody incubation was conducted for one hour
at room temperature on a platform rocker. Lanes were then washed 6 times in 1X TBST
for 5 minutes each time before using a chemiluminescent kit according to the
manufacturer’s instructions (Amersham ECL Prime; GE Healthcare, Piscataway, NJ).
Antibody recognition was visualized using a FluorChemE imager (ProteinSimple, Santa
Clara, CA). Molecular weights of proteins were estimated using the AlphaVIEW SA
program (Version 3.2.4.0; Cell BioSciences Inc., Santa Clara, CA).
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Results
IgE, IgM, and IgG(T) Antibodies
When sera from P. equorum positive horses VSF1 and VSF2 were tested using
anti-equine IgE at the manufacturer’s recommended dilutions, no bands were present
on the western blots. Sera from Mare4 and Foal4 samples were also tested, with the
same results. Use of anti-equine IgE was discontinued following these results, although
a true control was not available to test efficacy of the secondary antibody.
A doublet at approximately 53 and 58 kDa was recognized by IgM from Mare4
and Foal4 post-suckle, on weeks 1 and 2, and faintly on week 3 (Figure 5.1). Sera from
ascarid positive foals VSF2 and Foal4 did not contain measurable IgM antibodies that
recognized P. equorum ESA. Thus, anti-equine IgM was not pursued further for
diagnostic use.
All 8 VSF ascarid positive foal serum samples contained IgG(T) antibodies that
recognized proteins at approximately 19 kDa, 22 kDa, 24kDa, 26 kDa, 34 kDa, and 250
kDa or larger.
MCF Mare and Foal Fecal Flotation Tests
None of the 18 mares were found to be shedding P. equorum eggs in the feces
by FEC. The only parasite eggs identified were strongyle-type eggs, which were found in
the feces of 67% of the mares. Of those shedding strongyle eggs, the mean EPG was 105
(SD= 91; range 10-290).
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All foals became naturally infected with P. equorum. Foals first began shedding P.
equorum eggs in feces 11-18 weeks after birth (Figure 5.2). The mean age at first
shedding was 13.5 weeks (SD=1.6 weeks). Foals also became infected with other types
of parasites (Table 5.1). When fecal results from the complete study were examined, all
foals shed strongyle-type eggs and S. westeri eggs, and most foals also shed Eimeria
leukarti oocysts at some point during the study. Prevalence of parasite eggs in feces was
also examined (Table 5.1), although these results are weighted towards the first portion
of the study when foals were sampled weekly. The most commonly noted parasite ova
in the feces were strongyle-type eggs and S. westeri eggs (Table 5.1). The second
negative P. equorum fecal flotation result (Figure 5.3) was obtained between 21 to over
54 weeks (for Foal13 that did not complete the study). Excretion of adult ascarids by
two foals was observed during the study. Foal2 excreted an adult ascarid one month
after his second negative fecal flotation test (without recent dewormer use), and Foal16
excreted an adult female ascarid two days after deworming with fenbendazole.
MCF Mare Sera and Foal Sera over Time
Mare and foal sera recognized antigen at 19 kDa, 22 kDa, 26 kDa, and 34 kDa
molecular weights (Table 5.2). All but one mare sera exhibited IgG(T) antibodies against
these immunodominant antigens. All post-suckle foal sera and foal sera drawn at the
time of first ascarid positive fecal had antibodies that recognized P. equorum ESA (Table
5.2). No foal sera contained IgG(T) antibodies against ESA prior to drinking colostrum.
Foal antibody recognition of ESA appeared to decrease over time (Figures 5.4-5.6). By
the time two successive negative fecal flotation examinations were conducted, antibody
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recognition of most immunodominant antigens were still present, although antibody
recognition of the 22 kDa and 26 kDa antigens became less apparent for some foals
(Table 5.2, Figure 5.6). Fifteen of the foals showed a decrease in IgG(T) recognition of
immunodominant antigens over the first 13 weeks of life. For three foals (Foal9, Foal11,
and Foal13), IgG(T) recognition of ESA appeared to increase several months after initially
shedding P. equorum eggs in feces (Figure 5.7-5.8). Sera from one mare and foal pair
(Mare1 and Foal1) showed little initial IgG(T) antibody recognition of ESA, but Foal1 sera
displayed increased antibody recognition about 6 weeks prior to first shedding P.
equorum eggs (Figure 5.9). A reduction in band intensity was noted for this foal during
the last few months on the study (Figure 5.10).
Parasite-Free and Monospecific Infection Sera
Although banding intensity was low, the pooled parasite-free pony sera
recognized antigen at 19 kDa and 26 kDa (Figure 5.11). Serum from the horse
monospecifically infected with P. equorum recognized antigens at 19 kDa, 26 kDa, 34
kDa, 66 kDa, and approximately 110 kDa. Serum from the foal monospecifically infected
with S. westeri recognized only the 19 kDa antigen. With the exception of weak IgG(T)
recognition of ESA at 66 kDa and 110 kDa by pony 105, antibody recognition of ESA was
not apparent by pre-cyathostome infection pony foals 101 and 105. Post-cyathostome
infection, antibodies from pony 105 recognized antigen at 19 kDa, 22 kDa, 34 kDa, 66
kDa, and approximately 110 kDa. Only the 66 kDa and 110 kDa antigens were
recognized by antibodies from pony 101 after cyathostome infection.
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Discussion
IgE, IgM, and IgG(T) Antibodies
Western blot analyses for IgE antibodies against P. equorum ESA did not appear
to have diagnostic potential. As controls for the anti-equine IgE secondary antibody
were not available, we cannot rule out the possibility that the secondary antibody was
not effective, or that IgE antibodies within the sera had deteriorated prior to testing due
to the short half-life. Alternatively, the horses may not have produced measurable
quantities of IgE antibodies against P. equorum larval ESA. Very low levels of unbound
IgE have been detected in young foals, but these antibodies were of maternal origin
[166]. We did not detect any IgE antibody recognition of ESA or evidence of passive
transfer when using serum from Mare4 and Foal4. Other researchers have proposed
that endogenous IgE production in the foal does not begin until 6 months [229] or 9-11
months [166] of age. Similarly, none of our ascarid positive foal sera exhibited IgE
antibody recognition of the P. equorum antigen. Another study using western blot
analysis of sera from humans with toxocariasis found that although the test had high
specificity, only 35% of symptomatic patients and 24% of asymptomatic patients
displayed serum IgE reactivity to T. canis larval ESA [230]. Levels of free circulating
P.equorum-specific IgE may be too low to measure, even in positive horses.
Serum IgM antibodies did show some reactivity against P. equorum larval ESA.
Passive transfer of IgM was observed from Mare4 to her foal. Other researchers have
also found passive transfer of IgM, with levels in foals dropping rapidly within the first
month after birth [176]. Our results were similar, as IgM recognition of ESA by Foal4 was
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apparent for only the first 3 weeks after birth. It is possible that IgM could be associated
with immunity against patent infections and could provide some protection against
ascarid infection for the first few weeks in life, but this would need to be studied
further. Immunoglobulin M against P. equorum ESA may have been present in mare sera
as a result of recent infection with P. equorum larvae, or due to cross-reactivity with
similar antigens. Transfer of maternal IgM, IgA, and IgG antibodies directly into the small
intestine of newborn offspring can provide protection against parasites [231].
Interestingly, although IgM has been observed as the first antibody produced in young
foals [176], endogenous IgM antibody production against P. equorum larval ESA was not
noted for this foal during the first 14 weeks of age. Monitoring for P. equorum specific
IgM antibodies in serum for diagnostic purposes does not appear promising, as the two
infected foal samples displayed no IgM recognition of antigen on the western blot. This
test would also not allow for diagnosis of migrating larvae, as there was no indication of
antibody binding to ESA by Foal4 during the migratory period prior to patent infection.
Recognition of a greater number of P. equorum larval antigens was observed
with IgG(T). As all of the P. equorum positive VSF foals had IgG(T) antibodies that
recognized P. equorum immunodominant larval ESA, IgG(T) appears more promising
than IgM or IgE for diagnostic test development. Serum IgG(T) has been linked to a Th2
immune response [157], and increases in IgG(T) have been associated with artificial S.
vulgaris infection in horses [161]. Serum IgG(T) has also been used for diagnosis of
infection with S. vulgaris, A. perfoliata, and cyathostominae in horses [158, 179, 232]. It
appears that horses produce IgG(T) antibodies against P. equorum larval ESA as well.
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MCF Mare and Foal Fecal Flotation Tests
Fecal flotation test results for the MCF broodmares were not surprising, as
horses older than 2 years of age typically do not have patent P. equorum infections
[7, 11, 127]. The identification of low-level strongyle-type egg shedding by the majority
of mares was also expected.
The time at which MCF foals began shedding P. equorum eggs matched what has
previously been described in the literature. A central Kentucky study reported the mean
age at first appearance of P. equorum eggs in the feces to be 11.3 weeks, with a
maximum of 15 weeks [233]. Our mean was slightly higher, at 13.5 weeks. The foal that
did not become positive until week 18 (Foal 7) had been stalled for several weeks: first
due to a broken rib at birth, and second due to Rhodococcus equi infection, so this foal
may have had less exposure to P. equorum eggs when compared to the other foals that
lived on pasture. All of the MCF foals became naturally infected with P. equorum, as had
been reported previously when weekly examinations were conducted on Thoroughbred
foals in Kentucky [233]. Incidence of P. equorum infection in foals may be considerably
higher than prevalence, as studies have reported copromicroscopic prevalence in the
central Kentucky area to be at 22% in 10-223 day old foals [4] and 39% in 28-330 day old
foals [114]. We found only 29% of MCF foal fecal flotation tests to be positive for P.
equorum eggs, so there may be potential to miss infections if samples are not taken as
frequently. Similarly, as a diagnostic tool, the FEC (modified Stoll) has been shown to
have lower sensitivity (0.72) than specificity (0.94), indicating the potential for missed
infections of adult P. equorum [37].
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Although we cannot prove that two consecutive negative fecal examinations
signifies immunity to P. equorum, the ages at which this occurred was similar to what
has been reported for the development of immunity. Epidemiological studies have
concluded that foals and yearlings are more likely to shed ascarid eggs than older equids
[7, 136]. One study found that after 3-5 months of age, worm burdens decreased
monthly to nearly zero by 10 months of age (as determined by necropsy) [3]. Other
research indicates that immunity may begin to develop around 6 months of age, even
for P. equorum naïve foals [38, 186].
Along with P. equorum, MCF foals developed other natural infections. It is not
uncommon to find strongyle-type eggs, S. westeri eggs, and E. leukarti oocysts in foal
fecal samples. Our percentage of fecal samples containing S. westeri may have been
higher than other recent reports [4, 114] because the mares were not treated with
ivermectin prior to or following giving birth. Also, we sampled more frequently when
the young foals had not yet begun shedding P. equorum eggs, so this is expected to bias
the percentages. Concurrently, the percentage of fecal samples with strongyle-type eggs
also appeared high when compared with other reports [4, 114]. This could have been
because foals were not treated with an anthelmintic until one week after shedding
ascarid eggs, and so the treatment protocols of the farm were delayed by approximately
1-2 months. Strongyle resistance to fenbendazole, one of the primary anthelmintics
used, has also been documented on this farm [234].
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MCF Mare Sera and Foal Sera over Time
Although none of the mares had patent P. equorum infections, all of the mares
except one had IgG(T) antibodies against larval P. equorum ESA. In another study,
Quarter Horse broodmares were found to have high serum precipitin titers to P.
equorum antigen from homogenized whole adult worms [235]. The mares maintained
these titers throughout the 52 week study. Broodmares live in an environment with high
exposure to P. equorum eggs, and are expected to have constant challenge from
ingestion of eggs. It appears that the larvae hatch out and migrate in the adult horse,
causing an immune response, but then are unable to complete the life cycle. Clayton
and Duncan found that in previously helminth naïve 6-12 month old horses, fewer P.
equorum returned to the small intestine following artificial infection, when compared
with younger foals [186]. This indicated that the larvae may be destroyed during
migration, possibly in the liver or lungs in the older horse. Alternatively, larvae could
return to the small intestine and be expelled immediately afterwards, but this does not
seem likely as larvae would be noticed during fecal examinations. The exact mechanisms
and the role of IgG(T) regarding immunity to P. equorum in the older horse have yet to
be described.
The pre-suckle foal sera displayed no antibody recognition of P. equorum ESA, as
would be predicted. Because of the diffuse epitheliochorial placenta of the horse [164],
the foal is first exposed to the dam’s antibodies through the colostrum [164]. The postsuckle sera for all foals contained IgG(T) antibodies that recognized P. equorum larval
ESA similarly to the dams or colostrum donors, indicating passive transfer of those
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antibodies from mare to foal. This would not be so problematic for diagnostic analyses if
the maternal antibody waned quickly, but foal sera samples over time show that
maternal antibody is still present during the points in time when foals become infected
with P. equorum. This clearly limits the usefulness of a western blot test for IgG(T)
antibodies in P. equorum infected equids.
Nevertheless, this provides structure for new questions regarding immunity to
P. equorum. The transfer of IgG(T) from mare to foal does not appear to prevent
infection, so the function of these immunoglobulin isotypes is not yet obvious. Even
though maternal antibodies did not prevent infection, they could still have a protective
effect. In rats experimentally infected with Taenia taeniaeformis, those receiving
maternal antibodies against T. taeniaeformis through colostrum had smaller tapeworm
burdens following experimental infection when compared with controls [236]. In foals,
maternal antibodies appear to have a protective effect against some pathogens.
Successful passive transfer of IgG in foals is imperative, as failure of passive transfer has
been associated with contracting infectious diseases and consequently, foal mortality
[170, 180, 237].
Equine maternal transfer of antibodies specific to other infectious diseases, such
as West Nile Virus [238], equine protozoal myeloencephalitis [239], strangles [167],
piroplasmosis [240], tetanus [174], and influenza [174] has been documented
previously. In some cases, maternal antibody transfer can actually be harmful to foal
health. Maternal antibody transfer of anti-tetanus IgGa, IgGb, and IgG(T) antibodies
were found to inhibit foal endogenous production of antibodies following vaccination
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[174]. Studies of other parasite and host species have found that passive transfer of
antibody can lead to negative effects, such as suppression of priming of immune cells
and inhibition of endogenous antibody production [231]. Further research is needed to
determine whether maternal antibodies have a protective effect, harmful effect, or no
effect at all on foal immunity to parasites.
Although maternal antibodies masked the endogenous antibody production by
foals, Mare1 sera did not exhibit strong antibody recognition on the western blot test.
Accordingly, Foal1 sera displayed weak antibody recognition post-suckle and thereafter.
This foal appeared to produce detectable quantities of endogenous antibody by around
8 weeks of age, particularly to the 19 kDa antigen. Other studies have estimated IgG(T)
endogenous production to occur between 1 and 3 months of age [172, 173], closer to 34 months of age [176], or as early as around 2 weeks for foals deprived of maternal
antibody [173]. Foal1 did not begin shedding P. equorum eggs in feces until 14 weeks of
age, so endogenous antibody production was detectable 6 weeks prior to egg shedding.
By the time Foal1 began IgG(T) antibody production, the first larvae would already have
reached the small intestine. IgG(T) antibody production began to wane around 4 months
after Foal1 began shedding ascarid eggs, and one month before his last P. equorum
positive fecal.
The majority of the foal sera displayed a reduction in band intensity over the first
13 weeks of age, probably due to the decrease in maternal antibody. Because all of the
foals became infected with ascarids, we cannot determine the timeline for persistence
of these maternal antibodies in foal sera. Other studies have found a sharp decline in
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foal IgG(T) occurring by 1 month of age [172, 173]. Maternal IgG(T) antibodies specific
to influenza have been found to decrease to undetectable levels in foals by 12 weeks,
while maternal IgG(T) antibodies against tetanus persisted for over 26 weeks [174].
There was also individual variation among foals [174].
A few of the foals that were followed for longer time periods displayed more
intense banding several months post-shedding. These foals may have been infected
enough times to build up antibody levels more similar to the dams. One study using a
mouse model found fewer Toxocara vitulorum migratory larvae in mice that had been
immunized with T. vitulorum larval ESA when compared to controls, and the degree of
protection was associated with the number of immunizations given [241]. However,
Foal13 was still shedding eggs several months after the increase in band intensity. The
majority of foals appeared to cease egg shedding (at least temporarily) without
apparent changes in band intensity, so this may not be associated with the development
of immunity.
Parasite-Free and Monospecific Infection Sera
The parasite-free pooled pony sera most likely recognized P. equorum larval ESA
because upon necropsy, one control pony foal was found to have eighteen P. equorum
in the small intestine, and several ponies in the experimental groups also became
infected [21]. Also, these ponies may have had residual maternal antibodies against P.
equorum from colostrum. These results point out the difficulties in keeping foals
parasite free, as many precautions were taken during this study.
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Similarly, the foals with monospecific P. equorum or S. westeri infections were
originally intended to be parasite free (M. Chapman, unpublished, as referenced in
[218]). The foal with the monospecific P. equorum infection had antibodies that
recognized antigen similarly to infected MCF and VSF foals. The foal with the S. westeri
infection may have recognized the 19 kDa molecule because of cross-reactivity, or due
to passive antibody transfer, but the suckling status and age of this foal at necropsy are
not known.
The helminth-naïve Pony 101 pre-inoculation serum [228] could be considered a
parasite-free negative control, as no antibody recognition was noted. These foals had
been raised with their dams, but by the time the pre-infection serum was collected (age
6-12 months) maternal antibody could have declined, or the dams may not have had
antibodies to P. equorum. However, the post-cyathostome inoculation sera did exhibit
antibody binding of ESA at the immunodominant molecular weights characteristic of a P.
equorum infection. Either cyathostome infection is highly cross-reactive with P.
equorum infection on the western blot, or the ponies may have contracted P. equorum
infections. Pony 103, a control pony, was reported to sporadically excrete P. equorum
eggs [228]. Although Pony 101 and Pony 105 were not reported to have P. equorum
infections, it is possible that eggs from Pony 101 were transmitted to the other ponies.
Conclusion
IgE immunoglobulins with reactivity against P. equorum ESA were not recognized
using the western blot test. Mare IgM antibodies were found to bind to P. equorum
larval ESA at approximately 53 and 58 kDa, and antibodies were passively transferred to
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the foal. Foals positive for P. equorum did not exhibit antibody recognition of P.
equorum antigen; thus, anti-equine IgM is not useful for diagnostic purposes. Antiequine IgG(T) showed the most potential of the secondary antibody types, with
antibody binding of ESA at approximately 19 kDa, 22 kDa, 26kDa, and 34 kDa in most
infected VSF and MCF foals. However, passive transfer of antibody distorts
interpretation of results on the western blot test. Control sera from parasite-free foals
and foals with monospecific parasite infection also recognized some of the same
antigens as the P. equorum positive sera, emphasizing the difficulty in preventing P.
equorum infection, and obtaining true controls for equine parasitology studies. Future
work should examine the prevalence of antibodies to P. equorum in other equine
populations, identify the function of IgG(T) antibodies that recognize P. equorum ESA,
and explore other avenues for diagnostic testing in foals. These data indicate that
serological testing for antibodies in foals may be contraindicated, especially in situations
where maternal antibodies against the infective organism are prevalent.
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Table 5.1. Percentage of foals and percentage of fecal flotation tests positive for
different parasite types over the course of the study. No other parasite types were
identified.
Parasite Type
P. equorum
Strongyle-type
S. westeri
Eimeria leukarti

Percentage of foals
positive (n=18)

Percentage of fecal tests
positive (n=197)

100%

29%

100%

89%

100%

78%

89%

18%
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Table 5.2. Percentage of mares and foals with IgG(T) antibodies recognizing
immunodominant P. equorum larval antigens.

MW
(kDa)

Mares
n=18

19
22
26
34

94%
83%
89%
94%

Pre-Suckle
Foals
n=18
0%
0%
0%
0%

Post-Suckle
Foals
n=18
100%
89%
94%
100%
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First Positive
Fecal Foals
n=18
100%
89%
100%
100%

Second
Negative Fecal
Foals n=16
88%
56%
63%
88%

Figure 5.1. Western blot of VSF2, Mare4, and earliest Foal4 samples with IgM
recognition of larval P. equorum ESA. Lane 1, molecular weight standards; Lane 2,
ascarid positive foal VSF2; Lane 3, Mare4; Lane 4, Foal4 pre-suckle; Lane 5, Foal4 one
day post-suckle; Lanes 6-18, Foal4 weeks 1-13; Lane 19, Foal4 week 14 at first P.
equorum positive fecal.
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Figure 5.2. Number of MCF foals that have begun shedding P. equorum eggs by age in
weeks.

115

Number of Foals on Trial

Foals on Trial by Age
18
16
14
12
10
8
6
4
2
0
20

25

30

35

40

Foal Age in Weeks

Figure 5.3. The number of MCF foals remaining on the trial by age. Foals were removed
from the trial after two consecutive fecal flotation tests were negative for P. equorum
eggs. One foal had a second consecutive negative fecal on week 44, and the remaining
two foals were censored while still shedding eggs.
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Figure 5.4. Western blot of earliest Foal3 samples with IgG(T) recognition of larval P.
equorum ESA. Lane 1, molecular weight standards; Lane 2, ascarid positive foal VSF1;
Lane 3, Mare3; Lane 4, Foal3 pre-suckle; Lane 5, Foal3 one day post-suckle; Lanes 6-17,
Foal3 weeks 1-12; Lane 18, Foal3 first P. equorum positive fecal week 13.
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Figure 5.5. Western blot of earliest Foal4 samples with IgG(T) recognition of larval P.
equorum ESA. Lane 1, molecular weight standards; Lane 2, ascarid positive foal VSF1;
Lane 3, Mare4; Lane 4, Foal4 pre-suckle; Lane 5, Foal4 one day post-suckle; Lanes 6-18,
Foal4 weeks 1-13.
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Figure 5.6. Western blot of latest Foal3 and Foal4 samples with IgG(T) recognition of
larval P. equorum ESA. Lane 1, molecular weight standards; Lane 2, ascarid positive foal
VSF1; Lane 3, Foal3 pre-suckle; Lane 4, Foal3 week 13 first P. equorum positive fecal;
Lanes 5-7, Foal3 months 1-3; Lane 8, Foal4 week 13; Lane 9, Foal4 week 14 first P.
equorum positive fecal; Lanes 10-12, Foal4 months 1-3.
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Figure 5.7. Western blot of earliest Foal13 samples with IgG(T) recognition of larval P.
equorum ESA. Lane 1, molecular weight standards; Lane 2, VSF1 ascarid positive foal;
Lane 3, Mare13 mare; Lane 4, Foal13 pre-suckle; Lane 5, Foal13 post-suckle; Lanes 6-18,
Foal13 weeks 1-13.
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Figure 5.8. Western blot of last Foal13 samples with IgG(T) recognition of larval P.
equorum ESA. Lane 1, molecular weight standards; Lane 2, VSF1 ascarid positive foal;
Lane 3, Foal13 pre-suckle; Lanes 4-6, Foal13 weeks 13-15; Lane 7, Foal13 week 16 first P.
equorum fecal; Lanes 8-15, Foal13 months 1-8.
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Figure 5.9. Western blot of earliest Foal1 samples with IgG(T) recognition of larval P.
equorum ESA. Lane 1, molecular weight standards; Lane 2, VSF1 ascarid positive foal;
Lane 3, Mare1; Lane 4, Foal1 pre-suckle; Lane 5, Foal1 post-suckle; Lanes 6-18, Foal1
weeks 1-13.
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Figure 5.10. Western blot of last Foal1 samples with IgG(T) recognition of larval P.
equorum ESA. Lane 1, molecular weight standards; Lane 2, VSF1 ascarid positive foal;
Lane 3, Foal1 pre-suckle; Lane 4, Foal1 week 13; Lane 5, Foal1 week 14 first ascarid
positive fecal; Lanes 6-12, Foal1 months 1-7.
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Figure 5.11. Western blot of monospecific or parasite-free control IgG(T) antibody
recognition of larval P. equorum ESA. Lane 1, molecular weight standards; Lane 2, Foal3
pre-suckle; Lane 3, parasite-free pooled pony sera; Lane 4, P. equorum monospecifically
infected foal; Lane 5, S. westeri monospecifically infected foal; Lane 6, pony 105 precyathostome infection; Lane 7, pony 105 post-cyathostome infection; Lane 8, pony 101
pre-cyathostome infection; Lane 9, pony 101 pre-cyathostome infection; Lane 10,
Foal18 at first P. equorum positive fecal.
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CHAPTER 6: SERUM IgG(T) RESPONSES TO L2/L3 AND L5 PARASCARIS EQUORUM
ANTIGENS BY HORSES IN LOW AND HIGH RISK ENVIRONMENTS
Introduction
Parascaris equorum is a roundworm parasite that is often found in the small
intestine of foals and yearlings. The first stage of the life cycle begins when an infected
horse sheds eggs in the feces. This stage is important to the epidemiology of the
parasite, as the eggs have a thick, multilayered shell [23] and can remain viable for at
least 18 months to 3 years [21, 22]. One horse can shed millions of eggs per day [15].
For the life cycle to continue, a horse must ingest the larvated eggs. Larvae then hatch
and migrate from the small intestine to the liver, then to the lungs, and back to the
small intestine [15]. The worms mature and reproduce in the small intestine. This
parasite is of concern to horse owners because of the clinical signs and pathogenicity
that can occur. Larval migration can lead to lesions in the liver, lungs, and bronchial and
hepatic lymph nodes [16], and horses may display respiratory symptoms [17]. Large
burdens of P. equorum in the small intestine may lead to depression, anorexia, weight
loss [17], or even intestinal impaction or intestinal rupture in severe cases [18-20].
The durability of the egg in the environment makes transmission difficult to
prevent, and the potential for pathogenicity increases the importance of correct and
timely diagnosis. Currently, copromicroscopic methods are the only means for diagnosis.
However, the use of serological testing for antibodies has recently been explored
(Chapters 4 and 5). Although testing for IgE, IgM, or IgG(T) antibodies against P.
equorum larval excretory-secretory antigens (ESA) does not appear valid for diagnosis
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(Chapter 5), the results lead to more questions about the immune response of the horse
to this parasite, particularly in the adult horse.
In a recent study using western blot analyses, 18 Thoroughbred broodmares
were tested for IgG(T) response to P. equorum larval ESA (Chapter 5). None of these
mares were coprologically positive for P. equorum, yet all had IgG(T) antibodies against
at least some of the proteins at 19 kDa, 22 kDa, 26 kDa, and 34 kDa molecular weights.
Earlier work found similar results, as coprologically negative Quarter Horse broodmares
had high serum precipitin titers against P. equorum whole worm antigen throughout the
year [47]. The same study demonstrated a continual increase in the level of serum
precipitin titers of foals and yearlings against whole P. equorum worm antigen as the
horses developed immunity [47]. The function of these antibodies in the adult horse is
not yet known, but maternal transfer of the antibodies did not prevent P. equorum
infection in foals (Chapter 5). It is also unknown if all horses maintain a high titer of
antibodies to P. equorum larval ESA throughout life, or if these results occurred because
broodmares live in a high-exposure environment, contaminated annually by each foal
crop. Broodmares maintained antibodies against P. equorum larvae, yet did not have
patent infections. This could be explained by the ingestion of infective eggs that hatch,
migrate briefly, but then are stopped by the immune system prior to returning to the
small intestine to mature. Examination of IgG(T) response to adult P. equorum ESA could
be of value in describing the antibody response of the mature, immune horse. The
objectives for this study were to (1) compare IgG(T) antibody recognition of larval P.
equorum ESA by a group of low-exposure horses with previous results from a group of
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high P. equorum exposure horses (2) compare IgG(T) antibody recognition of adult P.
equorum ESA by sera from broodmares, older horses, and foals shedding ascarid eggs.
Materials and Methods
Antigen Collection
Collection, embryonation, and hatching of P. equorum eggs was conducted as
previously described (Chapter 4). Larvae were maintained in culture for collection of
ESA, and antigen was processed and stored as previously described (Chapter 4). Two live
immature adult (L5) P. equorum (approximately 5 centimeters in length) were collected
from the small intestine of a foal at necropsy. These ascarids were also cultured for ESA
collection, and antigen was collected and processed as previously described (Chapter 4).
Animals and Housing
Eighteen Thoroughbred broodmares from University of Kentucky’s Maine
Chance Farm were used for this study. All broodmares were in-foal to Thoroughbred
stallions, and had a mean age of 8.8 years (SD=4.4 yr, range=4-20 yrs). Broodmares were
maintained on pasture most of the year. At least one month prior to expected foaling
date, broodmares were moved to smaller 5 acre pastures in groups of 4-7 near the
foaling barn. Mares were moved to foaling stalls prior to giving birth. Foaling dates were
between 2/29/12 and 4/7/12. Mares were designated Mare1-18, and foals were
correspondingly designated Foal1-18, based on the order in which foals were born.
During the first 1-2 weeks after birth, foals were stalled with dams at night and
turned out in small paddocks during the day. Afterwards, mare and foal pairs were
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grouped with others in larger pastures and only stalled for brief periods of time for
management procedures.
Sera from a group of older horses were obtained from a veterinarian after use
for routine health testing in March 2012. This group included twelve horses of varying
breeds (Quarter Horse, Haflinger, Thoroughbred, Appaloosa, Paso Fino, and mixedbreed), with a mean age of 21.8 years (SD=4.0 yr, range=17-29 yr). The mean length of
time at the facility was 4.5 years (SD=2.2 yr, range=0.3-7 yr). Six of the horses were
mares and six were geldings. This group of horses was selected to compare with the
broodmares because of differences in expected exposure to P. equorum eggs. Although
the facility was not examined for the presence of eggs, several factors indicate that risk
of environmental contamination of eggs should be low. The facility was built in 2005 on
land that had not previously housed equids, and topsoil was stripped prior to
construction of the facility. Once horses were accepted into the facility, they were not
permitted to leave the grounds. All horses accepted into the facility were mature or
aging (as described below). Horses were turned out in groups on pasture for
approximately 12 hours each day, and were stalled for the remaining 12 hours. Several
mature outside horses were brought in for one day each year for an intercollegiate
horse show. Fecal examinations had been performed once every two months since 2011
using a modified McMaster’s method (egg detection limit 25 EPG) [57], and no P.
equorum eggs had ever been identified.
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Sera and Fecal Collection
The University of Kentucky Institutional Animal Care and Use Committee
approved (2012-0924) all procedures performed on University of Kentucky horses in this
study. Sera were collected by jugular venipuncture and processed as previously
described (Chapter 5).
From older horses in the low-exposure environment, freshly deposited fecal
samples were collected on the same day and processed using a modified Stoll method
described elsewhere (Chapter 5). These horses had not been dewormed for 2-5 months
prior to sample collection, depending on strongyle egg shedding levels.
Sera and feces were collected from broodmares in the spring of 2012, one
month prior to expected foaling date, and from foals weekly beginning at 8 weeks of age
until the first ascarid positive fecal (Chapter 5). Feces from broodmares were collected
from freshly deposited samples and were examined using a previously described
modified Stoll method (Chapter 5). Mares had not been dewormed for at least 10 weeks
prior to sampling, and were not treated with anthelmintics for S. westeri after giving
birth, as is the typical procedure at this farm. Feces from foals were collected either
rectally or from freshly deposited samples, and examined using a qualitative fecal
flotation test [113].
Serum was also collected from an 8-month-old colt positive for P. equorum in the
small intestine, as confirmed by necropsy (kindly provided by Drs. Eugene Lyons and
Martin Nielsen) for use as a positive control. For use as an antibody-negative control, a
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pre-suckle sample was collected from a Maine Chance Farm foal immediately after
birth, and prior to ingesting colostrum.
Western Blot Analyses
Samples (4 µg of either P. equorum larval ESA or immature adult ESA) were heat
denatured for 5 minutes 95 ˚C in 5x sample buffer (1.5 M Tris HCl, pH 6.8, with 2% SDS,
10% glycerol, 5% β-mercaptoethanol, and 0.01% bromophenol blue), with an extra 100
µl of 1x sample buffer (62.5 mM Tris HCl, pH 6.8, with 2% SDS, 10% glycerol, 0.01% βmercaptoethanol, 0.01% bromophenol blue). Larval and immature adult P. equorum ESA
were separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE) with 0.75 mm 2-D/prep 12% gels with a 4% stacking gel. Broad Range Precision
Plus Protein Unstained Standards (Bio-Rad, Hercules, CA) were used as a molecular
weight reference. Western blotting was conducted as previously described (Chapter 4),
using horseradish peroxidase (HRP) conjugated goat anti-horse IgG(T) at 1/100,000
dilution (AbD Serotec, Raleigh, NC) for chemiluminescent detection. Molecular weights
of proteins were estimated using the AlphaVIEW SA program (Version 3.2.4.0; Cell
BioSciences Inc., Santa Clara, CA).
Statistical Analyses
Statistical analyses were conducted using SAS version 9.3 (SAS Institute Inc.,
Carey, NC). Western blot banding patterns were compared using PROC FREQ and the
Fisher’s exact test function. Where statistical comparisons were made, a p-value of
<0.05 was deemed significant.
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Results
Copromicroscopic Results
None of the older horses were found to be shedding P. equorum eggs at the time
serum was collected. In 42% of the horses, strongyle-type eggs were identified in the
feces (Table 6.1). Of those shedding strongyle-type eggs, the mean EPG was 180
(SD=249 EPG, range=10-620 EPG). No other types of parasite eggs were identified. Fecal
results for the broodmares and foals were described in detail in Chapter 5. Briefly, none
of the broodmares were shedding ascarid eggs at the time of sampling, and all of the
foals began shedding P. equorum eggs by age 11-18 weeks.
Older Horse IgG(T) Recognition of L2/L3 ESA
Sera from older horses recognized larval P. equorum antigen at some of the
same molecular weights as has been previously described for immunized rabbits and
naturally infected horses (Chapters 4 and 5). Sera from five of the twelve horses (42%)
did not have any IgG(T) antibody recognition of the antigen, while 58% had antibodies
that recognized proteins at 26 and 34 kDa, and 50% at 19 and 22kDa (Figure 6.1). When
compared with the broodmare results reported in Chapter 5, the older horse sera were
less likely to recognize the 19 kDa antigen (p=0.009) and 34 kDa antigen (p=0.026).
There was no significant difference between the groups with regards to the 22 kDa
antigen (p=0.102) but there was a trend towards higher recognition of the 26 kDa
antigen (p=0.084) by broodmare sera.
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Foal, Broodmare, and Older Horse Recognition of L5 ESA
Positive control necropsied foal serum recognized P. equorum immature adult
ESA at approximately 12 kDa, 70 kDa, and higher molecular weights at and above 120
kDa (Figure 6.2). Pre-suckle foal serum did not recognize any antigens.
Sera from 39% of broodmares recognized P. equorum immature adult ESA at 12
kDa, 22% at 70 kDa, and 39% at molecular weights of 120 kDa or higher. Sera from 17%
of older horses recognized the 12 kDa molecule, and 8% recognized the 70 kDa molecule
or molecular weights of 120 kDa or higher. There were no significant differences
between the broodmares and older horses for recognition of the molecules. All
broodmare sera that recognized P. equorum immature adult ESA also recognized larval
ESA, except one. Of the two older horse sera that recognized P. equorum adult ESA, one
strongly recognized both adult and larval ESA, while the other did not recognize larval
ESA, and had only weak recognition of the 12 kDa L5 protein.
Sera from 17% of the MCF ascarid positive foals recognized the 12 kDa antigen,
and 61% recognized the 70 kDa molecule and molecular weights of 120 kDa or higher
(Figure 6.2). There was no significant difference between sera from mares and foals with
patent infections for recognition of the 12 kDa molecule or at molecular weights of 120
kDa or above, but foal sera were more likely to recognize the 70 kDa molecule
(p=0.041). Overall, antibody recognition of adult ESA was lower than antibody
recognition of larval ESA by sera from broodmares and older horses. Of broodmares, 6%
of sera did not exhibit any antibody recognition of larval ESA, while 50% did not
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recognize adult ESA. Of older horses, 42% did not recognize larval ESA, while 83% did
not recognize adult ESA.
When sera from one seronegative mare and her foal were examined through
western blot, faint antibody recognition of two high molecular weight proteins and the
12 kDa antigen were apparent by week 11 after birth (Figure 6.3), which was three
weeks before the foal began shedding ascarid eggs (Figure 6.2).
Discussion
Older Horse IgG(T) Recognition of L2/L3 ESA
The older horses were not expected to show much antigen recognition because
of their ages, and amount of time spent in an environment with presumably little to no
exposure to P. equorum eggs. However, over half of the horse sera recognized P.
equorum larval ESA. It is possible that because of the durability of the chitinous layer
and the sticky nature of the proteinaceous layer of the shell [23], eggs could have been
transported into the facility by staff, students, or a health care professional, and
remained infective until ingested. Alternatively, a visiting horse could have been
shedding P. equorum eggs during the annual intercollegiate horse show, although these
horses were mature and not likely to have patent infections. Cross-reactivity cannot be
ruled out, as it has not been fully examined for other equine parasites (Chapter 5).
However, this is not the most likely explanation because of the similarities to responses
by P. equorum immunized or infected animals (Chapters 4 and 5). It is also possible that
some of the horses maintained antibodies against P. equorum over a long period of
time. Lengthy persistence of serum IgG antibodies against other infectious diseases has
133

been reported. For example, by western blot, IgG antibodies remained detectable for at
least a year against Campylobacter jejuni [242] and at least three years against Toxocara
canis [243] and Borrelia burgdorferi [244]. It appears that the degree of egg
contamination in the environment and/or age may have some effect on IgG(T) antibody
production against P. equorum larval ESA, as fewer old horse sera recognized two of the
antigens. This effect could be amplified with larger sample sizes. Additional samples
could be examined to report the seroprevalence of antibodies to P. equorum larval ESA.
Of the five older horses that were positive for strongyle-type eggs, three
displayed no antibody recognition of the P. equorum larval ESA (Table 6.1). One of these
mares had a strongyle EPG of 620. Of the seven horses with a negative strongyle EPG,
five were displayed antibody recognition of P. equorum larval ESA. These data suggest
that there may not be issues with cross-reactivity with strongyles on western blot
analyses, but testing of additional samples and determination of actual strongyle
species may be necessary to conclusively declare this.
Foal, Broodmare, and Older Horse Recognition of L5 ESA
Western blot banding patterns for P. equorum positive horses indicate that
immature adult P. equorum produce different ESA molecules that stimulate an antibody
response when compared with newly-hatched larvae. Alternatively, the protease
inhibitors used were changed between the larval and L5 cultures, which could have
preserved different molecules. The main dissimilarity was that aspartic proteases could
be present in the larval antigen, but not in the L5 antigen. More likely, there are some
differences in proteins produced by stage, with L5 producing mainly immunogenic ESA
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of higher molecular weight. Other researchers have found differences in antigens
produced by ascarid stage. One researcher found small differences in B. procyonis larval
protein production during the first few weeks in culture [77]. Other research has
identified stage-specific ESAs produced by L2 and L3/L4 Ascaris suum larvae [208].
Production of varied proteins by life stage could aid in survival by performing different
functions, as L2/L3 larvae are migratory and L5 remain in the small intestine. Excretorysecretory proteins produced by other nematode species have been shown to assist in
migration by cleaving cellular molecules [80, 81, 86], aid in modulation or evasion of the
host’s immune response [82, 83, 88, 89], improve feeding sites and environment [69],
and possibly prevent worm expulsion from the host’s intestine [85]. Protease inhibitors
from homogenized adult P. equorum have shown activity against bovine trypsin and
chymotrypsin (activity against equine digestive proteases was not tested) [94]. Further
study is needed to characterize the excreted/secreted proteins of larval and adult P.
equorum.
Examination of a mare that was seronegative to P. equorum immature adult ESA
provided information about the timeline for antibody development in a naturally
infected foal. Parascaris equorum larvae complete their migration back to the small
intestine by between 17-23 days after ingestion of embryonated eggs [15, 16, 46] and
reproduce 10-15 weeks post-infection [15, 17, 46, 47]. This suggests that Foal4 became
infected sometime between weeks 0-4, and that P. equorum were present in the small
intestine for 3-8 weeks prior to production of detectable levels of IgG(T) antibodies
against adult ESA at week 11. When compared to the response of a previously examined
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foal (Foal1) to P. equorum larval ESA (Chapter 5, Figure 5.9), antibodies to immature
adult ESA were detected three weeks later. Both foals began shedding P. equorum eggs
on week 14, but antibody to larval ESA was detected by week 8, while antibody to L5
ESA was detected by week 11. This could have been due to individual differences
between foals, but it is likely that antibody production against larval ESA occurs prior to
antibody produced against immature adult ESA.
It is also of interest to compare the IgG(T) antibody recognition of immature
adult ESA by the Mare4/Foal4 pair with previous findings. Although Mare4 did not have
detectable IgG(T) antibodies against L5 ESA, the same mare did passively transfer IgG(T)
and IgM antibodies against larval ESA to her foal (Chapter 5). Similarly, fewer
broodmares and older horses recognized adult ESA when compared with larval ESA. It is
possible that in some horses, the immune response destroys migratory parasites before
they are able to begin excretion/secretion of adult-stage proteins.
Conclusion
Sera from older horses in a low-egg exposure environment were less likely to
recognize the P. equorum larval 19 kDa molecule (p=0.009) and 34 kDa molecule
(p=0.026) when compared with broodmare sera. However, more of the old horse sera
recognized antibody than expected, given their environment. This suggests that either
(1) horses maintain high titers of antibodies to P. equorum larvae over very long periods
of time or (2) adult horses are likely to encounter and ingest ascarid eggs regardless of
whether or not foals are housed at the facility.
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Sera from horses confirmed as positive for P. equorum recognized antigens of
different molecular weights when P. equorum larval and immature adult ESA were
compared. This indicates that the parasite produces some stage-specific proteins, thus
inducing stage-specific antibody production in the host. Additionally, fewer adult horse
sera recognized the immature adult ESA when compared with larval ESA. This could
occur if the horses destroy larvae before they reach the L4 or L5 stage in the small
intestine. However, this could mean that in some adult horses without patent
infections, larvae survive long enough to produce adult antigens. Although only one foal
was examined for endogenous antibody production, his results indicate that larvae are
present in the small intestine for at least 3 weeks before detectable quantities of
antibody against immature adult ESA are endogenously produced. The exact identities
and functions of the larval and immature adult ESA should be the subject of further
study.
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Table 6.1. Older horse data.
Horse Number Horse Age

Years at Facility

1
2
3
4
5
6
7
8
9
10
11
12

7
7
7
6
5
5
5
4
4
3
1
0.3

28
26
23
20
29
21
20
22
17
17
18
21
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Strongyle
EPG
100
0
0
620
0
60
0
0
10
0
0
110

IgG(T) Response
to larval ESA
Yes
Yes
No
No
Yes
No
Yes
Yes
No
No
Yes
Yes

Figure 6.1. Western blot of older horse IgG(T) antibody recognition of P. equorum larval
ESA. Lane 1, molecular weight standards; Lane 2, foal positive for P. equorum at
necropsy; Lane 3, pre-suckle foal; Lanes 4-15, older horses negative for P. equorum eggs
in feces in order from greatest number of years at facility to fewest.
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Figure 6.2. Western blot of IgG(T) antibody recognition of P. equorum immature adult
ESA by foals with patent infections. Lane 1, molecular weight standards; Lane 2, foal
positive for P. equorum at necropsy; Lane 3, Foal1 pre-suckle; Lanes 4-18, Foals1-12 and
14-16 at first week of patent shedding.
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Figure 6.3. Western blot of Foal4 IgG(T) antibody recognition of P. equorum immature
adult ESA over time. Lane 1, molecular weight standards; Lane 2, foal positive for P.
equorum at necropsy; Lane 3, Pregnant Mare4; Lane 4, Foal4 pre-suckle; Lane 5, Foal4
post-suckle; Lanes 6-18, Foal4 weeks 1-13. Week 14 was the first week of patent
infection.
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CHAPTER 7: CONCLUSIONS AND IMPLICATIONS
Prior to this research, the larval culture of P. equorum for collection of ESA and
the antibody response of the horse to these proteins had not been described in the
literature. Results indicate that P. equorum larvae can be hatched using a modified
technique and maintained in culture for up to 3 weeks with adequate survival for ESA
collection. Larvae molted while in culture, indicating that the molt from L2 to L3 stages
occurs within the first week or two after hatching. SDS-PAGE of P. equorum larval ESA
revealed heterogenous proteins ranging from 12-94 kDa, and immature adult (L5)
proteins ranged between 12-189 kDa. Western blot results suggest that IgG(T) or IgG
antibody binding to proteins at 19 kDa and 34 kDa may be important for distinguishing
P. equorum infections from B. procyonis or T. canis infections. Cross-reactivity between
species was noted at 22 kDa, 26 kDa, and at high molecular weights.
Western blot analyses did not detect IgE recognition of larval P. equorum ESA.
Mare IgM antibodies recognized antigen at approximately 53 and 58 kDa, and
antibodies were passively transferred to the foal. However, serological testing for IgM is
not useful for diagnostic purposes, as foals with patent infections did have IgM
antibodies that recognized antigen. Serological examination for IgG(T) had the most
potential, with antibody binding at approximately 19 kDa, 22 kDa, 26kDa, and 34 kDa in
most foals with patent infections. Nevertheless, the majority of broodmares passively
transferred IgG(T) antibody against P. equorum larval ESA to their foals. This illustrates
the complications of antibody testing in foals for diagnostic purposes, especially in
situations where the infectious pathogen is common and induces an antibody response
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in mares. The purpose of the IgG(T) antibodies against larval ESA is not yet known, but
the antibodies did not prevent infection, as all of the foals became naturally infected
with P. equorum.
To further explore the antibody response of the immune horse, older horses in a
low-egg exposure environment were examined. These horses were less likely to
recognize two of the larval molecules when compared with broodmares, but more than
half of the older horses displayed an antibody response. This points to the ease in which
eggs can be transmitted between facilities, and indicates that many adult horses
probably do maintain IgG(T) antibodies to P. equorum larvae.
When P. equorum larval and immature adult ESA were compared, differential
banding patterns by positive foals were noted on western blot analyses. It appears that
P. equorum produces stage-specific proteins and prompts stage-specific antibody
production in the host. When adult horses without patent infections were compared,
fewer recognized the immature adult ESA when compared with larval ESA. It is possible
that in some horses, larvae are destroyed before producing late stage proteins, while in
others horses, larvae survive long enough to produce adult antigens. The exact identities
and functions of P. equorum ESA and the antibody response of the host require further
study before the development of immunity to this parasite can be fully understood.
Future attempts to develop new tools for diagnosis of P. equorum infection
should not focus on circulating antibody detection. As P. equorum is primarily a disease
of foals, maternal antibody will be too much of a confounding factor if serological
antibody detection is used. For the detection of migratory larvae, testing for antigen
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instead of antibody could be examined. Other researchers have utilized tests for
circulating ESA in diagnosis of T. canis infection [197, 245]. In dogs, antigen has been
detected by sandwich ELISA assay [197]. Higher levels of antigen were found early
during infection, with lower but still detectable levels identified during chronic infection
[197]. Another study found that levels of antigen detected by sandwich ELISA decreased
at the time when antibody levels increased [245]. In experimentally infected mice,
antigen was detected early during infection, but then was complexed with antibody
[245]. It is possible that maternal antibody could distort the results of an antigen-based
test by binding to antigen.
Similarities in ascarid migration during the early phase of infection in immune
adult horses and foals may make it difficult to distinguish between the two types of
infection. Other approaches may need to be examined for diagnosis. In sheep, a
diagnostic test has been developed for the presence of IgA in saliva against a particular
trichostrongylid surface antigen [246]. One advantage of this test is the non-invasive
sampling procedure, which would be practical for routine diagnosis. This test was also
found to be correlated with worm burden [246]. Migratory P. equorum larvae induce
coughing while in the lungs, and then migrate up the trachea and be swallowed;
therefore, it is possible that ESA or anti-P. equorum IgA could be detected in saliva. As
this stage of the life cycle is towards the end of the migratory phase, a saliva test could
help to distinguish between responses of immune and susceptible horses. Another
possible route for diagnosis might include testing for the presence of antigen in
bronchoalveolar lavage fluid, although this would be more invasive than using saliva. In
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summary, there are several alternative approaches for diagnosis that could be explored.
Although we did not find testing for antibodies to P. equorum ESA to be useful for
diagnosis, our research still provides new information about P. equorum and the
immune response of the horse.
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APPENDIX A:
Appendix 1: Mare ages and foaling data.
Mare/Foal
Code
Mare 1/
Foal 1
Mare 2/
Foal 2
Mare 3/
Foal 3
Mare 4/
Foal 4
Mare 5/
Foal 5
Mare 6/
Foal 6
Mare 7/
Foal 7
Mare 8/
Foal 8
Mare 9/
Foal 9
Mare 10/
Foal 10
Mare 11/
Foal 11
Mare 12/
Foal 12
Mare 13/
Foal 13
Mare 14/
Foal 14
Mare 15/
Foal 15
Mare 16/
Foal 16
Mare 17/
Foal 17
Mare 18/
Foal 18

Brave Boco

Mare
Age
(2012)
11

Expected
Foaling
Date
2/22/12

Actual
Foaling
Date
2/29/12

Yes

So Beautiful

6

2/26/12

3/6/12

Yes

Italian Opera

5

3/8/12

3/8/12

Yes

Tabadabado

15

3/7/12

3/13/12

Yes

Marinade

13

2/26/12

3/13/12

Classy Ensign

20

3/21/12

3/22/12

Whom Shall I
Fear
Vinlear

6

3/15/12

3/22/12

Yes, but plasma a few
days later
No, Italian Opera and
Emerald Buddha
No, used Tabadabado

9

3/29/12

3/23/12

Yes

Engaging Gigi

4

3/3/12

3/29/12

Yes

To the Right

11

3/22/12

3/31/12

No, Brave Boco

Run Nola Run

5

3/27/12

4/5/12

No, Run Carrie Run

Vickie’s Girl

4

3/29/12

4/6/12

Yes

Distinctive View

7

4/9/12

4/9/12

Yes

Blue Stream

12

4/3/12

4/10/12

Yes

Ziffy

6

4/6/12

4/11/12

Yes

Possesting

5

4/9/12

4/18/12

Sweet
Champagne
Chatelian

9

4/21/12

4/21/12

Yes, but plasma a few
days later
Yes

11

5/5/12

5/7/12

Yes

Mare Name
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Acceptable Colostrum?

APPENDIX B: LABORATORY PROTOCOLS
Ascarid Dissection Protocol
Materials Needed:
Safety Equipment Needed:
• Metal Tray
• Class II Biological Safety
Cabinet
• Aluminum Foil
• Lab Coat, gloves
• 15 ml Tenbroek Homogenizer
• Goggles/Surgical Mask
• Microscope and…
(Baylisascaris/Toxocara)
o Slides
o Cover slips
• Autoclave and…
o Autoclave Tray
• Scalpel(s)
o Small Autoclave Bag(s)
• Probe (optional)
• Blunt tip tweezers
• Sharp tip tweezers
• Iris Forceps (Sharp)
• Thumbs Dressing Forceps (have teeth)
• Blunt Forceps
• 50 ml Beaker(s)
• Large Petri Dish
• 3 Autoclavable plastic dishes
• 50 ml Conical Tube
• Centrifuge
• Container of Ascarids
*Make sure equipment has been sterilized (autoclaved) prior to use to reduce risk of
contamination by other species’ eggs.
Chemicals Needed:
• Double Distilled H20
• 0.1% Formalin, 0.85% Saline
• 2% Formalin
• 10% Formalin
Ascarid Collection Procedure:
1. Put Parascaris equorum (equine ascarid), Baylisascaris procyonis (raccoon
ascarid), and Toxocara canis (dog ascarid) or Toxocara cati (cat ascarid) in plastic
specimen container with 0.5% formalin, 0.85% saline.
2. Transport to Garrigus in a lined cooler.
3. Record relevant information about collection and label container.
4. Refrigerate at 4˚C until dissection.
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Dissection Procedure:
1. Put a layer of aluminum foil on biological safety cabinet working surface.
2. Sex parasites. Keep females in container and autoclave any males.
a. Males have a hooked tail and seem to not have internal white area as far up
as females (white coloration seems to begin about 1/3 from the anterior
end in females, and slightly further down for males).
3. Surface decontaminate females by putting several at a time in an autoclavable
bowl of 10% formalin for 5 minutes.
4. Move females to another autoclavable bowl of 2% formalin.
5. Rinse females in a large petri dish containing distilled water for one minute.
6. Fill large petri dish with distilled water and place on metal tray.
7. Place worm in petri dish. Make sure it is submerged. Be careful not to splash
water out of dish because it will be contaminated with eggs during following
procedure!
8. Identify anterior end (will have bulbous lips) and posterior end.
9. Hold anterior end by mouth with blunt forceps. Cut cuticle down towards the tail
with a scalpel or gently insert sharp Iris forcep tips into anterior end about a
centimeter from the mouth and cut the worm lengthwise with forceps.
10. Take thumbs forceps and grab cuticle. Peel cuticle down like a banana. Peel
segments until vagina and uterus come off with cuticle.
a. Vagina is very thin and will be attached to cuticle. Uterus is Y shaped and
light in color.
11. Move unwanted materials to the side in the dish.
a. Ovaries are very thin and do not contain viable eggs. Pharynx will be flat and
darker yellow or green color.
12. Remove vagina and anterior 1-2 centimeter(s) of uterus.
13. Place vagina and uterus piece in 50 ml beaker containing 0.1% formalin, 0.85%
saline.
14. Add portion of uteri and solution to the Tenbroek homogenizer.
15. Gently insert pestle into homogenizer. Make sure pestle doesn’t reach to bottom
or eggs will be damaged. Gently grind the uteri until large pieces are gone.
16. Add egg solution to beaker.
17. Cover beaker with aluminum foil with holes poked in top.
18. Check (see below) subsample of two 4 µl of egg solution for egg density and
larvation.
19. Add enough 0.1% formalin, 0.85% saline solution to put eggs at density of (or
below) 25 eggs/µl (Eriksen, 1990).
20. Autoclave dissected female parasites, male parasites, and uterine tissue.
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21. Autoclave sharps, dishes, homogenizer, or any other equipment in the BSC.
Embryonation Procedure:
1. Maintain beaker at room temperature for embryonation. Alternatively, store at
4˚ C in conical tube with screw cap loosened until ready for use.
2. Sit beaker on lab bench. Agitate gently 5x per week with applicator stick once
per day.
3. Maintain in solution until second stage larval development (3-5 weeks).
4. Check 4µl subsamples of eggs for larvation weekly.
a. Stir sample a few times with sterile applicator stick.
b. Pipet out one 4 µl drop from center of beaker (before eggs have time to
settle to bottom).
c. Put on microscope slide with cover slip.
d. Count number of eggs, recording number of eggs in each stage of
development. Do this quickly before eggs have time to dry out (they look
like little spores and you can’t see inside of them).
5. If solution in beaker evaporates, add double distilled water as needed in case
saline has remained in beaker.
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Ascarid Hatching Protocol
Materials Needed:
• CO2 Incubator
• 50 ml screw-top conical tubes
• Isotemp Incubator
• 15 ml screw-top conical tubes
• Water bath
• 50 ml beaker
• Centrifuge
• Waste beaker
• Shaker platform
• 125 ml flask containing…
• Stir plate with very slow speeds
o Glass beads (3 mm and 5 mm
• Timer
diameter)
• Microscope/slides/coverslips
 Fill flask to about 1 cm
• Aluminum foil
in height
• T25 culture flasks
o Stir bar
• 10-25 ml pipets
• Baermann apparatus
• Electronic pipet filler
o Funnel attached to clamped
• Bulb pipet filler
tubing
o Stand
o Beaker to hold conical tube
o Metal sieve fit in funnel (large
holes)
o Two fluffed cotton balls
o 2 g layered cotton gauze
*Make sure equipment has been sterilized (autoclaved) prior to use to reduce risk of
contamination by other species’ eggs.
Chemicals Needed:
Safety Equipment Needed:
• Bleach- Great Value unscented
• Class II Biological Safety Cabinet
• 0.85% NaCl solution (sterile)
• Lab coat
• Hank’s Balanced Salt Solution (sterile)
• Gloves
without phenol red
• Goggles/surgical mask
• Dulbecco’s Phosphate Buffered Saline
(Baylisascaris/Toxocara)
• RPMI-1640 with phenol red, 25 mM
HEPES, and L-Glutamine
• 70% Ethyl alcohol
• Protease Inhibitor Cocktail (Thermo
Scientific 87785)
• Antibiotics: 100x concentrated
solution (MP Biomedicals 1674049)
o Penicillin-10,000 IU/mL
o Streptomycin-10mg/mL
o Amphotericin B-25µg/mL
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All procedures must be performed asceptically (especially important after bleaching
step). Perform all pipetting or any procedures where eggs are exposed to air in BSC. Use
70% ethanol to clean gloves and all items placed in cabinet. When removing tubes from
BSC, cap tightly.
Formalin Removal Procedure:
1. If eggs had been stored at 4 ˚C, remove from refrigerator at least two days prior
to hatching so that larvae can acclimate to room temperature and become more
active.
2. Pipet eggs into sterile 50 mL conical tube. Cap tightly.
3. Gently rotate tube to mix solution and eggs.
4. Estimate number of active larvated eggs by counting viable larvae in at least two
5 ul subsamples. Record amount of solution and calculate an estimation for total
viable larvae.
5. Wash eggs three times in 0.85% NaCl.
a. Centrifuge at 200 x g for 1 minute with no braking of centrifuge.
Acceleration: 8, deceleraton: 4. Do not use bucket covers- they can turn
sideways and jam.
b. Carefully remove tube and put in BSC without shaking it!
c. Use bulb pipet filler to carefully remove supernatant without disturbing
eggs. Eggs should be visible at the bottom of the tube.
d. Use electronic pipet to insert fresh 0.85% NaCl solution. Do not let pipet
touch sides of tube.
e. Repeat for two more washes.
f. After last wash, remove supernatant to just above the eggs.
Egg Decoating Procedure:
22. Spray off rocker platform and place in BSC/hood.
23. Turn on Isotemp incubator (37 ˚C) and CO2 incubator (5% CO2, 37 ˚C – better to
turn on a few days beforehand).
24. Turn on water bath and set at 37 ˚C.
25. Pipet straight bleach (5.25% sodium hypochlorite) into conical tube with egg
solution at ratio of 1 ml bleach: 1 ml egg soln. Make sure to use Great Value
bleach (Chlorox Lemon Fresh will decoat too quickly).
26. Rotate tube several times to coat eggs in bleach and place on shaker platform for
3 minutes. Do not let tube sit without rocking or bleach could harm eggs.
27. At minute 3, begin taking subsamples to examine the eggs once per minute.
151

a. Pipet 4 µl subsample onto microscope slide. Do not add cover slip or eggs
may appear to burst prematurely.
b. Check eggs on 10x, then 40x for decoating of layers of egg shell. Shells of
larvae may decoat faster than unlarvated eggs. Decoating should remove
the outermost acid mucopolysaccharide/protein uterine layer, lipoprotein
vitelline layer, and part of the thicker chitin/protein layer. This will leave the
part of the chitin layer and the inner lipoprotein layer (ascaroside layer).
When bleached enough, eggs may not be perfectly round anymore. Bleach
until the chitinous layer of the shell is very thin.
Before bleaching

After 8 minutes of
bleaching

c. Length of time for bleaching should be at least 8 minutes but will vary by
batch of eggs. The egg pictured above should be bleached for a couple more
minutes to thin the chitinous layer a little more.
28. Remove tube from rocker and pipet in sterile 0.85% saline solution to 50 ml mark
and centrifuge for 1 minute at 200 xg (acc. 7, dec. 4). This will help eggs pellet to
bottom and decrease bleaching action. Pipet out supernatant after wash.
29. Wash out bleach solution with 8 more washes of sterile 0.85% saline.
a. Centrifuge for 1 minute at 200 xg (acc. 8, dec. 4).
b. Most bleach will be washed out by wash #5.
c. For P. equorum, wash 2 more times in 0.85% saline, then put cap on loosely
and let sit for one week at room temperature in 0.85% saline for a week.
Then repeat decoating steps 1-8 again, bleaching for 1-2 minutes to remove
any bacteria. When decoating the second time, switch to Hank’s Balanced
Salt Solution (HBSS) for the last two washes, and continue to hatching.
d. For other species, Use sterile 1x Hank’s Balanced Salt Solution (HBSS), pH
6.8-7.0 without phenol red starting on wash #8. Then continue straight from
step 8 to hatching.
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Hatching Procedure:
1. Set up sterile Baermann apparatus in CO2 incubator. Funnel should contain metal
sieve with layered gauze and finally fluffed cotton balls on top. Tubing should be
attached to funnel and clamped with metal clamp. Funnel should sit in stand and
end of tubing should go into sterile conical tube.
2. Pipet out most of HBSS from the conical tube containing washed eggs, taking care
not to disturb eggs.
3. Pipet in 10 µl of 100x concentrated antibiotic solution per ml of HBSS/egg solution.
a. Gives 100 IU penicillin/ml, 100 µg streptomycin/ml, 0.25 µg/ml amphotericin.
b. Cap tube and gently mix antibiotic and HBSS.
4. Pipet egg solution into flask containing stir bar and glass beads. Only pipet in enough
solution so that beads are coated with solution (probably around 7 ml total). Do not
pipet in so much solution that it sits above the beads (or the eggs won’t receive
enough mechanical stimulation)!
5. Rinse and pipet any remaining eggs from conical tube into flask using
HBSS/antibiotic solution, monitoring level of solution in flask.
6. Cover top of flask with sterile aluminum foil or parafilm so that no air can get in and
cause bacterial contamination.
7. Place flask on stir plate (one that can rotate at slow speeds, 1-2x per second) in the
incubator at 37 ˚C (CO2 is not necessary). Monitor to make sure stir bar doesn’t get
stuck.
a. For larval homogenization, let stir faster in cold room overnight.
b. Pipet some HBSS into conical tube and put in water bath. Make sure lid area does
not touch water (bacteria can get in)!
c. Check hatching by asceptically removing a 5 µl subsample every 10 minutes and
putting on microscope slide without cover slip. Cover slipping can cause
premature explosion of the eggs once the shells are thinner. Count unhatched
larvated eggs, healthy hatched larvae, and damaged larvae in each subsample.
When 80-90% of eggs have hatched, remove from stir plate. Should take 20-40
minutes. Debris will be apparent from hatched eggs.
Larval Washing Procedure:
a. Remove larvae from beads by pipetting solution out and into 50 ml conical tube.
Rinse flask several times with HBSS and pipet rest of solution into conical tube. Fill
conical tube up to 50 ml line with warm HBSS.
b. Centrifuge at 100 x g (acc. 7 dec. 4) for 5 minutes to clarify suspension. This will
help to remove egg debris.
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c. While larvae is washing, wash cotton twice in incubator with HBSS to remove fine
particles.
d. Repeat washing of larvae 2 more times, pipetting out supernatant and adding
warm HBSS.
e. Pipet out majority of HBSS without disturbing eggs.
Baermannizing Procedure:
1. Add 10 µl antibiotic per ml larvae/HBSS solution. Cap and gently rotate to mix.
2. Make sure tubing in Baermann is clamped and pour larval pellet into funnel.
3. Rinse conical tube with warm HBSS to get more larvae out and to ensure cotton
is saturated and solution sits above cotton. Add 10 µl antibiotic per ml
larvae/HBSS solution, cap, and gently rotate to mix.
4. Put sterile aluminum foil on top of funnel to keep larvae wet.
5. Let stand in incubator for 4 hours.
a. Healthy larvae should migrate down the flask while debris, dead
larvae, and egg shells remain on cotton.
6. Warm a conical tube of HBSS in water bath to 37 ˚C.
7. Remove tube from water bath. Add 10 µl antibiotic per ml HBSS to tube and
vortex to mix.
8. Remove larvae by unclamping tubing and put sterile conical tube below the
tubing to collect larvae.
Culture Prep Procedure:
1. Turn on water bath and set to 37 ˚C.
2. Pipet Dulbecco’s Phosphate Buffered Saline (DPBS) into a couple 50 ml conical
tubes.
3. Tightly screw on lids and put tubes in water bath to warm them. Do not let lids
touch water (avoid contamination)!
4. Pipet warm DPBS into conical tube containing larvae.
5. Wash by centrifuging at 200 x g for 1 minute (8 acc., 4 dec.).
6. Pipet out supernatant without disturbing larvae. Pipet in fresh DPBS.
7. Wash in DPBS 7 more times (8 DPBS washes total).
a. In between washes, put RPMI-1640 in a conical tube and put in water
bath to warm up.
8. After 8th wash, pipet out supernatant and add warm RPMI-1640 to 50 ml line.
9. Pipet out 25 µl of solution and count number of active larvae. Repeat for a total
of 50 µl.
a. Determine # of larvae.
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i. (X larvae/25 µl) (1000 µl/1 ml) (50 ml/tube)= larvae in tube
b. Determine # of culture flasks to make.
i. Larvae in tube/10,000= # ml RPMI-1640 needed.
1. Larval concentration should be 10,000 larvae/ml for ES
collection.
c. Measure sizes of newly hatched larvae.
i. Lengths and widths (1/3 of way from anterior end) of 5 larvae.
10. Centrifuge larvae in RPMI-1640.
11. Pipet out supernatant and do one more wash in RPMI-1640 (10 post-collection
washes total: 8 washes in DPBS and 2 washes in RPMI-1640).
12. Remove supernatant.
13. Add fresh warm RPMI-1640.
a. Determine how many ml RPMI-1640 remain in the tube, and how many
need to be added.
b. Choose appropriately-sized conical tube and pipet in...
i. RPMI-1640 (amount to be added to the larvae).
ii. 10 µl of antibiotic solution per ml total RPMI 1640.
iii. 10 µl 100x concentrated protease inhibitor cocktail (Thermo
Scientific 87785) per ml RPMI-1640. (40 µl 25x concentrated
Sigma P2714 protease inhibitor cocktail was used during early
cultures but led to higher larval mortality).
iv. Vortex tube to mix RPMI-1640, antibiotics, and protease inhibitor.
c. Pipet mixed solution into conical tube containing larval pellet.
14. Gently tap or shake tube to homogenize larvae, then pipet aliquots of 2-5 ml into
T25 culture flasks.
a. Incubate flasks at 37 ˚C and 5% CO2.
b. Sit flasks upright.
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Excretory-Secretory Protein Collection Protocol
Materials Needed:
• 50 ml, 15 ml screw-top conical tube
• Pipettors (1000 µl, 200 µl, 50 µl)
• 1000 µl pipet tips
• 200 µl electrophoresis pipet tips
• 50 µl normal pipet tips
• 1 L beaker
• Scintillation vial

•
•
•
•
•
•
•

CO2 Incubator
Water bath
5-10 ml syringe
18-20 gauge needle
0.2 µm syringe filter
Vortex
Snakeskin dialysis tubing
(3.5 MWCO)
• Two dialysis tubing clips
• Stir bar
• Freeze dryer (lyophilizer)
*Make sure equipment in contact with media/larvae has been sterilized prior to use to
reduce risk of bacterial contamination.
Chemicals Needed:
• RPMI-1640 with phenol red, 25 mM HEPES,
and L-Glutamine
• 70% Ethyl alcohol
• Antibiotics: 100x concentrated solution
o MP Biomedicals 1674049
o Penicillin-10,000 IU/mL
o Streptomycin-10mg/mL
o Amphotericin B-25µg/mL
• 100 x concentrated protease inhibitor
cocktail (PIC) Thermo Scientific HALT 87785
• 0.1 M ammonium bicarbonate

Safety Equipment Needed:
• Class II Biological Safety
Cabinet
• Lab coat
• Gloves
• Goggles/surgical mask
(Baylisascaris/Toxocara)
• Sharps container

All procedures involving flasks must be performed asceptically. Perform all pipetting or
any procedures where larvae are exposed to air in BSC. Use 70% ethanol to clean gloves
and all items placed in hood. When removing tubes from hood, cap tightly.
1.
2.
3.
4.

Turn on water bath to 37 ˚C.
Put 0.1 M ammonium bicarbonate in refrigerator (4 ˚C) to chill.
Sterilize hood with 70% ethanol.
Make sure T25 flasks (in incubator) containing larvae are in the upright position.
If not already, flasks should sit in this position for at least 10 minutes to allow
larvae to sink to bottom of flask.
5. Calculate amount of RPMI-1640, PIC, and antibiotic needed.
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a. RPMI-1640 needed will be half the amount that is in the flask (eg. 2 ml
needed for a flask currently containing 4ml)
b. PIC needed is 10 µl per ml RPMI-1640.
c. Antibiotic needed is 10 µl per ml RPMI-1640.
6. Remove RPMI-1640 from fridge along with PIC and antibiotic. Pipet calculated
amounts of each into a conical tube, vortex, and place in water bath. Do NOT
allow water in bath to reach cap of conical tube or contamination may result.
7. Carefully remove flask containing larvae from incubator and gently sit it in the
hood. Do not shake it or larvae will be disturbed!
8. Set pipet to 200 µl and attach electrophoresis tip.
9. Remove flask lid and very carefully pipet from TOP of media in flask. Continue to
pipet until half the liquid in the flask is removed. Put removed supernatant
media into the conical tube (or microcentrifuge tube if only a small amount of
media).
10. Remove conical tube from water bath and vortex.
11. Use 1000 µl pipet to put appropriate amount of fresh media solution into flask.
12. Return flask to incubator.
13. Repeat steps for other flasks in incubator, combining removed media.
14. Cut several inches of 3.5 MWCO snakeskin dialysis tubing. See directions for how
much to cut, but probably 3 inches minimum.
15. Fold one end of dialysis tubing over several times and clip with tubing clip.
16. Attach needle to appropriately sized syringe and draw up the removed media. A
10 ml syringe won’t fit in a 15 ml conical tube, but a 5 ml one will.
17. Recap needle and remove from syringe.
18. Screw syringe filter (0.2 µm pore size) on to syringe.
19. Push plunger down to push media through syringe filter, into the dialysis tubing.
20. Roll the top of the tubing over several times and clip with dialysis tubing clip.
Check for leaks.
21. Pour chilled 0.1 M ammonium bicarbonate buffer into large beaker.
a. Over the course of dialysis, the buffer will need to equal at least 300x the
amount of the sample, and should be changed at least 3x.
22. Put dialysis tubing containing sample into buffer and add stir bar.
23. Put on stir plate at low speed in refrigerator (4 ˚C).
24. Leave for a few hours, then change buffer.
25. Change buffer again before leaving the dialysis to go overnight.
26. Change buffer again as necessary until red/pink color of phenol red leaves the
baggie.
27. Remove baggie from buffer, carefully unclip one end, and pipet out sample.
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28. Pipet sample into a labeled scintillation vial. Fill the vial to a maximum of
halfway.
29. Turn the vial so that it is at a 45˚ angle, increasing surface area of liquid, and
store in freezer (-20 ˚C) at this angle.
30. After freezing, sample can be freeze dried in scintillation vial. Freeze dry until
nearly all of the liquid has been removed.
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Protein Concentration Estimation
Materials needed:
• Freeze-dried ES proteins in scintillation
vials
• Pipets (1000 µl, 200 µl, 50 µl, 10 µl) and
tips
• Multichannel pipet, 200 µl (optional)
• Pierce BCA Assay kit
• Microcentrifuge tubes (2 ml)
• 0.1 M ammonium bicarbonate
• Conical tube
• Plate shaker/rocker

•
•
•
•

Non-CO2 incubator
96-Well microplate
Microplate reader
Flash drive

Safety equipment:
• Gloves
• Lab coat

Thawing Procedure:
1. Turn on non-CO2 incubator to 37 ˚C.
2. Remove previously freeze-dried samples from -20 ˚C.
3. Thaw rapidly by putting bottoms of scintillation vials under running lukewarm
water.
4. If proteins do not appear to resuspend, add as small amounts of 0.1 M
ammonium bicarbonate as possible until proteins resuspend.
5. Combine batches of proteins for the same species in a microcentrifuge tube.
BCA Kit Procedure:
6. Perform dilutions to make BCA kit microplate standards as specified by kit
instructions, copied below. For diluent, use 0.1 M ammonium bicarbonate.

Tube

Volume of
Diluent (µl)

Volume and Source of BSA (µl)

A
B
C
D
E
F
G
H
I

0
125
325
175
325
325
325
400
400

300 of Stock
375 of Stock
325 of Stock
175 of tube B dilution
325 of tube C dilution
325 of tube E dilution
325 of tube F dilution
100 of tube G dilution
0
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Final BSA
Concentration
(µg/ml)
2,000
1,500
1,000
750
500
250
125
25
0 (Blank)

7. Calculate the amount of working reagent (WR) needed.
Formula:
(# standards + # unknowns) x (# replicates) x (volume of WR per sample) = total
volume WR required
Formula for microplate procedure:
(9 + # unknowns) x 3 x 200 µl = total volume WR required
Round total required WR volume up so that you don’t run out of WR due to pipetting
error.
8. Prepare WR by mixing 50 parts BCA reagent A with 1 part BCA reagent B (50:1,
Reagent A:B).
Formula:
Calculated total volume WR required (this will be your reagent A): X = 50:1
Solve for x to get volume B needed.
9. Vortex conical tube containing A and B. Turbidity should disappear to yield a
clear, green WR.
a. WR is stable for several days at RT in a closed container.
10. Draw out standards and unknowns on a blank microplate reader plan, so you
know what will be in each well.
11. Pipette 25 µl of each standard or unknown replicate into a microplate well.
a. This will require 75 µl total for each standard or unknown.
i. If sample size is limited, or if samples appear to contain traces of
RPMI-1640, pipet 40 µl of sample and 40 µl 0.1 M ammonium
bicarbonate into a microcentrifuge tube and vortex. This would
give a dilution of 1:2, and will need to be accounted for when
calculating protein concentration.
12. Add 200 µl of WR to each well. If a lot of samples on plate, may want to use a
multichannel pipet to speed up the process.
13. Mix plate thoroughly on a shaker plate for 30 seconds.
14. Cover plate and incubate at 37 ˚C in non-CO2 incubator for 30 minutes.
15. Cool plate to RT on benchtop.
16. While plate cools, turn on computer next to microplate reader.
Using Microplate Reader:
17. Open Softmax Pro.
18. Click assays  protein assays BCA
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a. This should automatically set the wavelength to 562 nm.
19. Click Template.
a. Assign correct protein values to each standard.
b. Assign sample names and dilutions, if applicable.
c. Click OK.
20. Click Fit under Standard Curve. Change to 4-Parameter.
21. Make sure wavelength is at 562 nm.
22. Once plate is cool, turn microplate reader on using button in back. Turn on
immediately before use so bulb doesn’t get burnt out.
23. Make sure plate cover is off and place plate in drawer, matching A1 on drawer to
A1 on plate.
24. Click “Read” on computer screen.
25. Click the arrow by Standard Curve. R2 should be above 0.9.
26. Click Standards. Check CVs to make sure they are below 10.
a. If 10 or above, identify the well of the outlier.
b. If appropriate, remove the outlier by selecting the well on the template
and pressing backspace.
27. Repeat for Samples.
28. Copy and paste template, standards, standard curve, and samples to an excel
file. Save on flash drive.
29. Remove plate from machine and shut drawer.
30. Push power button on machine and replace plastic cover.
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Fecal Flotation Protocol
Materials Needed:
• Microscope
• Double distilled water
• Microscope slide
• Centrifuge
• Cover slip
• Beaker (50 ml)
• Fecal sample in plastic bag
• 15 ml test tube(s)
• Scale
• Sheather’s sucrose solution (1.27
g/mL)
• Timer
• Applicator sticks
• Mortar and pestle
• Sieve with fairly large holes
This procedure is ideal for small volume samples, such as foal grab samples. It provides a
more sensitive measure of whether the foal is positive or negative for parasites, but
does not provide an EPG. This procedure was courtesy of Dr. Eugene Lyons.
Procedure:
1. Label tube and microscope slide.
2. Squish sample around in bag for 30 seconds to 2 minutes to make sample more
uniform.
3. Weigh out 1 g of feces into mortar.
4. Return sample to refrigerator.
5. Pour a small amount of ddH20 into plastic cup or mortar to moisten the sample.
6. Use pestle to make sample uniform in water.
7. Put sieve on top of beaker and pour solution from mortar or cup into sieve.
8. Rinse any remaining debris from mortar or cup into sieve using more ddH20.
9. Pour solution into a labeled test tube.
10. Centrifuge at 200 x g for 5 minutes.
11. Use flinging motion to decant supernatant into sink, keeping pellet in bottom of
tube.
12. Fill tube halfway with sucrose solution.
13. Use applicator stick to stir pellet and sucrose, completely breaking up the pellet.
14. Put tube in centrifuge and fill tube to the top with sucrose without overflowing.
15. Sit cover slip on top (gently tap cover slip or add more liquid if it does not
contact the sucrose).
16. Spin at 200 x g for 10 minutes.
17. Remove cover slip from tube and put on microscope slide.
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18. Put a second cover slip on the tube (the one that you just took the other cover
slip from). This will allow you to capture any remaining eggs that float to the top.
19. Check first slide for presence/absence of parasite eggs. Do not count them! This
is only a qualitative (+/-) test.
20. Check for eggs on the second slide.
21. Record which parasites the foal or horse is positive or negative for.
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Modified Stoll Fecal Egg Count Protocol
Materials Needed:
•
•
•
•
•
•
•
•

•
•
•
•
•
•

Microscope
Microscope slide
Cover slip
Fecal sample in plastic bag
Scale
Timer
Plastic cup or beaker
Sucrose solution (1.275 g/mL)

90 mL double distilled water
Disposable 10 mL pipet
Centrifuge
Centrifuge bucket cover (optional)
14 mL tube

Procedure:
1. Label plastic cup, conical tube, and microscope slide.
2. Squish sample around in bag for 30 seconds to 2 minutes to make sample more
uniform.
3. Weigh out 10 g of feces into tared plastic cup on scale.
4. Return sample to refrigerator.
5. Measure 90 mL ddH20 in a graduated cylinder, and pour into plastic cup.
6. Stir sample with disposable pipet or stir bar for 1 minute, trying to make the
solution as consistent as possible.
7. Take 1 mL from middle of sample in cup using pipet and put into conical tube.
8. Refrigerate sample in plastic cup.
9. Sit tube in centrifuge.
10. Pour sucrose to top of tube, sit cover slip on top (gently tap cover slip or add
more liquid if it does not contact the sucrose).
11. Spin at 200 x g for 10 minutes.
12. Put cover slip on slide and count number of ascarid eggs and strongyle eggs
(added separately) using microscope.
13. Multiply the number of ascarid eggs on slide by 10 to get the ascarid EPG (Eggs
Per Gram).
14. Multiply the number of strongyle eggs on slide by 10 to get the strongyle EPG.
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Polyacrylamide Gel Casting Protocol
Materials Needed:
• Microcentrifuge tubes
• Mini-gel glass plates
• 10-1000 µl Pipets
o One spacer plate per gel
• 50 ml conical tubes
o One short plate per gel
• Kimwipes
• Casting stand (clear plastic)
• Saran wrap and paper towels
• Casting frame (green plastic clamp)
(if storing gels)
• Gel comb
Chemicals Needed:
Safety Equipment Needed:
• 70-100% ethanol
• Lab coat
• ddH20
• Gloves
• Ammonium persulfate
• Safety glasses
Acrylamide is a carcinogen! Wear
• TEMED
PPE when working with it.
• Acrylamide for running gel (stored at
Acrylamide or any items that
4˚C)
contact acrylamide (gloves,
o For 8% gels: 29% acrylamide, 1%
pipets, tubes, etc.) should be
bis-acrylamide
disposed of in hazardous waste
o For 12% gels: 19% acrylamide, 1%
container.
bis-acrylamide
• Acrylamide for stacking gel
o 37.5% acrylamide, 1% bisacrylamide
• 4X running buffer (1.5 M, stored at 4˚C)
• 4X stacking buffer (0.5M, stored at 4˚C)
• 10% SDS
• Water saturated butanol (80% butanol)
• 1x TBST (if storing gels)
Equipment Preparation:
1. Determine which combs you will need for your gels (10 well, 15 well, 2D prep).
2. Select appropriately sized glass spacer plate to correspond with the size of the
comb.
3. Clean spacer and short plates by scrubbing with soap, being careful not to
scratch them, until the water runs off cleanly as a sheet (no water droplets left
on the plate).
4. Wipe both plates with 70-100% ethanol and a kimwipe. Let dry.
5. Wipe the gasket (grey foam rubber rectangle) down with 70-100% ethanol on a
kimwipe.
6. Place a clean gasket down on the bottom of the casting stand within the
grooves.
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7. Place the short plate on top of the spacer plate.
8. Slide the two plates into the casting frame, keeping the short plate facing to the
front (where the clamp flaps are).
9. Lock the clamp to secure the plates together. Run your finger along the bottom
of the two plates to ensure that their bases are even.
10. Place the clamped plates on the gasket and clamp them into place on the
casting stand.
Making the Running Gel:
1. Make 10% ammonium persulfate fresh in a microcentrifuge tube.
a. For 2 gels, weigh 30 mg (0.03 g) APS into tared microcentrifuge tube. Add
300 µl ddH20.
2. Make 10% TEMED in hood in a microcentrifuge tube.
a. For 2 gels, pipet 30 ul TEMED into tube. Add 270 µl ddH20.
3. Determine what % gel you want to make for your running gel.
4. Label a conical tube for the running gel and combine chemicals in the order as
follows:
8% Running Gel
# of 1.5 mm Mini-Gels
# of 0.75 mm Mini-Gels

1

2

3

4

2

4

6

8

ddH20 (ml)
5.2
10.4
15.6
20.8
1.5 M Running Buffer (ml)
2.5
5
7.5
10
Acrylamide (29% acryl:1%bis- 2
4
6
8
acryl) (ml)
10% SDS (ml)
0.1 (100 µl) 0.2 (200 µl) 0.3 (300 µl)
0.4 (400 µl)
APS and TEMED start the solidification process…add them last and be ready!
10% APS
0.1(100 µl) 0.2 (200 µl) 0.3 (300 µl)
0.4 (400 µl)
10% TEMED
0.1(100 µl) 0.2 (200 µl) 0.3 (300 µl)
0.4 (400 µl)
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12% Running Gel
# of 1.5 mm Mini-Gels
# of 0.75 mm Mini-Gels

1

2

3

4

2

4

6

8

ddH20 (ml)
4.2
8.4
12.6
16.8
1.5 M Running Buffer (ml)
2.5
5
7.5
10
Acrylamide (19%
3
6
9
12
acryl:1%bis-acryl) (ml)
10% SDS (ml)
0.1 (100 µl) 0.2 (200 µl) 0.3 (300 µl) 0.4 (400 µl)
APS and TEMED start the solidification process…add them last and be ready!
10% APS
0.1 (100 µl) 0.2 (200 µl) 0.3 (300 µl) 0.4 (400 µl)
10% TEMED
0.1 (100 µl) 0.2 (200 µl) 0.3 (300 µl) 0.4 (400 µl)
Once all ingredients have been added, vortex very briefly.
5. Save the rest of the APS and TEMED for the stacking gel.
6. Use a 1000 µl pipet to insert the gel solution into the slot between the spacer
and gel plate.
Some tips for pipetting:
a. Pipet in a corner against the spacer plate so that the fluid runs down the
side and spreads evenly.
b. Use a kimwipe to prevent bubbles from getting into the assembly.
c. Avoid bubbles by being careful and not fully emptying pipet tip.
d. For 0.75 mm gels, you will need to pipet quickly and carefully so that the
gel does not solidify in an uneven manner. May not want to attempt
more than 2 of these gels at once.
7. Pipet carefully, but quickly until the solution reaches the top of the green clamp
flaps (1 cm from the top of the short plate).
8. Keep the remainder of the gel and the pipet tip in the conical tube.
9. Shake water saturated butanol to mix (80% butanol).
10. Once the solution has reached the line, CAREFULLY and slowly pipet 80% butanol
to the top of the gel. Butanol can distort the gel if squirted with too much force.
Add 1 ml of the 80% butanol for 1.5 mm gels, or 500 µl for 0.75 mm gels. The
butanol prevents air from entering and drying out the gel.
11. Leave the gel to harden for 30 minutes. Check the conical tube containing the
gel and pipet tip to see if it has hardened. Also, moving the casting frame should
move the butanol but not the gel.
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12. Invert the gel over the sink to dump off water and butanol layers. Rinse with
ddH20 wash bottle until butanol smell is gone (4+ times).
13. Wipe off excess H20 and turn clamping frame on its side. Use a kimwipe to wick
the last of the water from the gel.
Making the Stacking Gel:
1. Label a conical tube for the stacking gel and combine chemicals in the order as
follows:
4% Stacking Gel
# of 1.5 mm Mini-Gels
# of 0.75 mm Mini-Gels

1

2

3

4

2

4

6

8

ddH20 (ml)
1.86
3.72
5.58
7.44
0.5 M Stacking Gel (ml)
0.75 (750 µl) 1.5
2.25
3
Acrylamide (37.5%
0.3 (300 µl)
0.6 (600 µl) 0.9 (900 µl) 1.2
acryl:1%bis-acryl) (ml)
10% SDS (ml)
0.03 (30 µl)
0.06 (60 µl) 0.09 (90 µl) 1.2
APS and TEMED start the solidification process…add them last and be ready!
10% APS
0.03 (30 µl)
0.06 (60 µl) 0.09 (90 µl) 0.12 (120 µl)
10% TEMED
0.03 (30 µl)
0.06 (60 µl) 0.09 (90 µl) 0.12 (120 µl)
2. Vortex the conical tube briefly.
3. Use a 1000 µl pipet to add the stacking gel on top of the running gel. Pipet
carefully but quickly (especially for 0.75 mm gels). Try not to make any bubbles.
If necessary, gel can be added from both sides for equal distribution.
4. Fill gel to the top of the short plate.
5. Leave the remainder of the gel and pipet tip in the conical tube
6. Locate the gel comb of the appropriate size and well formation.
7. Wearing safety glasses, cover the front (side with the text) of the gel comb with a
kimwipe to prevent splashing. Insert the comb straight down into the space
between the glass plates.
8. Allow to harden for 60 minutes at room temperature.
9. After the gel has hardened, proceed to run the SDS-PAGE gel or…
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Prepare the gel for storage:
a. Lay a square of saran wrap on the benchtop.
b. Lay a paper towel flat overtop the saran wrap, leaving a few inches of
saran wrap around the edges.
c. Squirt 1x TBST on the paper towel until it is saturated.
d. Put the gel (still in plates with comb inserted) flat on the paper towel.
Wrap it up in the paper towel and saran wrap.
e. Store at 4˚C.
f. Gels can be stored for up to two weeks. Check occasionally to make sure
the paper towel is still moist.
Composition of 4X stacking buffer (0.5 M Tris Base):
Ingredient

Amount needed per liter

Tris Base

60.5g

ddH2O

850 mL

6 or 10 N HCl to adjust to pH = 6.8
ddH2O

to bring volume up to 1 L

Store at 4 ˚C.

Composition of 4X running buffer (1.5 M Tris Base):
Ingredient

Amount needed per liter

1.5 M Tris base 181.65 g/L
ddH2O

750 mL

6 or 10 N HCl

to adjust to pH = 8.8

ddH2O

to bring volume up to 1 L

Store at 4 ˚C.
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Polyacrylamide Gradient Gel Casting Protocol
Materials Needed:
• Mini-gel glass plates
o One 1.5 mm spacer plate per gel
o One short plate per gel
• Casting stand (clear plastic)
• Casting frame (green plastic clamp)
• Gel comb (1.5 mm)
• Stir plate
• Two small stir bars
• Empty syringe
Chemicals Needed:
• 70-100% ethanol
• ddH20
• Ammonium persulfate
• TEMED
• 40% Acrylamide for (stored at 4˚C)
o 37.5% acrylamide, 1% bisacrylamide
• 4X running buffer (1.5 M, stored at 4˚C)
• 4X stacking buffer (0.5M, stored at 4˚C)
• 10% SDS
• Water saturated butanol (80% butanol)
• 1x TBST (if storing gels)

•
•
•
•
•
•

Microcentrifuge tubes
10-1000 µl Pipets
50 ml conical tubes
Kimwipes
Saran wrap and paper towels
(if storing gels)
15 mL Gradient Mixer and
tubing (clear plastic square
with 2 chambers)

Safety Equipment Needed:
• Lab coat
• Gloves
• Safety glasses
Acrylamide is a carcinogen! Wear
PPE when working with it.
Acrylamide or any items that
contact acrylamide (gloves,
pipets, tubes, etc.) should be
disposed of in hazardous waste
container.

Equipment Preparation
1. Clean spacer and short plates by scrubbing with soap, being careful not to
scratch them, until the water runs off cleanly as a sheet (no water droplets left
on the plate).
2. Wipe both plates with 70-100% ethanol and a kimwipe. Let dry.
3. Wipe the gasket (grey foam rubber rectangle) down with 70-100% ethanol on a
kimwipe.
4. Place a clean gasket down on the bottom of the casting stand within the
grooves.
5. Place the short plate on top of the spacer plate.
6. Slide the two plates into the casting frame, keeping the short plate facing to the
front (where the clamp flaps are).
7. Lock the clamp to secure the plates together. Run your finger along the bottom
of the two plates to ensure that their bases are even.
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8. Place the clamped plates on the gasket and clamp them into place on the
casting stand.
9. Sit stir plate on high area above benchtop.
10. Sit the casting stand on the benchtop.
11. Add a tiny stir bar to each chamber of the gradient mixer.
12. Make sure both valves on gradient mixer are in the closed position (upright)
Making the Running Gel:
1. Make 10% ammonium persulfate fresh in a microcentrifuge tube.
a. For 2 gels, weigh 30 mg (0.03 g) APS into tared microcentrifuge tube. Add
300 µl ddH20. Vortex.
2. Determine what % light and heavy gels you want to combine.
3. Label a conical tube for the light gel and another for the heavy gel. Mix chemicals
in the conical tubes using the amounts below:
Gradient Running Gel Ingredients (for two 1.5mm gels)
Gel %
4%
ddH20 (ml)
40% Acrylamide
(37.5% acryl:1%bis-acryl) (ml)
1.5 M Tris (pH 8.8) (ml)
10% SDS (ml)
Total Volume (ml)

10%

15%

20%

6.3
1.0

4.8
2.5

3.55
3.75

2.3
5.0

2.5
0.1 (100
µl)
10

2.5
0.1 (100 µl)

2.5
0.1 (100 µl)

2.5
0.1 (100 µl)

10

10

10

4. Once all ingredients have been added, vortex very briefly.
5. Pipet 5 ml of the light solution into the back gradient mixer chamber (furthest
from the tubing attachment).
6. Pipet 5 ml of the heavy solution into the front gradient mixer chamber (closest to
the tubing attachment).
7. Add 50 ul of 10% APS to each chamber. The gel will begin to polymerize at this
point.
8. Add 3 ul of straight TEMED into each chamber.
9. Sit gradient mixer on top of stir plate.
10. Put a 200 ul yellow pipet tip on the end of the tubing.
11. Insert pipet tip end into space between glass plates to fill the gel.
12. Open back chamber valve first, then open the front chamber valve.
13. Gravity should pull polyacrylamide solution down to the pipet tip to fill the gel.
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14. Fill by positioning the pipet tip in the center of the plate, not on the sides.
15. Once the gel has all run out, disconnect the end of the tubing and flush excess
solution out with an empty syringe (and into gel plates, if more solution is
needed).
16. Gel should fill up to top of green clamp flaps (1 cm from top of short plate).
17. Flush tubing and gradient mixer with double distilled water immediately after
use.
18. Add 1 ml of 80% butanol to top of gel.
19. Repeat steps 5-18 if a second gel is needed.
20. Leave the gel to harden for at least 60 minutes. Moving the casting frame should
not move the gel.
Making the Stacking Gel:
Stacking Gel Ingredients (for two 1.5mm gels)
ddH20 (ml)
3.72
4x Stacking Buffer (0.5 M Tris) (ml)
1.5
40% Acrylamide
0.6 (600 µl
(37.5% acryl:1%bis-acryl) (ml)
10% SDS (ml)
0.06 (60 µl)
Total Volume (ml)
6
1. Vortex stacking gel ingredients well.
2. Pipet 3 ml of stacking solution into another tube.
3. Make 100 µl 10% TEMED by combining 10 µl TEMED with 90 µl ddH20 in a
microcentrifuge tube.
4. Add 30 µl 10% APS and 30 µl 10% TEMED to one of the 3 ml tubes. Vortex very
briefly.
5. Vortex the conical tube briefly.
6. Use a 1000 µl pipet to add the stacking gel on top of the running gel. Pipet
carefully but quickly (especially for 0.75 mm gels). Try not to make any bubbles.
If necessary, gel can be added from both sides for equal distribution.
7. Fill gel to the top of the short plate.
8. Leave the remainder of the gel and pipet tip in the conical tube
9. Locate the gel comb of the appropriate size and well formation.
10. Wearing safety glasses, cover the front (side with the text) of the gel comb with a
kimwipe to prevent splashing. Insert the comb straight down into the space
between the glass plates.
11. Allow to polymerize for 60 minutes at room temperature.
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12. After the gel has polymerized, proceed to run the SDS-PAGE gel or…
Prepare the gel for storage:
a. Lay a square of saran wrap on the benchtop.
b. Lay a paper towel flat overtop the saran wrap, leaving a few inches of
saran wrap around the edges.
c. Squirt 1x TBST on the paper towel until it is saturated.
d. Put the gel (still in plates with comb inserted) flat on the paper towel.
Wrap it up in the paper towel and saran wrap.
e. Store at 4˚C.
f. Gels can be stored for up to two weeks. Check occasionally to make sure
the paper towel is still moist.
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Running an SDS-PAGE Gel Protocol
Materials Needed:
• Vortex
• Eppendorf tubes
• Heat block
• Electrophoresis Tank
• Tank Lid
• Green and white electrode clamp
• Previously made gel
Chemicals Needed:
• Samples and 5x Laemmli buffer
• Molecular weight standards
• Prestained molecular weight ladder
(optional)
• 1x TBST (optional)
• Unused 1x electrophoresis buffer
• Used 1x electrophoresis buffer

•
•
•
•
•
•
•

Buffer dam (if only 1 gel)
Centrifuge
Small volume pipets
Gel loading pipet tips
Kimwipes
PowerPac HC
Gel releaser tool or scalpel

Safety Equipment Needed:
• Lab coat
• Gloves
Acrylamide is a carcinogen! Wear
PPE when working with it.
Dispose of in hazardous waste
container.

Sample Preparation:
1. Turn on the heat block to 95 ˚C. It will take about an hour to heat up. Put a
microcentrifuge tube rack in the freezer to chill.
2. Calculate amount of samples and laemmli buffer to load using 5x Laemmli buffer
calculator (excel file). Use concentrations determined previously by BCA kit when
inputting concentrations into sheet. Type in desired µg protein per well, and final
loading volumes should be calculated. 40 µl is the maximum loading volume for
a 15-well 1.5 mm gel.
3. Fill out Gel Loading Plan sheet for appropriate well type (1, 10, 15 wells).
4. When heat block is almost ready, remove samples and 5x Laemmli buffer (if not
already combined) from freezer and allow to thaw.
5. If sample is not already diluted in 5x Laemmli buffer:
a. In eppendorf tubes, combine sample and 5x Laemmli buffer to make
required loading volume. Use 4 parts sample, 1 part Laemmli buffer.
Account for a few extra microliters to make pipetting easier.
b. Aliquot and freeze (-20 ˚C) any excess Laemmli-diluted sample.
6. Start thawing standards.
7. Vortex samples and standards.
8. Heat samples (but not standards if they have already been heated previously) in
heat block for 5 minutes at 95 ˚C. This helps to unfold the protein.
9. Put samples and standards in chilled microcentrifuge rack while waiting to use.
Tank Preparation:
10. Remove gel from fridge and slowly remove comb. If afraid of tearing the wells,
squirt 1x TBST in to lubricate.
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11. Begin preparing the tank.
a. Put gels in the green and white electrode clamp. Make sure spacer plates
are facing the outside of the clamp. If only running one gel, use a buffer
dam on the other side with the writing towards the inside of the clamp.
Pull green clamps up to secure.
b. Put electrode/gel assembly into tank, matching the red side of assembly
to red side of tank.
c. Check to make sure tank lid fits on electrodes correctly, matching red to
red.
12. Centrifuge samples in gray buckets at 1000xg for 1 minute to make them easier
to pipet.
13. Fill chamber of electrode/gel assembly with unused 1x electrophoresis buffer to
the top. Check for leakage.
14. Fill outside of the tank with new or used 1x electrophoresis buffer (halfway for 2
gels, fully for 4 gels). If there was leakage from inner chamber, fill the tank up the
entire way.
15. Find Gel Loading Plan Sheet that was previously filled out.
16. Using gel loading pipet tips, load amount of Laemmli-diluted standard/sample
into each of the designated wells, without puncturing the gel with the tip or
leaking the sample outside of the well.
a. Hint: Wipe tip on kimwipe before loading to get excess sample from
outside of tip.
b. Hint: Pull tip up a little when pipetting in last little bit so that the bubble
doesn’t force sample out of the well.
Running the Gel:
17. Plug PowerPac HC into electrical outlet.
18. Put lid on tank, matching red electrode to red plug.
19. Turn on PowerPac using black button on side.
20. Plug lid in to PowerPac, matching red plug to red socket.
21. Set voltage to 100V.
22. Press start (running man picture). Bubbles should be moving within the chamber.
23. Run for 15-30 minutes at 100V. The blue color should leave the wells. The
stacking gel should help “stack” the proteins, and the dye should flatten in
shape.
24. Increase voltage to 180V. Run at 180V until the blue color just comes off the
bottom of the plate, then press stop. This should take around 30-40 minutes.
a. The dye is smaller than the proteins, so they should remain on the gel.
b. The length of the run will affect where particular proteins end up on the
gel.
c. Pre-stained standards can help you to time run appropriately for
particular proteins if you know their size.
25. Push the black power button on the side of the PowerPac.
26. Unplug and remove lid.
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27. In sink, pour used electrophoresis buffer into the used buffer container to save
for future runs.
28. Unclamp gel and plates from electrode assembly.
29. Use green gel releaser or scalpel to carefully pry up short plate, leaving gel on
spacer plate.
30. Cut off stacking gel (there is a line where the stacking and running gels meet) and
put gel waste into hazardous acrylamide waste container.
31. Proceed to appropriate protocol (western blot, coomassie, silver stain).
Composition of 1X Electrophoresis buffer:
Ingredient Amount needed per liter

4L

Tris base

3.0285 g/L

12.114 g

Glycine

14.4135 g/L

57.654 g

SDS

1 g/L

4g

ddH2O

to bring volume up to 1 L to bring volume up to 4 L

**pH should be between 8.3 and 8.5, but in the event that it is not, new buffer must
be made (cannot “adjust” pH). Also a 10X running buffer can be made (multiply all
values in the table above by 10) and then before using add 100 mL of 10X running
buffer to 900 mL of ddH2O.

Composition of 5x Laemmli buffer:
Ingredient

Amount needed per 20 ml

1.5 M Tris-HCl pH 6.8

4 ml

Glycerol

10 ml

SDS

2g

Β-mercaptoethanol

5 ml

1% bromophenol blue 1 ml
*PREPARE SOLUTION IN HOOD*
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Directions:
1) Add 1 ml of 1% bromophenol blue to 4 ml of 1.5 M Tris-Cl pH 6.8.
2) Add 10ml of glycerol and mix.
3) Add 2 g of SDS and mix (the SDS will take a few minutes to dissolve).
4) Add 5 ml of β-mercaptoethanol and mix.
5) Aliquot and store at -20°C.
(Protocol by Joseph T.E. Roland http://www.cytographica.com/lab/solutions/5XSB.htm)
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Western Blotting Protocol
Materials Needed:
• Pre-run gel
• Polyvinylidene fluoride (PVDF)
membrane
• 2 pieces Whatman blotting paper (per
gel)
• Scissors
• Slide staining boxes
• Blunt end tweezers
• Orbital rocker
• Gel releaser (green wedge)
• 1000-2000mL volumetric flask
• Stir bar
• Conical Tubes
• Multiscreen apparatus (for 2-D/Prep
gels)
• Vacuum flask (for 2-D/Prep gels)
• Microcentrifuge tube
• ½” binder
• Vari-mix platform rocker
Chemicals Needed:
• 100% methanol
• 1x transfer buffer (chilled and made the
day of)
• 10x transfer buffer
• 0.1% India Ink

•
•
•
•
•
•
•
•
•
•
•
•

Rubbermaid transfer
container
Tupperware box for methanol
Tupperware box for chilled 1x
transfer buffer
Tupperware box for used 1x
transfer buffer
Gel holder cassette (clear and
black with holes)
2 Sponges (per gel)
Electrode module (black and
red with electrodes)
Ice pack
Buffer tank
Buffer tank lid
Flattener roller (roller with
handle or pipet)
Filter paper

Safety Equipment Needed:
• Gloves
• Lab coat
• Hazardous acrylamide waste
bin

Preparation:
1. Run proteins in gel as specified in the “Running an SDS-PAGE gel” protocol.
2. While running the gel, make fresh 1x transfer buffer and chill at 4˚C
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1x Transfer Buffer
Ingredient
10x Transfer Buffer
(see end of protocol for instructions)
Methanol
ddH20

Amount needed for
1 liter (1-2 gels)
100 mL

Amount needed for 2
liters (3-4 gels)
200 mL

200 mL
~700 mL (bring to
volume)

400 mL
~1400 mL

3. Activate the membrane:
a. Cut a piece of PVDF membrane with a notch in the top left corner.
b. Fill a small tupperware box with 100% methanol. Use tweezers to grasp a
corner of the membrane and submerge the membrane in the methanol.
Make sure membrane is completely saturated and remains in methanol
for no more than 15 seconds.
c. Transfer the membrane to another Tupperware box with fresh chilled 1x
transfer buffer. Put on the orbital rocker for 5 minutes.
4. Remove and equilibrate gel:
a. Pour used 1x transfer buffer into another Tupperware box.
b. Carefully and slowly use gel releaser to pry open glass plates surrounding
gel. If the gel sticks to the short plate, submerge the gel and plates in the
1x transfer buffer box until the short plate can be removed.
c. Cut off the stacking gel and put the stacking gel in the hazardous
acrylamide waste bin.
d. Cut a very small portion of the gel’s top right corner off (where the
standard was).
e. For 1.5 mm gels, carefully pick up gel with gloves and place in the
Tupperware box with 1x used transfer buffer to equilibrate.
f. For 0.75 mm gels, submerge the spacer plate and gel in the used 1x
transfer buffer until the gel loosens from the plate. These gels rip very
easily!
g. Put Tupperware containing gel on orbital rocker on low for 5 minutes.
This will remove salts that could generate heat during transfer.
5. Make the transfer sandwich:
a. Fill the large Rubbermaid transfer container with enough used (or new)
1X transfer buffer to submerge the gel holder cassette.
b. Place the gel holder cassette into the 1x transfer buffer in the open
position.
c. Get the sponges completely wet and push out all potential air bubbles by
rolling with the flattener. Bubbles will appear as white spots on the
sponge. Keep sponges immersed in the 1x transfer buffer.
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d. Align one sponge on the black side of the gel cassette holder.
e. Put one piece of Whatman blotting paper on top of the sponge and apply
gentle pressure to keep it wet and prevent any bubbles from forming
between the sponge and the paper.
f. Transfer the gel to the top of the Whatman blotting paper by gently
picking up the gel at the corners. Make sure there are no bubbles.
g. Place the activated PVDF membrane on top of the gel. Line up the notch
on the PVDF membrane with the notch on the gel (top right).
h. Apply the second piece of Whatman blotting paper on top of the PVDF
membrane, ensuring there are no air bubbles.
i. Place the second sponge on top of the Whatman blotting paper. Push out
any more bubbles.
j. Clamp the gel cassette holder to secure.

6. Set up the buffer tank and run the transfer:
a. Put the black and red electrode module in the buffer tank, matching red
to red and black to black.
b. Insert a plastic ice pack into the buffer tank.
c. Put 500mL of new pre-chilled 1x transfer buffer in the buffer tank.
d. Put the gel cassette in the electrode module, white clamp facing up. 2 gel
cassettes can fit in one electrode module.
e. Add more pre-chilled 1x transfer buffer if necessary, to bring solution in
tank up to the “blotting” line.
f. Put buffer tank lid on buffer tank (red-to-red, black-to-black).
g. Plug buffer tank lid cord into Powerpac.
h. Set Powerpac to run at 300 milliamps for 1 hour (may need to adjust run
time for certain proteins). 300 milliamps= 0.3 amps.
i. Should see small bubbles floating up from hole in
electrode module.
i. After one hour, pause, then stop the Powerpac. Remove lid.
7. Wash and stain the membrane:
a. Remove the gel cassette sandwich from the buffer tank, squeezing out as
much buffer as possible.
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b. Place the gel cassette sandwich into the empty Rubbermaid transfer
container. Put the black side on the bottom and open the clamp.
c. Carefully peel the top filter paper from the membrane. Note where the
gel is underneath the membrane. If the membrane is larger than the gel
and appears too large to fit in a glass slide staining box, carefully cut
some of the excess membrane from the sides (do NOT cut off any
membrane that was touching the gel).
d. Carefully peel the membrane off the gel using tweezers. Place the
membrane protein side up (notch should now be in top left corner) in a
glass slide staining box. Always keep membrane moist.
e. Wash in 1x TBST twice for 5 minutes each time on the rocker.
f. After pouring out second wash, keep the slide box rocking and pour 5-10
ml 0.1% India Ink into the box. Keep membrane rocking while pouring to
avoid making swirl patterns on membrane.
i. To make 50 ml 0.1% India Ink, add 50 µl India Ink to 50 mL
1x TBST.
g. Stain on rocker in 0.1% India Ink for 15-20 minutes. Standards should
start to appear after about 5 minutes.
h. Pour out 0.1% India Ink solution.
i. Wash membrane 4 times with 1x TBST on a rocker for 5 minutes each
time.
j. Determine whether you want to continue with the procedure or dry and
store the blots. For overnight primary antibody incubations, continue
with blocking. For short primary antibody incubations, dry and store the
blot. Dried, refrigerated blots should last at least 2 weeks.
8. To dry:
a. Remove membrane protein side up and lay on a piece of filter paper or
paper towel.
b. Let membrane air dry for at least 20 minutes, moving it to a dry spot
several times.
c. Place membrane within the folds of a kimwipe, then put in a labeled
plastic baggie and seal.
d. Store at 4 ˚C for up to 2 weeks. Make sure membrane doesn’t get bent or
creased while storing.
9. To remove stored blots:
a. Remove membrane from kimwipe and let sit on benchtop at room
temperature for 10 minutes to equilibrate.
b. Put 1x TBST in a glass slide box. Sit membrane on top of the liquid and let
it slowly soak in.
c. Rock in 1x TBST for 10 minutes to equilibrate. Proceed to blocking.
10. Block the membrane:
a. Calculate amount of blocking buffer (5% w/v non-fat dry milk in 1x TBST)
needed.
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i. 10 mL solution (made with 0.5g milk powder, 1x TBST to
volume) per membrane. Vortex well in conical tube.
b. Discard the 1x TBST from the slide box.
c. Add blocking buffer and block the membrane for 1 hour at room
temperature with the slide box on the rocker.
i. While blocking, do calculations and make samples as directed
in Primary Antibody Incubation section.
d. Wash the membrane 3 times in 1x TBST on a rocker for 5 minutes each time.
e. Primary antibody incubation:
f. Follow the appropriate protocol for your gel/membrane type.
i. Determine if you need to use the multiscreen apparatus (for
2-D/prep gels containing standards in one lane, and then the
same protein across the gel in a second long lane).
For 10 or 15-well membranes:
a. Make 5 mL of blocking solution.
i. 0.25g non-fat dry milk
ii. 1x TBST to volume
iii. Serum for primary antibody.
1. Dilution of 1/1250 for adult horse serum samples and
post-suckle samples.
a. 4 µl serum per 5 ml blocking solution.
2. Dilution of 1/500 for older serum samples.
a. 20 µl serum per 5 ml blocking solution.
iv. Vortex and add solution to slide staining box. Rock overnight at
4˚C.
For 2-D/prep membranes:
a. Make sure the multiscreen is clean. It should be cleaned with ddH20 and Contrex
and dried before use. Do not use >50% ethanol to clean it or it will degrade the
plastic.
b. Sample prep:
i. Make 250 µl of each 1˚ antibody per lane.
ii. Determine how many lanes you want to add 1˚ antibody to and
multiply by 0.25 (representing the 250 µl per well) to get total ml
blocking buffer needed. Round up.
1. The MW standard will take up lanes 1 and 2 on the multiscreen, so you don’t need to add 1˚ antibody to these
lanes. Leave lane 20 blank because it will probably not
contain protein.This leaves 17 possible sample lanes.
iii. Multiply total ml blocking buffer by 0.05 (representing 5% milk) to
get grams of milk needed.
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iv. Add milk to conical tube and vortex. Aliquot 250 µl per
microcentrifuge tube for each sample.
v. Pipet 1˚ antibody (serum) into each microcentrifuge tube,
expelling and drawing the buffer in to the pipet several times to
get all serum out.
1. Dilution of 1/1250 for recently collected serum samples.
a. 0.2 µl per 250 µl lane.
2. Dilution of 1/500 for old serum samples.
a. 0.5 µl per 250 µl lane.
11. Assemble multiscreen apparatus:
a. Remove blot from slide box using tweezers on one edge.
b. Pick up the plastic piece containing the lanes and position the membrane
face-down on the BACK side of this piece. You should see the protein side
when looking from the front.
c. You should still be able to see the standards at the left. Make sure they are in
lanes 1 or 2. Check to make sure protein bands in the large well run across all
of the lanes that you plan to use. Place this plastic piece on the gasket, lining
up the pegs and screws.
d. By hand, tighten the screws in the pattern below and tighten well:

a. Sit the apparatus on a ½ inch binder so that the top of the apparatus is slightly
higher than the bottom.
b. Pipet 250 µl of each sample into the pre-designated lanes.
i. Tips:
1. Check tightness and keep membrane moist by pipetting 1x
TBST in the standard lanes. Make sure there is no leakage
before pipetting any primary antibodies.
2. Pipet 1˚ antibody solution out from the tube slowly and
smoothly to avoid bubbles.
3. Place the pipet tip into the hole on the bottom of the lane
and slowly eject the 1˚ antibody solution.
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c. Carefully place the multiscreen on the Vari-Mix
platform rocker, positioned so that solution will
run up and down the lanes. The Vari-Mix rocker
should be set on angle 18.
12. Wash the membrane after 1˚ antibody
incubation:
a. Remove 1˚ antibody solution.
i. For 10 or 15 well
membranes, pour it out.
ii. For 2-d/Prep membranes,
use a vacuum flask with
tubing cut straight across on
the vacuum end. Put vacuum flask tubing overtop of lane
holes to remove the liquid.
b. Wash membrane with 1x TBST for 5 minutes each time.
i. For 10-15 well membranes
1. Perform this step 6 times on the orbital rocker
ii. For 2-D/Prep gels
1. Pipet 250 µl 1x TBST into each lane in the manner
described earlier.
2. Rock on the Vari-Mix for 5 minutes each wash. Remove
using vacuum suction after each wash. Wash in this
manner at least 3 times if all lanes receive the same
secondary antibody. If lanes receive different
secondary antibody, you will need to wash at least 6
times in the multiscreen.
3. If all lanes will receive the same secondary antibody,
unscrew the top part of the apparatus, remove
membrane, place it protein side up in a glass slide box,
and wash at least 4 more times on the orbital rocker.
c. This step is very important to remove the 1˚ antibody so that nothing other
than antigen-bound antibody will react with the 2˚ antibody.
13. Incubate in 2˚ antibody solution:
a. Prepare blocking buffer. For one membrane, use at least 10 ml blocking
buffer solution.
b. To make 20 ml blocking buffer, add the following to a conical tube and vortex
well:
i. 1.0 g non-fat dry milk
ii. 1x TBST to 20 ml volume
iii. 0.2 µl Strep-HRP (for binding to standards).
c. Determine which secondary antibody you need to use, depending on the
animal species that the primary antibody was produced in.
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i. Anti-rabbit IgG
1. 1/5,000 dilution (which is really 1/10,000 due to the
mixing procedure when glycerol was added).
2. Add 4 µl per 20,000 µl blocking buffer in the conical
tube. Vortex.
ii. Anti-horse IgG(T)
1. 1/100,000 dilution for fresh samples
a. Add 0.2 µl per 20,000 µl blocking buffer in the
conical tube. Vortex.
2. 1/50,000 dilution for old control sera
a. Add 0.4 µl per 20,000 µl blocking buffer in the
conical tube. Vortex.
iii. Anti-horse IgE or IgM
1. 1/1,000 dilution
a. Add 20 µl per 20,000 µl blocking buffer in the
conical tube. Vortex.
d. If doing same secondary antibodies for all samples:
i. Pour into glass slide box after 1x TBST is poured out and cover.
Rock on orbital rocker for 1 hour at room temperature.
e. If doing different secondary antibodies for all samples:
i. Pipet 250 µl into each lane after removing 1x TBST. Rock on
Vari-Mix rocker for 1 hour at room temperature.
f. While samples incubate, remove ECL prime from fridge. Per membrane,
pipet 0.5 ml of solution A into one conical tube, and 0.5 ml of solution B into
another. Let sit at room temperature, with tube A covered by aluminum foil
or another object to protect from light exposure.
14. Wash and prepare for exposure:
a. If doing same secondary antibodies for all samples:
i. Pour out secondary antibody solution and rinse several times
with 1x TBST.
ii. Wash using 1x TBST on orbital rocker 6 times.
b. If doing different secondary antibodies for all samples:
1. Pipet 250 µl 1x TBST into each lane in the manner
described earlier.
2. Rock on the Vari-Mix for 5 minutes each wash. Remove
using vacuum suction after each wash. Wash in this
manner at least 3 times.
3. Remove membrane, place it protein side up in a glass
slide box, and wash at least 4 more times on the orbital
rocker.
c. Cut a non-glare sheet protector into 6 pieces.
d. Put gloves, ECL tubes, an extra microcentrifuge tube, slide protectors, filter
paper, and slide boxes containing membranes in a box for transport to Gluck.
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15. Expose using FlourChemE in Gluck (Howe Lab 430):
a. Add ECL.
i. Remove membrane from 1xTBST and let corner drip onto
kimwipe.
ii. Lay membrane protein side up on a piece of filter paper. Using
a cut piece of filter paper, gently dab the top of the membrane
(don’t smear) to dry it.
iii. Insert membrane into the sheet protector piece.
iv. Mix 0.5 ml of ECL Prime A solution and 0.5 ml B solution in a
microcentrifuge tube.
v. Pipet 1 ml of solution on to the membrane. Cover with the top
plastic piece and push out any bubbles.
vi. Let sit for 5 minutes.
b. Set up machine and expose.
i. Open door and pull out sliding platform.
ii. Remove clear plate and put black plate in for
chemiluminescent blotting.
iii. Center blot on black plate.
iv. Use stylus to select “Chemiluminescence,” and adjust setting if
necessary (or set on auto).
v. Select “Expose.”
vi. After exposure, select the invert logo (black and white boxes)
to change from white bands to black bands.
vii. Select the logo with the four boxes. Select the best looking
exposure.
viii. Edit the blot image by entering username, editing the project
title or description, and selecting “Print.”
ix. Insert flash drive on top or side of machine and select “Copy.”
1. To find photos again, select “Images” and search for
your username.
x. To restart with a new blot, select “Darkroom.”
xi. When finished…
1. Make an entry into the log stating how many prints
you made.
2. Replace clear plate on the platform and put black plate
back into it’s bag.
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Chemical solutions that can be made prior and stored:
10x Transfer Buffer
Ingredient
Tris Base
Glycine
ddH20

Amount needed per liter
30.3 g
144.13 g
Bring to volume

10x TBS buffer
Ingredient
Tris Base
NaCl
HCl
ddH20

Amount needed per liter
24.2 g
80.0 g
To adjust pH to 7.6
Bring to volume

1x TBST buffer
Ingredient
10x TBS Buffer
Tween-20
ddH20

Amount needed per liter
100 ml
1 ml
Bring to volume
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